[{"text":"RT @MHRAmedicines: Company-led drug recalls: Company-led drug recall: Soliris (eculizumab) 300mg Concentrate for Solution for Inf... http:/…","id":"478921125884596225","created_at":"2014-06-17T15:24:29.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478921125884596225","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478911073223835648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @openFDA: Interested in using #openFDA data in Microsoft Excel? Check out the great video tutorial located here: https://t.co/ssSKm8PtXh","id":"478920654952345600","created_at":"2014-06-17T15:22:36.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"openFDA","id":"2227519598"}],"urls":[{"start":116,"end":139,"url":"https://t.co/ssSKm8PtXh","expanded_url":"https://www.youtube.com/watch?v=N-FhPq_0N0M","display_url":"youtube.com/watch?v=N-FhPq…"}],"annotations":[{"start":50,"end":64,"probability":0.8797,"type":"Product","normalized_text":"Microsoft Excel"}],"hashtags":[{"start":33,"end":41,"tag":"openFDA"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478920654952345600","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478906491848503296"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: 68th plenary meeting of the Scientific Committee – open to observers. Register here: http://t.co/uT3wIkWnHv","id":"478920277066539008","created_at":"2014-06-17T15:21:06.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":98,"end":120,"url":"http://t.co/uT3wIkWnHv","expanded_url":"http://bit.ly/1lyGAO5","display_url":"bit.ly/1lyGAO5"}],"annotations":[{"start":41,"end":60,"probability":0.8178,"type":"Organization","normalized_text":"Scientific Committee"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478920277066539008","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478899876508741634"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've released a reflection paper on patient-reported outcomes in #cancer studies for public #consultation: http://t.co/5DHIeJ5Asa","id":"478899595549089792","created_at":"2014-06-17T13:58:55.000Z","entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/5DHIeJ5Asa","expanded_url":"http://bit.ly/1qomEAO","display_url":"bit.ly/1qomEAO"}],"annotations":{},"hashtags":[{"start":66,"end":73,"tag":"cancer"},{"start":93,"end":106,"tag":"consultation"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"478899595549089792","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: PREZI on IMI Achievements @IMI_JU http://t.co/Tj8jbsKQR1","id":"478898288859832320","created_at":"2014-06-17T13:53:44.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":37,"end":44,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":45,"end":67,"url":"http://t.co/Tj8jbsKQR1","expanded_url":"http://bit.ly/1lx5Srq","display_url":"bit.ly/1lx5Srq"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478898288859832320","source":"TweetDeck","lang":"ht","referenced_tweets":[{"type":"retweeted","id":"478892469300781058"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Report on therapeutic positioning of pertuzumab (Perjeta ®) http://t.co/eziIllvIx5","id":"478897663371640832","created_at":"2014-06-17T13:51:15.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":74,"end":96,"url":"http://t.co/eziIllvIx5","expanded_url":"http://bit.ly/1iDTy8R","display_url":"bit.ly/1iDTy8R"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"478897663371640832","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Transdermal fentanyl patches: risk of accidental exposure in non-users http://t.co/it68Zscqma","id":"478897444428984320","created_at":"2014-06-17T13:50:22.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":85,"end":107,"url":"http://t.co/it68Zscqma","expanded_url":"http://bit.ly/1i7Ig25","display_url":"bit.ly/1i7Ig25"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478897444428984320","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: The French medicines agency has published an update on the topics dsicussed at the June #PRAC  http://t.co/MjM5mKJYVs","id":"478896675164270592","created_at":"2014-06-17T13:47:19.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":105,"end":127,"url":"http://t.co/MjM5mKJYVs","expanded_url":"http://bit.ly/1iDSYrU","display_url":"bit.ly/1iDSYrU"}],"annotations":{},"hashtags":[{"start":98,"end":103,"tag":"PRAC"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478896675164270592","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Deadline for nominations for @PHEgov National Preparedness and Response Science Board extended to June 29, 2014: http://t.co/…","id":"478896067346706432","created_at":"2014-06-17T13:44:54.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":43,"end":50,"username":"PHEgov","id":"1413194267326046216"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478896067346706432","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478880440854790144"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EAAD_EU: Guidance documents on prevention &amp; control carbapenem-resistant Enterobacteriaceae (CRE) fr various EU countries http://t.co/u…","id":"478895380659449856","created_at":"2014-06-17T13:42:10.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478895380659449856","source":"TweetDeck","lang":"ca","referenced_tweets":[{"type":"retweeted","id":"478876405686870016"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Do you know about Progressive Patient Access &amp; Adaptive Licensing for #raredisease treatments? Learn about it here. http://t.…","id":"478895338066305024","created_at":"2014-06-17T13:42:00.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{},"hashtags":[{"start":88,"end":100,"tag":"raredisease"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478895338066305024","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478874156042579968"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Ladies scientists, don’t hesitate to apply for #EFSApanel renewal. Deadline extended to 7 July. http://t.co/osrcX2XG6R","id":"478895081131622400","created_at":"2014-06-17T13:40:59.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":109,"end":131,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":60,"end":70,"tag":"EFSApanel"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478895081131622400","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478869675754127360"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: ‘Access to the #EuropeanLeadFactory has fast-forwarded our drug discovery programme in oncology by several years’ http://t.co/b…","id":"478893527272009728","created_at":"2014-06-17T13:34:48.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{},"hashtags":[{"start":27,"end":47,"tag":"EuropeanLeadFactory"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478893527272009728","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478849978606317569"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @INFARMED_IP: Voluntary recall of batch of medicine Tantum Verde (benzydamine benzocaine), tablets http://t.co/WB0BCjAk0r","id":"478844059680002048","created_at":"2014-06-17T10:18:14.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":102,"end":124,"url":"http://t.co/WB0BCjAk0r","expanded_url":"http://bit.ly/SPQdge","display_url":"bit.ly/SPQdge"}],"annotations":[{"start":55,"end":66,"probability":0.3202,"type":"Person","normalized_text":"Tantum Verde"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478844059680002048","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Companies: you need to update &amp; complete the information on #medicines submitted to us under #Article57 requirements: http://t.co/jkPGVRn8Ew","id":"478827007535759361","created_at":"2014-06-17T09:10:29.000Z","entities":{"mentions":{},"urls":[{"start":122,"end":144,"url":"http://t.co/jkPGVRn8Ew","expanded_url":"http://bit.ly/SNa0wG","display_url":"bit.ly/SNa0wG"}],"annotations":{},"hashtags":[{"start":64,"end":74,"tag":"medicines"},{"start":97,"end":107,"tag":"Article57"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"478827007535759361","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Entyvio (#vedolizumab), a #medicine for #ulcerative #colitis or #Crohn’s disease: http://t.co/mMcAaGFeDp","id":"478826574603890689","created_at":"2014-06-17T09:08:46.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/mMcAaGFeDp","expanded_url":"http://bit.ly/1kXJiNo","display_url":"bit.ly/1kXJiNo"}],"annotations":{},"hashtags":[{"start":29,"end":37,"tag":"Entyvio"},{"start":39,"end":51,"tag":"vedolizumab"},{"start":56,"end":65,"tag":"medicine"},{"start":70,"end":81,"tag":"ulcerative"},{"start":82,"end":90,"tag":"colitis"},{"start":94,"end":100,"tag":"Crohn"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"478826574603890689","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Jardiance (#empagliflozin), a #medicine for type-2 #diabetes, is available on our website: http://t.co/e2FDUaeiA3","id":"478826046356467712","created_at":"2014-06-17T09:06:40.000Z","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/e2FDUaeiA3","expanded_url":"http://bit.ly/1qUKDFb","display_url":"bit.ly/1qUKDFb"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"Jardiance"},{"start":25,"end":39,"tag":"empagliflozin"},{"start":44,"end":53,"tag":"medicine"},{"start":65,"end":74,"tag":"diabetes"}]},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"478826046356467712","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Anoro (#umeclidinium bromide / #vilanterol), a #medicine for #COPD, is available on our website: http://t.co/Kgk5qw1ot9","id":"478825876508139521","created_at":"2014-06-17T09:05:59.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/Kgk5qw1ot9","expanded_url":"http://bit.ly/1p9jldd","display_url":"bit.ly/1p9jldd"}],"annotations":{},"hashtags":[{"start":13,"end":19,"tag":"Anoro"},{"start":21,"end":34,"tag":"umeclidinium"},{"start":45,"end":56,"tag":"vilanterol"},{"start":61,"end":70,"tag":"medicine"},{"start":75,"end":80,"tag":"COPD"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"478825876508139521","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @nakosbalamotis: #Regulatory info: Companies required to update, complete and improve info quality on  medicines submitted to the #EMA h…","id":"478823771378548736","created_at":"2014-06-17T08:57:37.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":{},"annotations":{},"hashtags":[{"start":20,"end":31,"tag":"Regulatory"},{"start":133,"end":137,"tag":"EMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478823771378548736","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478808799986196480"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: IMI’s #EuropeanLeadFactory proves its potential for #drug #discovery with delivery of first results http://t.co/bGeuRya2Pr","id":"478821834578997248","created_at":"2014-06-17T08:49:56.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":112,"end":134,"url":"http://t.co/bGeuRya2Pr","expanded_url":"http://bit.ly/1kZzHFU","display_url":"bit.ly/1kZzHFU"}],"annotations":{},"hashtags":[{"start":18,"end":38,"tag":"EuropeanLeadFactory"},{"start":64,"end":69,"tag":"drug"},{"start":70,"end":80,"tag":"discovery"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478821834578997248","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478808144286863360"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: #Patients from all over Europe will be today at @Europarl_EN to discuss #EUresearch on #asthma #allergy #COPD Check: http…","id":"478821476393828352","created_at":"2014-06-17T08:48:30.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":66,"end":78,"username":"Europarl_EN","id":"36329597"}],"urls":{},"annotations":[{"start":42,"end":47,"probability":0.9929,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":18,"end":27,"tag":"Patients"},{"start":90,"end":101,"tag":"EUresearch"},{"start":105,"end":112,"tag":"asthma"},{"start":113,"end":121,"tag":"allergy"},{"start":122,"end":127,"tag":"COPD"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478821476393828352","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478802793848143872"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA needs plant #virologists for #EFSApanel on #PlantHealth. http://t.co/osrcX2XG6R","id":"478586218096361472","created_at":"2014-06-16T17:13:40.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":76,"end":98,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":31,"end":43,"tag":"virologists"},{"start":48,"end":58,"tag":"EFSApanel"},{"start":62,"end":74,"tag":"PlantHealth"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478586218096361472","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478567685610295296"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on a recommendation on #pharmacovigilance and signal detection for #veterinary #medicines: http://t.co/94KMDq8Wov","id":"478546528014200832","created_at":"2014-06-16T14:35:57.000Z","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/94KMDq8Wov","expanded_url":"http://bit.ly/SMW0mH","display_url":"bit.ly/SMW0mH"}],"annotations":{},"hashtags":[{"start":49,"end":67,"tag":"pharmacovigilance"},{"start":93,"end":104,"tag":"veterinary"},{"start":105,"end":115,"tag":"medicines"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"478546528014200832","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Want to work at IMI? We’re looking for #HR and #IT managers. Info and deadlines at http://t.co/sB937jBBV2 #vacancies #Brussels","id":"478545008266842112","created_at":"2014-06-16T14:29:55.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":95,"end":117,"url":"http://t.co/sB937jBBV2","expanded_url":"http://bit.ly/IMIjobs","display_url":"bit.ly/IMIjobs"}],"annotations":{},"hashtags":[{"start":51,"end":54,"tag":"HR"},{"start":59,"end":62,"tag":"IT"},{"start":118,"end":128,"tag":"vacancies"},{"start":129,"end":138,"tag":"Brussels"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478545008266842112","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478515567314624512"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Anoro (#umeclidinium bromide/#vilanterol), a #medicine for #COPD: http://t.co/Kgk5qw1ot9","id":"478544089827528704","created_at":"2014-06-16T14:26:16.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/Kgk5qw1ot9","expanded_url":"http://bit.ly/1p9jldd","display_url":"bit.ly/1p9jldd"}],"annotations":{},"hashtags":[{"start":42,"end":48,"tag":"Anoro"},{"start":50,"end":63,"tag":"umeclidinium"},{"start":72,"end":83,"tag":"vilanterol"},{"start":88,"end":97,"tag":"medicine"},{"start":102,"end":107,"tag":"COPD"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478544089827528704","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Jardiance (#empagliflozin), a #medicine for type 2 #diabetes: http://t.co/e2FDUaeiA3","id":"478503138312589312","created_at":"2014-06-16T11:43:32.000Z","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/e2FDUaeiA3","expanded_url":"http://bit.ly/1qUKDFb","display_url":"bit.ly/1qUKDFb"}],"annotations":{},"hashtags":[{"start":42,"end":52,"tag":"Jardiance"},{"start":54,"end":68,"tag":"empagliflozin"},{"start":73,"end":82,"tag":"medicine"},{"start":94,"end":103,"tag":"diabetes"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"478503138312589312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Entyvio (#vedolizumab), a #medicine for ulcerative colitis or Crohn’s disease: http://t.co/mMcAaGFeDp","id":"478502772212760576","created_at":"2014-06-16T11:42:05.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/mMcAaGFeDp","expanded_url":"http://bit.ly/1kXJiNo","display_url":"bit.ly/1kXJiNo"}],"annotations":{},"hashtags":[{"start":29,"end":37,"tag":"Entyvio"},{"start":39,"end":51,"tag":"vedolizumab"},{"start":56,"end":65,"tag":"medicine"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478502772212760576","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Companies are now obliged to update and complete the information on authorised #medicines submitted to us: http://t.co/jkPGVRn8Ew","id":"478497093641076736","created_at":"2014-06-16T11:19:31.000Z","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/jkPGVRn8Ew","expanded_url":"http://bit.ly/SNa0wG","display_url":"bit.ly/SNa0wG"}],"annotations":{},"hashtags":[{"start":79,"end":89,"tag":"medicines"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478497093641076736","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: #EC is looking for experts for #H2020 for the Framework Programme for #Research &amp; #innovation http://t.co/dRmRHN2Ze4 http:/…","id":"478464639916072960","created_at":"2014-06-16T09:10:34.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":114,"end":136,"url":"http://t.co/dRmRHN2Ze4","expanded_url":"http://bit.ly/1d7Qmjs","display_url":"bit.ly/1d7Qmjs"}],"annotations":{},"hashtags":[{"start":16,"end":19,"tag":"EC"},{"start":47,"end":53,"tag":"H2020"},{"start":86,"end":95,"tag":"Research"},{"start":102,"end":113,"tag":"innovation"}]},"public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478464639916072960","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478450838701359104"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ESEndocrinology: EJE Paper: D Maiter and E Delgrange review the challenges in managing giant prolactinomas in EJE http://t.co/nrtUnipoes","id":"478464151241912320","created_at":"2014-06-16T09:08:37.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":118,"end":140,"url":"http://t.co/nrtUnipoes","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0013","display_url":"dx.doi.org/10.1530/EJE-14…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478464151241912320","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"478459784568774656"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks to comment on draft recommendation on pharmacovigilance and signal detection for #veterinary #medicines: http://t.co/94KMDq8Wov","id":"478463001243418624","created_at":"2014-06-16T09:04:03.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/94KMDq8Wov","expanded_url":"http://bit.ly/SMW0mH","display_url":"bit.ly/SMW0mH"}],"annotations":{},"hashtags":[{"start":91,"end":102,"tag":"veterinary"},{"start":103,"end":113,"tag":"medicines"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478463001243418624","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#PRAC started a review to evaluate the cardiovascular risks with systemic #ibuprofen medicines: http://t.co/J1xAObCbQW","id":"478449787881410560","created_at":"2014-06-16T08:11:33.000Z","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/J1xAObCbQW","expanded_url":"http://bit.ly/1oXj0vQ","display_url":"bit.ly/1oXj0vQ"}],"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":74,"end":84,"tag":"ibuprofen"}]},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"478449787881410560","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"On Friday we published the #PRAC meeting highlights: http://t.co/dXrxH1YiGY","id":"478449106550267904","created_at":"2014-06-16T08:08:50.000Z","entities":{"mentions":{},"urls":[{"start":53,"end":75,"url":"http://t.co/dXrxH1YiGY","expanded_url":"http://bit.ly/1lp4kEt","display_url":"bit.ly/1lp4kEt"}],"annotations":{},"hashtags":[{"start":27,"end":32,"tag":"PRAC"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"478449106550267904","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: Increased transparency requirements for involvement of PCOs &amp; healthcare professionals in EMA's activities http://t.co/VEWVM…","id":"477495247099138048","created_at":"2014-06-13T16:58:33.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477495247099138048","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477494647271727104"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: EMA's Board to adopt in the upcoming weeks a slightly revised policy on publication of clinical trial data http://t.co/VEWVM…","id":"477491280399052800","created_at":"2014-06-13T16:42:47.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477491280399052800","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477489905053220864"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @sanidadgob: #CMin Government regulates authorisation of advanced-therapy medicines not manufactured industrially http://t.co/VL0YjDhUBr","id":"477491127726383104","created_at":"2014-06-13T16:42:10.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"urls":[{"start":117,"end":139,"url":"http://t.co/VL0YjDhUBr","expanded_url":"http://bit.ly/1kw8o0S","display_url":"bit.ly/1kw8o0S"}],"annotations":{},"hashtags":[{"start":16,"end":21,"tag":"CMin"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477491127726383104","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Publication of the Monthly Bulletin from the Spanish medicines agency for May 2014 http://t.co/nHOEaEpR2B","id":"477486578471030784","created_at":"2014-06-13T16:24:06.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":97,"end":119,"url":"http://t.co/nHOEaEpR2B","expanded_url":"http://bit.ly/1lt8WJE","display_url":"bit.ly/1lt8WJE"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477486578471030784","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Government regulates authorisation of advanced-therapy medicines that aren't manufactured industrially http://t.co/zUIKMFBgGg","id":"477486328813473792","created_at":"2014-06-13T16:23:06.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":117,"end":139,"url":"http://t.co/zUIKMFBgGg","expanded_url":"http://bit.ly/1kw3GAi","display_url":"bit.ly/1kw3GAi"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477486328813473792","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EMCDDA: Also published today, 'A year in review: Highlights from the EMCDDA’s General Report of Activities 2013': http://t.co/jnaUF2GLSh","id":"477476304607272960","created_at":"2014-06-13T15:43:16.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":118,"end":140,"url":"http://t.co/jnaUF2GLSh","expanded_url":"http://www.emcdda.europa.eu/publications/gra/2013-highlights","display_url":"emcdda.europa.eu/publications/g…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477476304607272960","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477474008720764928"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EMCDDA: Just published our General report of activities 2013: http://t.co/wWPTU1uK7u","id":"477476253461938176","created_at":"2014-06-13T15:43:04.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":66,"end":88,"url":"http://t.co/wWPTU1uK7u","expanded_url":"http://www.emcdda.europa.eu/publications/gra/2013","display_url":"emcdda.europa.eu/publications/g…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477476253461938176","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477473653765201920"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Communicable Disease Threat Report (CDTR) Week 24 now out; w/ updates on #chikungunya in the Caribbean &amp; #MERS- CoV http://t.c…","id":"477470429175898112","created_at":"2014-06-13T15:19:55.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{},"hashtags":[{"start":86,"end":98,"tag":"chikungunya"},{"start":122,"end":127,"tag":"MERS"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477470429175898112","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477469458165170176"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Amendment to CDC MERS-CoV emergency use authorization (via @FDADeviceInfo) http://t.co/tdcIrKkFRv #fda #medicaldevice #MERS @…","id":"477469090974810112","created_at":"2014-06-13T15:14:36.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":73,"end":87,"username":"FDADeviceInfo","id":"140427956"}],"urls":[{"start":89,"end":111,"url":"http://t.co/tdcIrKkFRv","expanded_url":"http://1.usa.gov/12huduQ","display_url":"1.usa.gov/12huduQ"}],"annotations":{},"hashtags":[{"start":112,"end":116,"tag":"fda"},{"start":117,"end":131,"tag":"medicaldevice"},{"start":132,"end":137,"tag":"MERS"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477469090974810112","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477460496346411009"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #ECDC_EU and #EFSA cooperate to map vectors in Europe and surrounding countries. #Vectornet http://t.co/c8ChxEnUiS http://t.co…","id":"477459062410735616","created_at":"2014-06-13T14:34:45.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":105,"end":127,"url":"http://t.co/c8ChxEnUiS","expanded_url":"http://bit.ly/1ijLCcO","display_url":"bit.ly/1ijLCcO"}],"annotations":[{"start":60,"end":65,"probability":0.9957,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":13,"end":21,"tag":"ECDC_EU"},{"start":26,"end":31,"tag":"EFSA"},{"start":94,"end":104,"tag":"Vectornet"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477459062410735616","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477457877188485120"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#PRAC has started a review to evaluate the cardiovascular risks with systemic #ibuprofen medicines: http://t.co/lyGOzgaI0G","id":"477457405253394432","created_at":"2014-06-13T14:28:10.000Z","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/lyGOzgaI0G","expanded_url":"http://bit.ly/1oXj0vQ","display_url":"bit.ly/1oXj0vQ"}],"annotations":{},"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":78,"end":88,"tag":"ibuprofen"}]},"public_metrics":{"retweet_count":10,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"477457405253394432","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've just published the #PRAC meeting highlights: http://t.co/aISeZKAM0I","id":"477456594532200448","created_at":"2014-06-13T14:24:57.000Z","entities":{"mentions":{},"urls":[{"start":51,"end":73,"url":"http://t.co/aISeZKAM0I","expanded_url":"http://bit.ly/1lp4kEt","display_url":"bit.ly/1lp4kEt"}],"annotations":{},"hashtags":[{"start":25,"end":30,"tag":"PRAC"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477456594532200448","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: EFSA is looking for top #scientists. Deadline for #EFSApanel call extended to 7 July. http://t.co/osrcX2XG6R","id":"477450527157284864","created_at":"2014-06-13T14:00:50.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":99,"end":121,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":37,"end":48,"tag":"scientists"},{"start":63,"end":73,"tag":"EFSApanel"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477450527157284864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477450326342369280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: 84th meeting of the Management Board of the European Medicines Agency, United Kingdom http://t.co/2XxDUz1TTV","id":"477450471431761920","created_at":"2014-06-13T14:00:37.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":101,"end":123,"url":"http://t.co/2XxDUz1TTV","expanded_url":"http://bit.ly/1l8txo0","display_url":"bit.ly/1l8txo0"}],"annotations":[{"start":86,"end":99,"probability":0.4075,"type":"Organization","normalized_text":"United Kingdom"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477450471431761920","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: 84th meeting of the European Medicines Agency's Management Board http://t.co/ZDn5dW92bo","id":"477450087082496000","created_at":"2014-06-13T13:59:06.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":78,"end":100,"url":"http://t.co/ZDn5dW92bo","expanded_url":"http://bit.ly/1itJbVb","display_url":"bit.ly/1itJbVb"}],"annotations":[{"start":33,"end":57,"probability":0.6272,"type":"Organization","normalized_text":"European Medicines Agency"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477450087082496000","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: \"Because we failed on #Stamina\" by Luca Pani, General Director, Italian medicines agency \" http://t.co/rRPxbQA2vu","id":"477449755094949888","created_at":"2014-06-13T13:57:46.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":111,"end":133,"url":"http://t.co/rRPxbQA2vu","expanded_url":"http://bit.ly/1l8sZhR","display_url":"bit.ly/1l8sZhR"}],"annotations":[{"start":55,"end":63,"probability":0.9928,"type":"Person","normalized_text":"Luca Pani"}],"hashtags":[{"start":42,"end":50,"tag":"Stamina"}]},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"477449755094949888","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Reminder, don’t be a victim of unproven stem cell therapies:  http://t.co/HEvkBbqmhp","id":"477445440775151616","created_at":"2014-06-13T13:40:38.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":75,"end":97,"url":"http://t.co/HEvkBbqmhp","expanded_url":"http://1.usa.gov/1sbv2Wd","display_url":"1.usa.gov/1sbv2Wd"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477445440775151616","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477442515373543426"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: #Horizon2020 in brief - the EU framework programme for #research &amp; #innovation http://t.co/Jtvd6b9OR4 @eubookshop","id":"477444958337921024","created_at":"2014-06-13T13:38:43.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":104,"end":126,"url":"http://t.co/Jtvd6b9OR4","expanded_url":"http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start?PublicationKey=KI0213413","display_url":"bookshop.europa.eu/is-bin/INTERSH…"}],"annotations":{},"hashtags":[{"start":21,"end":33,"tag":"Horizon2020"},{"start":76,"end":85,"tag":"research"},{"start":92,"end":103,"tag":"innovation"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477444958337921024","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477436336140713984"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe_VPI: The common experience uncommonly told in “Why I’m telling my #vaccine story”  http://t.co/PhIKmznsPx @voices4vaccines #…","id":"477444841639796736","created_at":"2014-06-13T13:38:15.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":121,"end":137,"username":"Voices4Vaccines","id":"880883612"}],"urls":[{"start":98,"end":120,"url":"http://t.co/PhIKmznsPx","expanded_url":"http://bit.ly/1hTlT0c","display_url":"bit.ly/1hTlT0c"}],"annotations":{},"hashtags":[{"start":81,"end":89,"tag":"vaccine"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477444841639796736","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477434345381445632"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: #Horizon2020 in brief - the EU framework programme for #research &amp; #innovation http://t.co/ywI8KIC26D @eubookshop","id":"477432428714541056","created_at":"2014-06-13T12:48:55.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":97,"end":119,"url":"http://t.co/ywI8KIC26D","expanded_url":"http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start?PublicationKey=KI0213413","display_url":"bookshop.europa.eu/is-bin/INTERSH…"}],"annotations":{},"hashtags":[{"start":14,"end":26,"tag":"Horizon2020"},{"start":69,"end":78,"tag":"research"},{"start":85,"end":96,"tag":"innovation"}]},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477432428714541056","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477432356836765696"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: #Horizon2020 in brief  The EU framework programme for research &amp; innovation http://t.co/c35vlxnNnE @eubookshop","id":"477431588561911808","created_at":"2014-06-13T12:45:35.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":94,"end":116,"url":"http://t.co/c35vlxnNnE","expanded_url":"http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start?PublicationKey=KI0213413","display_url":"bookshop.europa.eu/is-bin/INTERSH…"}],"annotations":{},"hashtags":[{"start":14,"end":26,"tag":"Horizon2020"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477431588561911808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477431477102444544"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: We’re looking for a member of the public to join our guideline development group on spondyloarthritis http://t.co/tq81uVyogN","id":"477430382795968512","created_at":"2014-06-13T12:40:48.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":117,"end":139,"url":"http://t.co/tq81uVyogN","expanded_url":"http://www.nice.org.uk/getinvolved/joinnwc/LayMemberSpondyloarthritisGDG.jsp","display_url":"nice.org.uk/getinvolved/jo…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477430382795968512","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477421943755636736"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: WATCH Webinar: The Patient’s Understanding of Benefit Risk http://t.co/0unuSy7yio http://t.co/ThNhjtXheO","id":"477429579226025984","created_at":"2014-06-13T12:37:36.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":70,"end":92,"url":"http://t.co/0unuSy7yio","expanded_url":"http://bit.ly/1kvbP8j","display_url":"bit.ly/1kvbP8j"},{"start":93,"end":115,"url":"http://t.co/ThNhjtXheO","expanded_url":"https://twitter.com/EFPIA/status/477428073605103616/photo/1","display_url":"pic.twitter.com/ThNhjtXheO"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477429579226025984","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477428073605103616"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_477428072728125442"]}},{"text":"RT @EFPIA: HAPPY FRIDAY! Efpia's newsletter is OUT! #adherence #pharma #health #Google #Autism #EDAS2014 http://t.co/WJs9SQMHpi  http://t.c…","id":"477429506979155968","created_at":"2014-06-13T12:37:19.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":105,"end":127,"url":"http://t.co/WJs9SQMHpi","expanded_url":"http://bit.ly/UyHGQk","display_url":"bit.ly/UyHGQk"}],"annotations":{},"hashtags":[{"start":52,"end":62,"tag":"adherence"},{"start":63,"end":70,"tag":"pharma"},{"start":71,"end":78,"tag":"health"},{"start":79,"end":86,"tag":"Google"},{"start":87,"end":94,"tag":"Autism"},{"start":95,"end":104,"tag":"EDAS2014"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477429506979155968","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477428221617901568"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our Excellence in #Pharmacovigilance #training course on #clinicaltrials and post-marketing is on 13-17 October: http://t.co/SfaoVVYKPF","id":"477405605486133248","created_at":"2014-06-13T11:02:20.000Z","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/SfaoVVYKPF","expanded_url":"http://bit.ly/1hPEJ89","display_url":"bit.ly/1hPEJ89"}],"annotations":{},"hashtags":[{"start":18,"end":36,"tag":"Pharmacovigilance"},{"start":37,"end":46,"tag":"training"},{"start":57,"end":72,"tag":"clinicaltrials"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"477405605486133248","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Laventair (#umeclidinium bromide / #vilanterol), a #medicine for #COPD, now available on our website: http://t.co/JW8jP0nAmV","id":"477405244524351488","created_at":"2014-06-13T11:00:54.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/JW8jP0nAmV","expanded_url":"http://bit.ly/1lgkivY","display_url":"bit.ly/1lgkivY"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"Laventair"},{"start":25,"end":38,"tag":"umeclidinium"},{"start":49,"end":60,"tag":"vilanterol"},{"start":65,"end":74,"tag":"medicine"},{"start":79,"end":84,"tag":"COPD"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477405244524351488","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: @WHO_Europe How does #research benefit #asthma #allergy and #COPD #patients in the EU? Answers next week. Register: http:…","id":"477404869163499520","created_at":"2014-06-13T10:59:25.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":18,"end":29,"username":"WHO_Europe","id":"125403342"}],"urls":{},"annotations":{},"hashtags":[{"start":39,"end":48,"tag":"research"},{"start":57,"end":64,"tag":"asthma"},{"start":65,"end":73,"tag":"allergy"},{"start":78,"end":83,"tag":"COPD"},{"start":84,"end":93,"tag":"patients"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477404869163499520","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477403071979716608"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: How does #research benefit #asthma #allergy and #COPD #patients in the EU? Answers next week. Register: http://t.co/GUN8n…","id":"477404858967146496","created_at":"2014-06-13T10:59:22.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"urls":{},"annotations":{},"hashtags":[{"start":27,"end":36,"tag":"research"},{"start":45,"end":52,"tag":"asthma"},{"start":53,"end":61,"tag":"allergy"},{"start":66,"end":71,"tag":"COPD"},{"start":72,"end":81,"tag":"patients"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477404858967146496","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477402847995518976"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: #Patients discussion at EP next Tuesday 17 on #EUResearch on #chronicrespiratorydiseases Places available: http://t.co/GU…","id":"477404638900420608","created_at":"2014-06-13T10:58:30.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"urls":{},"annotations":{},"hashtags":[{"start":18,"end":27,"tag":"Patients"},{"start":64,"end":75,"tag":"EUResearch"},{"start":79,"end":106,"tag":"chronicrespiratorydiseases"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477404638900420608","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477401873973252096"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: EP event with @C_Stihler_MEP on #EUResearch projects benefits for #asthma #allergy and #COPD #patients. Register now http…","id":"477404479105806336","created_at":"2014-06-13T10:57:52.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477404479105806336","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477400963121446912"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: One day to #WorldBloodDonorDay! Help increase awareness about the importance of safe blood products with the #EDQM http://t.…","id":"477394577310363648","created_at":"2014-06-13T10:18:31.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":26,"end":45,"tag":"WorldBloodDonorDay"},{"start":124,"end":129,"tag":"EDQM"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477394577310363648","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477394364441042944"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Register now for our Excellence in #Pharmacovigilance #training course on #clinicaltrials and post-marketing: http://t.co/OTUjiYOutX","id":"477392003471130626","created_at":"2014-06-13T10:08:17.000Z","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/OTUjiYOutX","expanded_url":"http://bit.ly/1hPEJ89","display_url":"bit.ly/1hPEJ89"}],"annotations":{},"hashtags":[{"start":35,"end":53,"tag":"Pharmacovigilance"},{"start":54,"end":63,"tag":"training"},{"start":74,"end":89,"tag":"clinicaltrials"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477392003471130626","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: HAPPY FRIDAY! Efpia's newsletter is OUT! #adherence #pharma #health #Google #Autism #EDAS2014 http://t.co/WJs9SQMHpi http://t.co…","id":"477387072974905344","created_at":"2014-06-13T09:48:42.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":105,"end":127,"url":"http://t.co/WJs9SQMHpi","expanded_url":"http://bit.ly/UyHGQk","display_url":"bit.ly/UyHGQk"}],"annotations":{},"hashtags":[{"start":52,"end":62,"tag":"adherence"},{"start":63,"end":70,"tag":"pharma"},{"start":71,"end":78,"tag":"health"},{"start":79,"end":86,"tag":"Google"},{"start":87,"end":94,"tag":"Autism"},{"start":95,"end":104,"tag":"EDAS2014"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477387072974905344","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477385513171959808"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Yesterday we agreed our policy on publication of clinical-trial data with more user-friendly amendments: http://t.co/B2k0cNsEGV #ctdata","id":"477384925382180864","created_at":"2014-06-13T09:40:10.000Z","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/B2k0cNsEGV","expanded_url":"http://bit.ly/SQReVn","display_url":"bit.ly/SQReVn"}],"annotations":{},"hashtags":[{"start":128,"end":135,"tag":"ctdata"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477384925382180864","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Yesterday our Management Board re-elected Sir Kent Woods as chair: http://t.co/m7Akjsqz3n","id":"477383581061644288","created_at":"2014-06-13T09:34:49.000Z","entities":{"mentions":{},"urls":[{"start":67,"end":89,"url":"http://t.co/m7Akjsqz3n","expanded_url":"http://bit.ly/1s8ZXT6","display_url":"bit.ly/1s8ZXT6"}],"annotations":[{"start":42,"end":55,"probability":0.8039,"type":"Person","normalized_text":"Sir Kent Woods"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477383581061644288","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Laventair (#umeclidinium bromide / #vilanterol), a #medicine for #COPD: http://t.co/4OfRZWrCyp","id":"477382712383131648","created_at":"2014-06-13T09:31:22.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/4OfRZWrCyp","expanded_url":"http://bit.ly/1lgkivY","display_url":"bit.ly/1lgkivY"}],"annotations":{},"hashtags":[{"start":42,"end":52,"tag":"Laventair"},{"start":54,"end":67,"tag":"umeclidinium"},{"start":78,"end":89,"tag":"vilanterol"},{"start":94,"end":103,"tag":"medicine"},{"start":108,"end":113,"tag":"COPD"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477382712383131648","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: European Medicines Agency agrees policy on publication of clinical trial data with more user-friendly amendments http://t.co/Y…","id":"477380529072144384","created_at":"2014-06-13T09:22:42.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":13,"end":37,"probability":0.8204,"type":"Organization","normalized_text":"European Medicines Agency"}],"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477380529072144384","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477379385801318400"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: European Medicines Agency Management Board re-elects Sir Kent Woods as chair: http://t.co/NkoAY3bY2C","id":"477379224341606400","created_at":"2014-06-13T09:17:31.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":91,"end":113,"url":"http://t.co/NkoAY3bY2C","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/06/news_detail_002123.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":54,"probability":0.3537,"type":"Organization","normalized_text":"European Medicines Agency Management Board"},{"start":66,"end":79,"probability":0.7269,"type":"Person","normalized_text":"Sir Kent Woods"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477379224341606400","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477379194700455936"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: #EUResearch advances on #asthma #allergy and #COPD discussion at @Europarl_EN Tuesday 17 June. Register http://t.co/GUN8n…","id":"477374035450658817","created_at":"2014-06-13T08:56:53.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":83,"end":95,"username":"Europarl_EN","id":"36329597"}],"urls":{},"annotations":{},"hashtags":[{"start":18,"end":29,"tag":"EUResearch"},{"start":42,"end":49,"tag":"asthma"},{"start":50,"end":58,"tag":"allergy"},{"start":63,"end":68,"tag":"COPD"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477374035450658817","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477372890980294656"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: Tuesday 17, innovative #EUresearch benefits on EU citizens’ #health. Register now: http://t.co/GUN8nviaBF @innovationunio…","id":"477371953809203200","created_at":"2014-06-13T08:48:37.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"urls":[{"start":101,"end":123,"url":"http://t.co/GUN8nviaBF","expanded_url":"http://bit.ly/1piouQl","display_url":"bit.ly/1piouQl"}],"annotations":[{"start":65,"end":66,"probability":0.5685,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":41,"end":52,"tag":"EUresearch"},{"start":78,"end":85,"tag":"health"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477371953809203200","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477371694567653376"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @gr2014eu: #gr2014eu media cluster on results achieved by 2nd #EU #Health Programme in area of HIV/AIDS, Day 2 underway http://t.co/hqvj…","id":"477368935646785536","created_at":"2014-06-13T08:36:38.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"gr2014eu","id":"1397477076"}],"urls":{},"annotations":{},"hashtags":[{"start":14,"end":23,"tag":"gr2014eu"},{"start":65,"end":68,"tag":"EU"},{"start":69,"end":76,"tag":"Health"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477368935646785536","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477363810769330176"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: #MRI brain scans detect people with early #Parkinson's: http://t.co/8kUqCRGQj6","id":"477368571618942976","created_at":"2014-06-13T08:35:11.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":74,"end":96,"url":"http://t.co/8kUqCRGQj6","expanded_url":"http://bit.ly/1ucHssv","display_url":"bit.ly/1ucHssv"}],"annotations":{},"hashtags":[{"start":18,"end":22,"tag":"MRI"},{"start":60,"end":70,"tag":"Parkinson"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477368571618942976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477362293768859648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our Board has re-elected Sir Kent Woods as chair: http://t.co/m7Akjsqz3n","id":"477142265325166592","created_at":"2014-06-12T17:35:55.000Z","entities":{"mentions":{},"urls":[{"start":50,"end":72,"url":"http://t.co/m7Akjsqz3n","expanded_url":"http://bit.ly/1s8ZXT6","display_url":"bit.ly/1s8ZXT6"}],"annotations":[{"start":25,"end":38,"probability":0.7065,"type":"Person","normalized_text":"Sir Kent Woods"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477142265325166592","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've agreed our policy on publication of #ctdata with more user-friendly amendments: http://t.co/B2k0cNsEGV","id":"477141807021977600","created_at":"2014-06-12T17:34:06.000Z","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/B2k0cNsEGV","expanded_url":"http://bit.ly/SQReVn","display_url":"bit.ly/SQReVn"}],"annotations":{},"hashtags":[{"start":42,"end":49,"tag":"ctdata"}]},"public_metrics":{"retweet_count":10,"reply_count":2,"like_count":2,"quote_count":0},"conversation_id":"477141807021977600","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @PrimaryCare4um: @EU_Health Specific calls open under EU 3rd Health Programme including health systems projects http://t.co/vKAUekdqJP","id":"477086019330646017","created_at":"2014-06-12T13:52:25.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":20,"end":30,"username":"EU_Health","id":"606325697"}],"urls":[{"start":115,"end":137,"url":"http://t.co/vKAUekdqJP","expanded_url":"http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/hp/#.U5mTyZhjFvo.twitter","display_url":"ec.europa.eu/research/parti…"}],"annotations":[{"start":57,"end":79,"probability":0.5509,"type":"Organization","normalized_text":"EU 3rd Health Programme"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477086019330646017","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477055788058279936"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: 9th International Conference on #Anticancer Research, #Sithonia,#Greece http://t.co/sUXYXhm2sL","id":"477085926506909697","created_at":"2014-06-12T13:52:03.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":86,"end":108,"url":"http://t.co/sUXYXhm2sL","expanded_url":"http://cordis.europa.eu/news/rcn/36596_en.html","display_url":"cordis.europa.eu/news/rcn/36596…"}],"annotations":{},"hashtags":[{"start":46,"end":57,"tag":"Anticancer"},{"start":68,"end":77,"tag":"Sithonia"},{"start":78,"end":85,"tag":"Greece"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477085926506909697","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477058181991239680"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @beuctweet: Antibiotics use in livestock: Time to act - BEUC position paper published http://t.co/RniiG5c5fe #AMR #antibioticresistance","id":"477085489359781888","created_at":"2014-06-12T13:50:19.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"}],"urls":[{"start":89,"end":111,"url":"http://t.co/RniiG5c5fe","expanded_url":"http://bit.ly/1xNWRUV","display_url":"bit.ly/1xNWRUV"}],"annotations":{},"hashtags":[{"start":112,"end":116,"tag":"AMR"},{"start":117,"end":138,"tag":"antibioticresistance"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477085489359781888","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477079294557294593"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: How can the #EU support #HIV prevention? http://t.co/F7rmaHVium","id":"477047006901571584","created_at":"2014-06-12T11:17:24.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":56,"end":78,"url":"http://t.co/F7rmaHVium","expanded_url":"http://europa.eu/!qu37cb","display_url":"europa.eu/!qu37cb"}],"annotations":{},"hashtags":[{"start":27,"end":30,"tag":"EU"},{"start":39,"end":43,"tag":"HIV"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477047006901571584","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477038862100103169"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Take a guided tour through the #EFSAJournal. Watch the video http://t.co/WhehWJ6nk2","id":"477046836415725569","created_at":"2014-06-12T11:16:43.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":74,"end":96,"url":"http://t.co/WhehWJ6nk2","expanded_url":"http://youtu.be/6Y24z2mQ0Xg","display_url":"youtu.be/6Y24z2mQ0Xg"}],"annotations":{},"hashtags":[{"start":44,"end":56,"tag":"EFSAJournal"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477046836415725569","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477043896833560576"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've responded to concerns on our publication of clinical trial data policy: http://t.co/sSkukGJlCf #ctdata","id":"477033646780870656","created_at":"2014-06-12T10:24:18.000Z","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/sSkukGJlCf","expanded_url":"http://bit.ly/1pjfz4k","display_url":"bit.ly/1pjfz4k"}],"annotations":{},"hashtags":[{"start":101,"end":108,"tag":"ctdata"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"477033646780870656","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: June issue of the ECHA Newsletter is out! http://t.co/S3ayTjshCQ http://t.co/VqpJ6SV3US","id":"477032057999470592","created_at":"2014-06-12T10:18:00.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":55,"end":77,"url":"http://t.co/S3ayTjshCQ","expanded_url":"http://newsletter.echa.europa.eu/home/-/newsletter/3/2014","display_url":"newsletter.echa.europa.eu/home/-/newslet…"},{"start":78,"end":100,"url":"http://t.co/VqpJ6SV3US","expanded_url":"https://twitter.com/EU_ECHA/status/477020679087595520/photo/1","display_url":"pic.twitter.com/VqpJ6SV3US"}],"annotations":[{"start":31,"end":45,"probability":0.5841,"type":"Organization","normalized_text":"ECHA Newsletter"}],"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"477032057999470592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"477020679087595520"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_477020677916991488"]}},{"text":"RT @EFSA_EU: #Dengue fever infects 390m people while 3bn people are at risk from #JapaneseEncephalitis http://t.co/R9kUuLShaB http://t.co/c…","id":"476765810430853120","created_at":"2014-06-11T16:40:01.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":103,"end":125,"url":"http://t.co/R9kUuLShaB","expanded_url":"http://bit.ly/1kMoBnD","display_url":"bit.ly/1kMoBnD"}],"annotations":{},"hashtags":[{"start":13,"end":20,"tag":"Dengue"},{"start":81,"end":102,"tag":"JapaneseEncephalitis"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476765810430853120","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476733100295458816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: New E-learning module: Cancer in Adolescents &amp; Young Adults in collaboration w/ @SIOPEurope http://t.co/P2YTEHxHQX #OncologyPRO","id":"476765631204032512","created_at":"2014-06-11T16:39:19.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":96,"end":107,"username":"SIOPEurope","id":"378478769"}],"urls":[{"start":108,"end":130,"url":"http://t.co/P2YTEHxHQX","expanded_url":"http://ow.ly/xSOFO","display_url":"ow.ly/xSOFO"}],"annotations":{},"hashtags":[{"start":131,"end":143,"tag":"OncologyPRO"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476765631204032512","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476740555222040576"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Subscribe to our #newsletter today. #Vector-borne diseases, #Video; #Biodiversity in #environmental #RiskAssessment. http://t.…","id":"476765231876931584","created_at":"2014-06-11T16:37:43.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{},"hashtags":[{"start":30,"end":41,"tag":"newsletter"},{"start":49,"end":56,"tag":"Vector"},{"start":73,"end":79,"tag":"Video"},{"start":81,"end":94,"tag":"Biodiversity"},{"start":98,"end":112,"tag":"environmental"},{"start":113,"end":128,"tag":"RiskAssessment"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476765231876931584","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476763296427933697"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We have a vacancy for an Internal Corporate Relations Assistant to work in Corporate Governance: http://t.co/toc0XYKNR1 #recruitment","id":"476765072107528192","created_at":"2014-06-11T16:37:05.000Z","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/toc0XYKNR1","expanded_url":"http://bit.ly/1u4E9DM","display_url":"bit.ly/1u4E9DM"}],"annotations":{},"hashtags":[{"start":120,"end":132,"tag":"recruitment"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476765072107528192","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We have a vacancy for a Planning Officer to support strategic planning processes: http://t.co/hUpnRM83wU #recruitment","id":"476764761796136960","created_at":"2014-06-11T16:35:51.000Z","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/hUpnRM83wU","expanded_url":"http://bit.ly/1klGQvb","display_url":"bit.ly/1klGQvb"}],"annotations":{},"hashtags":[{"start":105,"end":117,"tag":"recruitment"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"476764761796136960","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We have a vacancy for an Internal Auditor: http://t.co/49e0xMwZhq #recruitment #audit","id":"476764369960046592","created_at":"2014-06-11T16:34:18.000Z","entities":{"mentions":{},"urls":[{"start":43,"end":65,"url":"http://t.co/49e0xMwZhq","expanded_url":"http://bit.ly/1oMQ0qG","display_url":"bit.ly/1oMQ0qG"}],"annotations":{},"hashtags":[{"start":66,"end":78,"tag":"recruitment"},{"start":79,"end":85,"tag":"audit"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476764369960046592","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're recruiting a Scientific Officer to work in Risk Management and Signal Management: http://t.co/S31YhJik3b #recruitment","id":"476764234177871872","created_at":"2014-06-11T16:33:45.000Z","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"annotations":{},"hashtags":[{"start":111,"end":123,"tag":"recruitment"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"476764234177871872","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda of this week's #pharmacovigilance committee meeting is available: http://t.co/0znnL4HyLR #PRAC","id":"476763977389993984","created_at":"2014-06-11T16:32:44.000Z","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/0znnL4HyLR","expanded_url":"http://bit.ly/1hHEoVc","display_url":"bit.ly/1hHEoVc"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":45,"tag":"pharmacovigilance"},{"start":101,"end":106,"tag":"PRAC"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"476763977389993984","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ESEndocrinology: Fang et al. compare repaglinide and metformin monotherapy in patients with T2DM - read the article in EJE http://t.co/…","id":"476688016472551425","created_at":"2014-06-11T11:30:54.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476688016472551425","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476686227518029824"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a response to concerns on our publication of clinical trial data policy: http://t.co/sSkukGJlCf #ctdata","id":"476683752341790721","created_at":"2014-06-11T11:13:57.000Z","entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/sSkukGJlCf","expanded_url":"http://bit.ly/1pjfz4k","display_url":"bit.ly/1pjfz4k"}],"annotations":{},"hashtags":[{"start":112,"end":119,"tag":"ctdata"}]},"public_metrics":{"retweet_count":13,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"476683752341790721","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HepatitisEurope: First WHO global partners' meeting on hepatitis. Share the call to action:  http://t.co/B67ilCCRv4","id":"476674326809559040","created_at":"2014-06-11T10:36:30.000Z","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/B67ilCCRv4","expanded_url":"http://bit.ly/1idxJ53","display_url":"bit.ly/1idxJ53"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476674326809559040","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476645310148915201"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: 10-12 Sept: International #DigitalHealth &amp; #Care Congress in London, http://t.co/FUUXNyxOM1 @thekingsfund #mhealth #ehealth…","id":"476674055266136064","created_at":"2014-06-11T10:35:25.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":112,"end":125,"username":"TheKingsFund","id":"18045120"}],"urls":[{"start":89,"end":111,"url":"http://t.co/FUUXNyxOM1","expanded_url":"http://ow.ly/xRYNV","display_url":"ow.ly/xRYNV"}],"annotations":[{"start":77,"end":82,"probability":0.9948,"type":"Place","normalized_text":"London"}],"hashtags":[{"start":42,"end":56,"tag":"DigitalHealth"},{"start":63,"end":68,"tag":"Care"},{"start":126,"end":134,"tag":"mhealth"},{"start":135,"end":143,"tag":"ehealth"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476674055266136064","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476650833514602496"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: WHO guidelines for blood transfusion services on assessing which donors are suitable for donating blood http://t.co/L2zkx2rUNu #Gi…","id":"476674038002356224","created_at":"2014-06-11T10:35:21.000Z","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":113,"end":135,"url":"http://t.co/L2zkx2rUNu","expanded_url":"http://goo.gl/eZrBic","display_url":"goo.gl/eZrBic"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":79,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476674038002356224","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476650838929440768"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Joint annual ECDC &amp; WHO/Europe meeting on #influenza surveillance, #immunisation, outbreaks, 11-13 June, Vienna: http://t.co/…","id":"476673713728143360","created_at":"2014-06-11T10:34:04.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"annotations":[{"start":38,"end":43,"probability":0.9079,"type":"Place","normalized_text":"Europe"},{"start":119,"end":124,"probability":0.4738,"type":"Place","normalized_text":"Vienna"}],"hashtags":[{"start":60,"end":70,"tag":"influenza"},{"start":85,"end":98,"tag":"immunisation"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476673713728143360","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476658776515575808"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: New Intl Health Regulations text on #YellowFever vaccination &amp; certificates will come into force legally in June 2016 http://t.co/…","id":"476673575433543680","created_at":"2014-06-11T10:33:31.000Z","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":[{"start":45,"end":57,"tag":"YellowFever"}]},"public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476673575433543680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476663938135113728"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're recruiting an Internal Corporate Relations Assistant to support corporate governance: http://t.co/toc0XYKNR1 #recruitment","id":"476672717794840576","created_at":"2014-06-11T10:30:06.000Z","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/toc0XYKNR1","expanded_url":"http://bit.ly/1u4E9DM","display_url":"bit.ly/1u4E9DM"}],"annotations":{},"hashtags":[{"start":115,"end":127,"tag":"recruitment"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"476672717794840576","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're recruiting a Planning Officer to support our strategic planning processes:  http://t.co/hUpnRM83wU #recruitment","id":"476672163664396288","created_at":"2014-06-11T10:27:54.000Z","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/hUpnRM83wU","expanded_url":"http://bit.ly/1klGQvb","display_url":"bit.ly/1klGQvb"}],"annotations":{},"hashtags":[{"start":105,"end":117,"tag":"recruitment"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476672163664396288","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're recruiting an Internal Auditor: http://t.co/49e0xMwZhq #recruitment #audit","id":"476671824173232128","created_at":"2014-06-11T10:26:33.000Z","entities":{"mentions":{},"urls":[{"start":38,"end":60,"url":"http://t.co/49e0xMwZhq","expanded_url":"http://bit.ly/1oMQ0qG","display_url":"bit.ly/1oMQ0qG"}],"annotations":{},"hashtags":[{"start":61,"end":73,"tag":"recruitment"},{"start":74,"end":80,"tag":"audit"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476671824173232128","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're recruiting a Scientific Officer to work in the area of Risk Management and Signal Management: http://t.co/S31YhJik3b #recruitment","id":"476671430479069184","created_at":"2014-06-11T10:24:59.000Z","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/S31YhJik3b","expanded_url":"http://bit.ly/1mGJ3CV","display_url":"bit.ly/1mGJ3CV"}],"annotations":{},"hashtags":[{"start":123,"end":135,"tag":"recruitment"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"476671430479069184","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Study: #Smartphone coaching can boost #diabetes management &amp; help reduce risks: http://t.co/wTTHJjKj8x via @scoopit #mHealth","id":"476649014021353472","created_at":"2014-06-11T08:55:55.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":127,"end":135,"username":"scoopit","id":"209484168"}],"urls":[{"start":100,"end":122,"url":"http://t.co/wTTHJjKj8x","expanded_url":"http://sco.lt/6k8jsf","display_url":"sco.lt/6k8jsf"}],"annotations":{},"hashtags":[{"start":23,"end":34,"tag":"Smartphone"},{"start":54,"end":63,"tag":"diabetes"},{"start":136,"end":144,"tag":"mHealth"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476649014021353472","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476634656235073537"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Are you interested in a traineeship at @EU_ECHA? Apply by 15 June! http://t.co/N91WRj2mBQ","id":"476648892977930241","created_at":"2014-06-11T08:55:26.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":52,"end":60,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":80,"end":102,"url":"http://t.co/N91WRj2mBQ","expanded_url":"http://bit.ly/1fmq9xd","display_url":"bit.ly/1fmq9xd"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476648892977930241","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476637257873756160"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of our #pharmacovigilance committee meeting this week: http://t.co/0znnL4HyLR #PRAC","id":"476647186911207425","created_at":"2014-06-11T08:48:39.000Z","entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/0znnL4HyLR","expanded_url":"http://bit.ly/1hHEoVc","display_url":"bit.ly/1hHEoVc"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":35,"end":53,"tag":"pharmacovigilance"},{"start":106,"end":111,"tag":"PRAC"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476647186911207425","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: 2 calls for proposals under 3rd #EU #Health published. Deadline for online submissions: 25 September 2014 #funding http://t.…","id":"476391006645280769","created_at":"2014-06-10T15:50:41.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{},"hashtags":[{"start":47,"end":50,"tag":"EU"},{"start":51,"end":58,"tag":"Health"},{"start":121,"end":129,"tag":"funding"}]},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476391006645280769","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476390808141455360"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Meeting Minutes Available for the ADUFA III Conditional Approval Working Group http://t.co/Zg4Mk7etFM","id":"476390690478628864","created_at":"2014-06-10T15:49:26.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":100,"end":122,"url":"http://t.co/Zg4Mk7etFM","expanded_url":"http://1.usa.gov/zK3lZ4","display_url":"1.usa.gov/zK3lZ4"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476390690478628864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476389292936552448"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Italian medicines agency puts #Avastin on list of medicines for age-related macular degeneration http://t.co/2yGkxDE8RS","id":"476387202734497792","created_at":"2014-06-10T15:35:34.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":117,"end":139,"url":"http://t.co/2yGkxDE8RS","expanded_url":"http://bit.ly/TFgCy5","display_url":"bit.ly/TFgCy5"}],"annotations":{},"hashtags":[{"start":50,"end":58,"tag":"Avastin"}]},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"476387202734497792","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: PR - EFPIA calls for universal adherence to European Regulatory Framework http://t.co/SPXQSpe6B3","id":"476386737191944192","created_at":"2014-06-10T15:33:43.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":85,"end":107,"url":"http://t.co/SPXQSpe6B3","expanded_url":"http://bit.ly/1l2MXcG","display_url":"bit.ly/1l2MXcG"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476386737191944192","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476361995227500546"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Updated Listing of Approved Medicated Feed Mill Licenses http://t.co/0IqYvevpGm","id":"476378050448596992","created_at":"2014-06-10T14:59:12.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":78,"end":100,"url":"http://t.co/0IqYvevpGm","expanded_url":"http://bit.ly/1q0cK8d","display_url":"bit.ly/1q0cK8d"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476378050448596992","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476371675408515072"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EURLex: European Commission points to importance of #research &amp; #innovation for EU's economic recovery http://t.co/r4x0PxAdFp","id":"476367565485506561","created_at":"2014-06-10T14:17:32.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"urls":[{"start":111,"end":133,"url":"http://t.co/r4x0PxAdFp","expanded_url":"http://europa.eu/rapid/press-release_IP-14-646_en.htm","display_url":"europa.eu/rapid/press-re…"}],"annotations":{},"hashtags":[{"start":56,"end":65,"tag":"research"},{"start":72,"end":83,"tag":"innovation"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476367565485506561","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476366327096283136"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: The May 2014 newsletter has been published on the Polish medicines agency's website.\n\nhttp://t.co/lMgtIaUmKH","id":"476364213511016448","created_at":"2014-06-10T14:04:13.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":101,"end":123,"url":"http://t.co/lMgtIaUmKH","expanded_url":"http://bit.ly/SKqeH3","display_url":"bit.ly/SKqeH3"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476364213511016448","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #Malaria, spread by #mosquitoes, infects 200 million people/year, causing over 600,000 deaths http://t.co/R9kUuLShaB http://t.…","id":"476362101553131520","created_at":"2014-06-10T13:55:50.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":107,"end":129,"url":"http://t.co/R9kUuLShaB","expanded_url":"http://bit.ly/1kMoBnD","display_url":"bit.ly/1kMoBnD"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Malaria"},{"start":33,"end":44,"tag":"mosquitoes"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476362101553131520","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476361593660637184"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: _ @EFSA_EU &amp; @ECDC_EU join forces to fight #vectorbornediseases affecting people &amp; animals: http://t.co/OQ0G7X114q  #animal…","id":"476360497810653185","created_at":"2014-06-10T13:49:27.000Z","entities":{"mentions":[{"start":18,"end":26,"username":"EFSA_EU","id":"84582815"},{"start":33,"end":41,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":116,"end":138,"url":"http://t.co/OQ0G7X114q","expanded_url":"http://bit.ly/1oIrKpB","display_url":"bit.ly/1oIrKpB"}],"annotations":{},"hashtags":[{"start":63,"end":83,"tag":"vectorbornediseases"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476360497810653185","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476359032803196928"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Candidate universal #influenza A vaccine reduces virus transmission in mice http://t.co/dWEgtFOqsQ (via @FDACBER)","id":"476351760257536000","created_at":"2014-06-10T13:14:44.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":118,"end":126,"username":"FDACBER","id":"303777686"}],"urls":[{"start":90,"end":112,"url":"http://t.co/dWEgtFOqsQ","expanded_url":"http://ht.ly/xPDNz","display_url":"ht.ly/xPDNz"}],"annotations":{},"hashtags":[{"start":34,"end":44,"tag":"influenza"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476351760257536000","source":"TweetDeck","lang":"es","referenced_tweets":[{"type":"retweeted","id":"476351251958218752"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Human medicines highlights - Issue 63 - May 2014: The May 2014 issue of the European Medicines Agency's newsle... http://t.c…","id":"476350700432392192","created_at":"2014-06-10T13:10:31.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476350700432392192","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476350616403341313"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Six days left to register for the Biocidal Products Regulation webinar on Article 95 #Biocides http://t.co/e1wU7lI1iu","id":"476346610855972864","created_at":"2014-06-10T12:54:16.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":108,"end":130,"url":"http://t.co/e1wU7lI1iu","expanded_url":"http://bit.ly/1mlo4eD","display_url":"bit.ly/1mlo4eD"}],"annotations":[{"start":47,"end":74,"probability":0.2932,"type":"Product","normalized_text":"Biocidal Products Regulation"}],"hashtags":[{"start":98,"end":107,"tag":"Biocides"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476346610855972864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476343569125752833"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: What are #vector-borne diseases? Find out more in our latest video http://t.co/MQ5KZVQ8lK","id":"476346492199108608","created_at":"2014-06-10T12:53:48.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":80,"end":102,"url":"http://t.co/MQ5KZVQ8lK","expanded_url":"http://youtu.be/D9AJ02oEK9k","display_url":"youtu.be/D9AJ02oEK9k"}],"annotations":{},"hashtags":[{"start":22,"end":29,"tag":"vector"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476346492199108608","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476342593530626048"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: How @EFSA_EU &amp; #ECDC cooperate to combat #vector-borne diseases in EU. Watch new video: http://t.co/vfLCcyBbPq #Vectornet","id":"476341622352142336","created_at":"2014-06-10T12:34:27.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":17,"end":25,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":105,"end":127,"url":"http://t.co/vfLCcyBbPq","expanded_url":"http://bit.ly/1khmqnc","display_url":"bit.ly/1khmqnc"}],"annotations":[{"start":80,"end":81,"probability":0.6949,"type":"Place","normalized_text":"EU"}],"hashtags":[{"start":32,"end":37,"tag":"ECDC"},{"start":58,"end":65,"tag":"vector"},{"start":128,"end":138,"tag":"Vectornet"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476341622352142336","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476341525320724481"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Human medicines highlights - Issue 63 - May 2014 http://t.co/W4Bw5t2Vav","id":"476327831526723584","created_at":"2014-06-10T11:39:39.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":64,"end":86,"url":"http://t.co/W4Bw5t2Vav","expanded_url":"http://bit.ly/1pA8rhA","display_url":"bit.ly/1pA8rhA"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476327831526723584","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476326438740586496"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: What is Synthetic Biology? Public consultation by @EU_Commission @EU_Health - http://t.co/5eiDiCiTwI #health #biology #gene…","id":"476327724894912514","created_at":"2014-06-10T11:39:14.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":66,"end":80,"username":"EU_Commission","id":"157981564"},{"start":81,"end":91,"username":"EU_Health","id":"606325697"}],"urls":[{"start":94,"end":116,"url":"http://t.co/5eiDiCiTwI","expanded_url":"http://ow.ly/xP7d4","display_url":"ow.ly/xP7d4"}],"annotations":{},"hashtags":[{"start":117,"end":124,"tag":"health"},{"start":125,"end":133,"tag":"biology"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476327724894912514","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476320397747830784"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The highlights from last week's #veterinary #medicines committee (#CVMP) meeting are live - 4 new medicines for dogs: http://t.co/s7yrdXKsmW","id":"476319906292854784","created_at":"2014-06-10T11:08:09.000Z","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/s7yrdXKsmW","expanded_url":"http://bit.ly/TmfT50","display_url":"bit.ly/TmfT50"}],"annotations":{},"hashtags":[{"start":32,"end":43,"tag":"veterinary"},{"start":44,"end":54,"tag":"medicines"},{"start":66,"end":71,"tag":"CVMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476319906292854784","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA and @ECDC_EU join forces to fight vector-borne diseases. #Vectornet http://t.co/c8ChxEnUiS http://t.co/6ILYorl13N","id":"476319692903440384","created_at":"2014-06-10T11:07:19.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":23,"end":31,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":87,"end":109,"url":"http://t.co/c8ChxEnUiS","expanded_url":"http://bit.ly/1ijLCcO","display_url":"bit.ly/1ijLCcO"},{"start":110,"end":132,"url":"http://t.co/6ILYorl13N","expanded_url":"https://twitter.com/EFSA_EU/status/476315112765399041/photo/1","display_url":"pic.twitter.com/6ILYorl13N"}],"annotations":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":76,"end":86,"tag":"Vectornet"}]},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476319692903440384","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476315112765399041"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_476315112513765376"]}},{"text":"RT @Aifa_ufficiale: AIFA Editorial\nThe outliers from clinical anecdotes to new allies in the fight against cancer? http://t.co/nk9GSKnsd2","id":"476319650419318785","created_at":"2014-06-10T11:07:08.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":115,"end":137,"url":"http://t.co/nk9GSKnsd2","expanded_url":"http://bit.ly/1hLv7vr","display_url":"bit.ly/1hLv7vr"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"476319650419318785","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Ebilfumin (#oseltamivir), a generic #medicine to treat or prevent #influenza, is now on our website: http://t.co/7yBFJ8xa9D","id":"476319085907968000","created_at":"2014-06-10T11:04:54.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/7yBFJ8xa9D","expanded_url":"http://bit.ly/1tO6dLq","display_url":"bit.ly/1tO6dLq"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"Ebilfumin"},{"start":25,"end":37,"tag":"oseltamivir"},{"start":50,"end":59,"tag":"medicine"},{"start":80,"end":90,"tag":"influenza"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476319085907968000","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #guideline on use of near infrared #spectroscopy and requirements for submissions &amp; variations is now available: http://t.co/kYb07TCFZ4","id":"476318320078356480","created_at":"2014-06-10T11:01:51.000Z","entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/kYb07TCFZ4","expanded_url":"http://bit.ly/1hDn9oj","display_url":"bit.ly/1hDn9oj"}],"annotations":{},"hashtags":[{"start":4,"end":14,"tag":"guideline"},{"start":39,"end":52,"tag":"spectroscopy"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476318320078356480","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've selected the first two medicines for our #adaptivelicensing pilot project: http://t.co/NrWFMziB3j","id":"476317925666979840","created_at":"2014-06-10T11:00:17.000Z","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/NrWFMziB3j","expanded_url":"http://bit.ly/SApXGS","display_url":"bit.ly/SApXGS"}],"annotations":{},"hashtags":[{"start":47,"end":65,"tag":"adaptivelicensing"}]},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"476317925666979840","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: The French medicines agency has updated its repository on #medicines and #G6PD deficiency\n http://t.co/s5rhujbFcm","id":"476306128075497472","created_at":"2014-06-10T10:13:24.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":101,"end":123,"url":"http://t.co/s5rhujbFcm","expanded_url":"http://bit.ly/1lk6F3p","display_url":"bit.ly/1lk6F3p"}],"annotations":{},"hashtags":[{"start":68,"end":78,"tag":"medicines"},{"start":83,"end":88,"tag":"G6PD"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476306128075497472","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Latest issue of the newsletter #ANSM Innovation, intended for holders of innovative projects, available at http://t.co/bSs6n5ZHWO","id":"476304690901450752","created_at":"2014-06-10T10:07:42.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":117,"end":139,"url":"http://t.co/bSs6n5ZHWO","expanded_url":"http://bit.ly/1ijFb9P","display_url":"bit.ly/1ijFb9P"}],"annotations":{},"hashtags":[{"start":41,"end":46,"tag":"ANSM"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476304690901450752","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: New gene found in #Parkinsons disease research could lead to new treatment http://t.co/MkB1C7UHMX","id":"476303573580800000","created_at":"2014-06-10T10:03:15.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":86,"end":108,"url":"http://t.co/MkB1C7UHMX","expanded_url":"http://bit.ly/TDQkwr","display_url":"bit.ly/TDQkwr"}],"annotations":{},"hashtags":[{"start":29,"end":40,"tag":"Parkinsons"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"476303573580800000","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"476293672078958592"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: #Exceptional #responders from anecdotes of clinical trials to allies in the fight against cancer http://t.co/GipJKj0nch","id":"476278204421140480","created_at":"2014-06-10T08:22:27.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":117,"end":139,"url":"http://t.co/GipJKj0nch","expanded_url":"http://bit.ly/1jhokEO","display_url":"bit.ly/1jhokEO"}],"annotations":{},"hashtags":[{"start":20,"end":32,"tag":"Exceptional"},{"start":33,"end":44,"tag":"responders"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"476278204421140480","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #pharmacovigilance committee (#PRAC) meets next week. Highlights to be published next Friday: http://t.co/9vsqU3wNvv","id":"474948224412028928","created_at":"2014-06-06T16:17:35.000Z","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/9vsqU3wNvv","expanded_url":"http://bit.ly/SAgT4L","display_url":"bit.ly/SAgT4L"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":34,"end":39,"tag":"PRAC"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474948224412028928","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to comment on the draft herbal monograph on Ginkgo biloba L., folium (#Ginkgo leaf): http://t.co/6gas9Zb39T","id":"474948101204357120","created_at":"2014-06-06T16:17:06.000Z","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/6gas9Zb39T","expanded_url":"http://bit.ly/1eWeyKC","display_url":"bit.ly/1eWeyKC"}],"annotations":{},"hashtags":[{"start":84,"end":91,"tag":"Ginkgo"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474948101204357120","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to answer our call for scientific data for assessment work on #Glycine max and/or #soy bean lecithin: http://t.co/N4vKrmDDvr","id":"474948055058632704","created_at":"2014-06-06T16:16:55.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/N4vKrmDDvr","expanded_url":"http://bit.ly/1tOtqip","display_url":"bit.ly/1tOtqip"}],"annotations":{},"hashtags":[{"start":76,"end":84,"tag":"Glycine"},{"start":96,"end":100,"tag":"soy"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474948055058632704","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on a draft reflection paper on #microbiological aspects of #herbal medicines: http://t.co/u19G34rUOM","id":"474947968710496256","created_at":"2014-06-06T16:16:34.000Z","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/u19G34rUOM","expanded_url":"http://bit.ly/1oRgc37","display_url":"bit.ly/1oRgc37"}],"annotations":{},"hashtags":[{"start":56,"end":72,"tag":"microbiological"},{"start":84,"end":91,"tag":"herbal"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474947968710496256","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to answer our call for scientific data for use in assessment work on #Polygoni avicularis herba: http://t.co/2BNOLbBSz8","id":"474947910963310592","created_at":"2014-06-06T16:16:20.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/2BNOLbBSz8","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"annotations":{},"hashtags":[{"start":83,"end":92,"tag":"Polygoni"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474947910963310592","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to answer our call for scientific data for systematic review of the monograph on #Meliloti herba: http://t.co/7wm33B5Fzq","id":"474947845901279233","created_at":"2014-06-06T16:16:05.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/7wm33B5Fzq","expanded_url":"http://bit.ly/Oqgtfa","display_url":"bit.ly/Oqgtfa"}],"annotations":{},"hashtags":[{"start":95,"end":104,"tag":"Meliloti"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474947845901279233","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights from this week's #veterinary #medicines committee meeting (#CVMP): http://t.co/s7yrdXKsmW","id":"474918655579652096","created_at":"2014-06-06T14:20:05.000Z","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/s7yrdXKsmW","expanded_url":"http://bit.ly/TmfT50","display_url":"bit.ly/TmfT50"}],"annotations":{},"hashtags":[{"start":48,"end":59,"tag":"veterinary"},{"start":60,"end":70,"tag":"medicines"},{"start":90,"end":95,"tag":"CVMP"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474918655579652096","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @kardamyla: @eurordis #summerschool Lise Murphy says that whatever is happening in the EMA @EMA_News goes through PCWP #patient_empowerm…","id":"474903437608775680","created_at":"2014-06-06T13:19:37.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":15,"end":24,"username":"eurordis","id":"26993786"},{"start":94,"end":103,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":39,"end":49,"probability":0.9887,"type":"Person","normalized_text":"Lise Murphy"}],"hashtags":[{"start":25,"end":38,"tag":"summerschool"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474903437608775680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474850733423329280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IBESocialMedia: Study sheds light on sudden death in epilepsy | Neurology Update: http://t.co/xUGZDxHo7a via @neuro_update","id":"474903254422536193","created_at":"2014-06-06T13:18:53.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"IBESocialMedia","id":"845720004"},{"start":113,"end":126,"username":"neuro_update","id":"118541345"}],"urls":[{"start":86,"end":108,"url":"http://t.co/xUGZDxHo7a","expanded_url":"http://www.neurologyupdate.com.au/latest-news/study-sheds-light-on-sudden-death-in-epilepsy#.U5Gl3p2e1LQ.twitter","display_url":"neurologyupdate.com.au/latest-news/st…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474903254422536193","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474875812055748608"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: Novel coronary stent materials reduce #heart #inflammation risk http://t.co/euts5h6ky1 @uniofleicester @Inserm @KU_Leuven","id":"474902713755774977","created_at":"2014-06-06T13:16:44.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":101,"end":116,"username":"uniofleicester","id":"81089247"},{"start":117,"end":124,"username":"Inserm","id":"102074868"},{"start":125,"end":135,"username":"KU_Leuven","id":"130828533"}],"urls":[{"start":78,"end":100,"url":"http://t.co/euts5h6ky1","expanded_url":"http://cordis.europa.eu/news/rcn/36593_en.html","display_url":"cordis.europa.eu/news/rcn/36593…"}],"annotations":{},"hashtags":[{"start":52,"end":58,"tag":"heart"},{"start":59,"end":72,"tag":"inflammation"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474902713755774977","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474889882893320194"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Ebilfumin (#oseltamivir), a #medicine to treat or prevent #influenza: http://t.co/7yBFJ8xa9D","id":"474901679272640512","created_at":"2014-06-06T13:12:38.000Z","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/7yBFJ8xa9D","expanded_url":"http://bit.ly/1tO6dLq","display_url":"bit.ly/1tO6dLq"}],"annotations":{},"hashtags":[{"start":42,"end":52,"tag":"Ebilfumin"},{"start":54,"end":66,"tag":"oseltamivir"},{"start":71,"end":80,"tag":"medicine"},{"start":101,"end":111,"tag":"influenza"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474901679272640512","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've issued a #guideline on use of near infrared #spectroscopy and data requirements for submissions and variations: http://t.co/kYb07TCFZ4","id":"474874772560826369","created_at":"2014-06-06T11:25:43.000Z","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/kYb07TCFZ4","expanded_url":"http://bit.ly/1hDn9oj","display_url":"bit.ly/1hDn9oj"}],"annotations":{},"hashtags":[{"start":15,"end":25,"tag":"guideline"},{"start":50,"end":63,"tag":"spectroscopy"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"474874772560826369","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our press release on the reinstatement of the GMP certificate for #Ranbaxy India has been published yesterday: http://t.co/E5d5NdmHYx","id":"474869455257083904","created_at":"2014-06-06T11:04:35.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/E5d5NdmHYx","expanded_url":"http://bit.ly/1kElf5V","display_url":"bit.ly/1kElf5V"}],"annotations":[{"start":75,"end":79,"probability":0.9548,"type":"Place","normalized_text":"India"}],"hashtags":[{"start":66,"end":74,"tag":"Ranbaxy"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474869455257083904","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published an update on our adaptive licensing pilot project: http://t.co/NrWFMziB3j #adaptivelicensing","id":"474857934217039872","created_at":"2014-06-06T10:18:48.000Z","entities":{"mentions":{},"urls":[{"start":67,"end":89,"url":"http://t.co/NrWFMziB3j","expanded_url":"http://bit.ly/SApXGS","display_url":"bit.ly/SApXGS"}],"annotations":{},"hashtags":[{"start":90,"end":108,"tag":"adaptivelicensing"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474857934217039872","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to answer our call for scientific data for systematic review of the monograph on #Meliloti herba: http://t.co/7wm33B5Fzq","id":"474836435082956800","created_at":"2014-06-06T08:53:22.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/7wm33B5Fzq","expanded_url":"http://bit.ly/Oqgtfa","display_url":"bit.ly/Oqgtfa"}],"annotations":{},"hashtags":[{"start":95,"end":104,"tag":"Meliloti"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474836435082956800","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to answer our call for scientific data for use in assessment work on #Polygoni avicularis herba: http://t.co/2BNOLbBSz8","id":"474836146951053312","created_at":"2014-06-06T08:52:14.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/2BNOLbBSz8","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"annotations":{},"hashtags":[{"start":83,"end":92,"tag":"Polygoni"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474836146951053312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to comment on a draft reflection paper on #microbiological aspects of #herbal medicines: http://t.co/u19G34rUOM","id":"474835800761597952","created_at":"2014-06-06T08:50:51.000Z","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/u19G34rUOM","expanded_url":"http://bit.ly/1oRgc37","display_url":"bit.ly/1oRgc37"}],"annotations":{},"hashtags":[{"start":56,"end":72,"tag":"microbiological"},{"start":84,"end":91,"tag":"herbal"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474835800761597952","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to answer our call for scientific data for assessment work on #Glycine max and/or #soy bean lecithin: http://t.co/N4vKrmDDvr","id":"474835415342784512","created_at":"2014-06-06T08:49:19.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/N4vKrmDDvr","expanded_url":"http://bit.ly/1tOtqip","display_url":"bit.ly/1tOtqip"}],"annotations":{},"hashtags":[{"start":76,"end":84,"tag":"Glycine"},{"start":96,"end":100,"tag":"soy"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474835415342784512","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on the draft herbal monograph on Ginkgo biloba L., folium (#Ginkgo leaf): http://t.co/6gas9Zb39T","id":"474834940950220800","created_at":"2014-06-06T08:47:26.000Z","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/6gas9Zb39T","expanded_url":"http://bit.ly/1eWeyKC","display_url":"bit.ly/1eWeyKC"}],"annotations":{},"hashtags":[{"start":84,"end":91,"tag":"Ginkgo"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474834940950220800","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We are closed on Monday 9 June. An emergency phone number will be available: http://t.co/Jp8lJUB3wJ","id":"474834518478946304","created_at":"2014-06-06T08:45:45.000Z","entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/Jp8lJUB3wJ","expanded_url":"http://bit.ly/1kwT362","display_url":"bit.ly/1kwT362"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474834518478946304","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #pharmacovigilance committee (#PRAC) meets next week. Highlights out next Friday: http://t.co/9vsqU3wNvv","id":"474834273565167616","created_at":"2014-06-06T08:44:47.000Z","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/9vsqU3wNvv","expanded_url":"http://bit.ly/SAgT4L","display_url":"bit.ly/SAgT4L"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":34,"end":39,"tag":"PRAC"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474834273565167616","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Today, @EU_Commission establishes expert group on #cancer control, call to be launched soon: http://t.co/7HWN05UWgl via @EU…","id":"474592307304734722","created_at":"2014-06-05T16:43:18.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":23,"end":37,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":109,"end":131,"url":"http://t.co/7HWN05UWgl","expanded_url":"http://ow.ly/xELDH","display_url":"ow.ly/xELDH"}],"annotations":{},"hashtags":[{"start":66,"end":73,"tag":"cancer"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474592307304734722","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474536575498719233"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: ECHA, European Commission and the Member States work together for the safety of human health and the environment.  http://t.co…","id":"474592207375433728","created_at":"2014-06-05T16:42:54.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474592207375433728","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474539136616243200"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: With just one week to go before the #WorldCup in Brazil, ECDC identifies the main #health threats to #EU travellers: http://t.…","id":"474591703626969088","created_at":"2014-06-05T16:40:54.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":62,"end":67,"probability":0.9991,"type":"Place","normalized_text":"Brazil"},{"start":70,"end":73,"probability":0.3119,"type":"Place","normalized_text":"ECDC"}],"hashtags":[{"start":49,"end":58,"tag":"WorldCup"},{"start":95,"end":102,"tag":"health"},{"start":114,"end":117,"tag":"EU"}]},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474591703626969088","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474561672599068672"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Guidance for Industry: Recognition &amp; Use of a Standard for Uniform Blood &amp; Blood Component Container Labels http://t.co/ptr9oB…","id":"474591135244251136","created_at":"2014-06-05T16:38:38.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474591135244251136","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474585270168608768"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a draft guide on #monitoring medical literature to identify adverse reactions to #medicines: http://t.co/vGBgdygQV9","id":"474574887341006848","created_at":"2014-06-05T15:34:04.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/vGBgdygQV9","expanded_url":"http://bit.ly/1nlwi3R","display_url":"bit.ly/1nlwi3R"}],"annotations":{},"hashtags":[{"start":33,"end":44,"tag":"monitoring"},{"start":97,"end":107,"tag":"medicines"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"474574887341006848","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've just published our press release on the reinstatement of the GMP certificate for #Ranbaxy in #Toansa, India : http://t.co/E5d5NdmHYx","id":"474538865521610752","created_at":"2014-06-05T13:10:56.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/E5d5NdmHYx","expanded_url":"http://bit.ly/1kElf5V","display_url":"bit.ly/1kElf5V"}],"annotations":[{"start":108,"end":112,"probability":0.9922,"type":"Place","normalized_text":"India"}],"hashtags":[{"start":87,"end":95,"tag":"Ranbaxy"},{"start":99,"end":106,"tag":"Toansa"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474538865521610752","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We are closed on Monday 9 June. An emergency telephone number will be available: http://t.co/Jp8lJUB3wJ","id":"474500471621955585","created_at":"2014-06-05T10:38:22.000Z","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/Jp8lJUB3wJ","expanded_url":"http://bit.ly/1kwT362","display_url":"bit.ly/1kwT362"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474500471621955585","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Previously unreported #MERS-CoV cases take total to 815 as of 4 June. New @ECDC_EU update: http://t.co/t7WrwfTPAT http://t.co…","id":"474484931071320064","created_at":"2014-06-05T09:36:37.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":88,"end":96,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":105,"end":127,"url":"http://t.co/t7WrwfTPAT","expanded_url":"http://bit.ly/1hdyWZX","display_url":"bit.ly/1hdyWZX"}],"annotations":{},"hashtags":[{"start":36,"end":41,"tag":"MERS"}]},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474484931071320064","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474470320993476608"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: #funding opportunities #health co-ordination activities #H2020 http://t.co/f7dx94asNL http://t.co/Hwc2CAhUyB","id":"474484374227156992","created_at":"2014-06-05T09:34:24.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":79,"end":101,"url":"http://t.co/f7dx94asNL","expanded_url":"http://bit.ly/SoisT8","display_url":"bit.ly/SoisT8"},{"start":102,"end":124,"url":"http://t.co/Hwc2CAhUyB","expanded_url":"https://twitter.com/EU_eHealth/status/474483974564499456/photo/1","display_url":"pic.twitter.com/Hwc2CAhUyB"}],"annotations":{},"hashtags":[{"start":16,"end":24,"tag":"funding"},{"start":39,"end":46,"tag":"health"},{"start":72,"end":78,"tag":"H2020"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474484374227156992","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474483974564499456"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_474483973545271297"]}},{"text":"We've published the EPAR for #Olysio (#simeprevir), a #medicine for chronic #hepatitisC: http://t.co/GCSFE4yC7L","id":"474481291736666112","created_at":"2014-06-05T09:22:10.000Z","entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/GCSFE4yC7L","expanded_url":"http://bit.ly/UbuKQs","display_url":"bit.ly/UbuKQs"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"Olysio"},{"start":38,"end":49,"tag":"simeprevir"},{"start":54,"end":63,"tag":"medicine"},{"start":76,"end":87,"tag":"hepatitisC"}]},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"474481291736666112","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@DaHammerstein Please see our website http://t.co/LNBEeY2duC or send us your query at http://t.co/WmzsxywJC8 so we can reply in detail.","id":"474480731709009920","created_at":"2014-06-05T09:19:56.000Z","entities":{"mentions":[{"start":0,"end":14,"username":"DaHammerstein","id":"18483956"}],"urls":[{"start":38,"end":60,"url":"http://t.co/LNBEeY2duC","expanded_url":"http://bit.ly/1hAZBAb","display_url":"bit.ly/1hAZBAb"},{"start":86,"end":108,"url":"http://t.co/WmzsxywJC8","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"474203684906471426","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"474277159356624896"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"18483956"},{"text":"RT @MHRApress: Joint MHRA &amp; PHE investigation into Bacillus cereus infections http://t.co/609bmWmZSh","id":"474235161136357378","created_at":"2014-06-04T17:04:07.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":82,"end":104,"url":"http://t.co/609bmWmZSh","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON423473","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474235161136357378","source":"Twitter for iPhone","lang":"fr","referenced_tweets":[{"type":"retweeted","id":"474231855722811392"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Class 1 Medicines Recall (Action Now – including out of hours): Lipid Phase only of Parenteral Nutrition man... http://t…","id":"474234674706145280","created_at":"2014-06-04T17:02:11.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474234674706145280","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474231291412361216"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Theft and #falsification of anticancer medicines: France not affected but take care http://t.co/W244SWWP4F","id":"474234492300042240","created_at":"2014-06-04T17:01:28.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":94,"end":116,"url":"http://t.co/W244SWWP4F","expanded_url":"http://ow.ly/xCyag","display_url":"ow.ly/xCyag"}],"annotations":[{"start":60,"end":65,"probability":0.9768,"type":"Place","normalized_text":"France"}],"hashtags":[{"start":20,"end":34,"tag":"falsification"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474220353502576640","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"replied_to","id":"474220353502576640"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"2443530930"},{"text":"RT @MHRAgovuk: First meeting of the generic medicine Quality Forum http://t.co/ShMIc8fAlz","id":"474233789800251392","created_at":"2014-06-04T16:58:40.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":67,"end":89,"url":"http://t.co/ShMIc8fAlz","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON423470","display_url":"mhra.gov.uk/NewsCentre/CON…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474233789800251392","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474219999708848128"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @gr2014eu: Forgot the term #pharmacovigilance?#gr2014euScoreboard 2 jog our memory on quality #medicines http://t.co/8FP7uJz0RO http://t…","id":"474211106576420864","created_at":"2014-06-04T15:28:32.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"gr2014eu","id":"1397477076"}],"urls":[{"start":108,"end":130,"url":"http://t.co/8FP7uJz0RO","expanded_url":"http://gr2014.eu/news/press-releases/council-confirms-deal-financing-reinforced-pharmacovigilance","display_url":"gr2014.eu/news/press-rel…"}],"annotations":{},"hashtags":[{"start":30,"end":48,"tag":"pharmacovigilance"},{"start":49,"end":68,"tag":"gr2014euScoreboard"},{"start":97,"end":107,"tag":"medicines"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474211106576420864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474209947916709888"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Olysio (#simeprevir), a new #medicine for chronic #hepatitisC: http://t.co/GCSFE4yC7L","id":"474205053105217536","created_at":"2014-06-04T15:04:29.000Z","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/GCSFE4yC7L","expanded_url":"http://bit.ly/UbuKQs","display_url":"bit.ly/UbuKQs"}],"annotations":{},"hashtags":[{"start":42,"end":49,"tag":"Olysio"},{"start":51,"end":62,"tag":"simeprevir"},{"start":71,"end":80,"tag":"medicine"},{"start":93,"end":104,"tag":"hepatitisC"}]},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"474205053105217536","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@DaHammerstein We have a policy in place on dealing with potential conflicts of interests for staff: http://t.co/wpDUz1KM38","id":"474203684906471426","created_at":"2014-06-04T14:59:03.000Z","entities":{"mentions":[{"start":0,"end":14,"username":"DaHammerstein","id":"18483956"}],"urls":[{"start":101,"end":123,"url":"http://t.co/wpDUz1KM38","expanded_url":"http://bit.ly/1ifD0lX","display_url":"bit.ly/1ifD0lX"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"474203684906471426","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"18483956"},{"text":"@commonsnetwork We have a policy in place on dealing with potential conflicts of interests for staff: http://t.co/wpDUz1KM38","id":"474203203924684800","created_at":"2014-06-04T14:57:08.000Z","entities":{"mentions":[{"start":0,"end":15,"username":"commonsnetwork","id":"2347362492"}],"urls":[{"start":102,"end":124,"url":"http://t.co/wpDUz1KM38","expanded_url":"http://bit.ly/1ifD0lX","display_url":"bit.ly/1ifD0lX"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474202093755322368","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"474202093755322368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"2347362492"},{"text":"RT @openFDA: #hdpalooza is over but #openfda is just beginning! We're in awe of the apps being built off the platform. Keep on telling us y…","id":"474192081377046529","created_at":"2014-06-04T14:12:56.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"openFDA","id":"2227519598"}],"urls":{},"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"hdpalooza"},{"start":36,"end":44,"tag":"openfda"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474192081377046529","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474190946163523584"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: European Commission establishes expert group on cancer control http://t.co/VjePt2FHrq","id":"474191973331783680","created_at":"2014-06-04T14:12:31.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":76,"end":98,"url":"http://t.co/VjePt2FHrq","expanded_url":"http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1490","display_url":"ec.europa.eu/dgs/health_con…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474191973331783680","source":"TweetDeck","lang":"fr","referenced_tweets":[{"type":"retweeted","id":"474190328711614464"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: .@EU_Commission establishes an expert group on #Cancer Control #CANCON cc. @2014CanCon http://t.co/JO3GpZEuTW","id":"474185306955350016","created_at":"2014-06-04T13:46:01.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{},"hashtags":[{"start":62,"end":69,"tag":"Cancer"},{"start":78,"end":85,"tag":"CANCON"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474185306955350016","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474174713628209152"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Commission establishes expert group on cancer control http://t.co/HKT7lDSXMY via @EU_Health","id":"474185119293767680","created_at":"2014-06-04T13:45:17.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":92,"end":102,"username":"EU_Health","id":"606325697"}],"urls":[{"start":65,"end":87,"url":"http://t.co/HKT7lDSXMY","expanded_url":"http://bit.ly/1l5ge60","display_url":"bit.ly/1l5ge60"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474185119293767680","source":"TweetDeck","lang":"fr","referenced_tweets":[{"type":"retweeted","id":"474173448538062848"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @agesnews: Medicine warning: #BASG on falsified cancer medicines - further products affected #Avastin #MabThera http://t.co/ijFBLlu6tC","id":"474184869900472320","created_at":"2014-06-04T13:44:17.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":115,"end":137,"url":"http://t.co/ijFBLlu6tC","expanded_url":"http://bit.ly/1tHLxER","display_url":"bit.ly/1tHLxER"}],"annotations":{},"hashtags":[{"start":32,"end":37,"tag":"BASG"},{"start":96,"end":104,"tag":"Avastin"},{"start":105,"end":114,"tag":"MabThera"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474184869900472320","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA: Update on investigation by Italian authorities into the supply of stolen medicines http://t.co/CAhOtmi2iK","id":"474184329409871872","created_at":"2014-06-04T13:42:08.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":101,"end":123,"url":"http://t.co/CAhOtmi2iK","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/06/news_detail_002113.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474184329409871872","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474168153774489600"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: Check out our pictograms &amp; Best Practice Guide for labelling #VeterinaryMedicines http://t.co/ncg4Y1VYXZ http://t.co/ESukpu…","id":"474183861262626816","created_at":"2014-06-04T13:40:17.000Z","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/ncg4Y1VYXZ","expanded_url":"http://bit.ly/1uhAogf","display_url":"bit.ly/1uhAogf"}],"annotations":{},"hashtags":[{"start":81,"end":101,"tag":"VeterinaryMedicines"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474183861262626816","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474164391651606528"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: Just published Best Practice Guide for Pictogram Use on #VeterinaryMedicines: http://t.co/GkvTwvJL2f @vetsonline @animalpha…","id":"474183503765331968","created_at":"2014-06-04T13:38:51.000Z","entities":{"mentions":[{"start":117,"end":128,"username":"vetsonline","id":"4860726625"}],"urls":[{"start":94,"end":116,"url":"http://t.co/GkvTwvJL2f","expanded_url":"http://bit.ly/1x6mQqh","display_url":"bit.ly/1x6mQqh"}],"annotations":{},"hashtags":[{"start":72,"end":92,"tag":"VeterinaryMedicines"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474183503765331968","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474163885902409728"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: #IFAHEurope just published Best Practice Guide for Pictogram Use on #VeterinaryMedicines: http://t.co/GkvTwvJL2f @Official_…","id":"474183432038518784","created_at":"2014-06-04T13:38:34.000Z","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/GkvTwvJL2f","expanded_url":"http://bit.ly/1x6mQqh","display_url":"bit.ly/1x6mQqh"}],"annotations":{},"hashtags":[{"start":16,"end":27,"tag":"IFAHEurope"},{"start":84,"end":104,"tag":"VeterinaryMedicines"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474183432038518784","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474163606146547714"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Updated information on stolen Italian medicines http://t.co/yN8v8BCQoM","id":"474174692061106176","created_at":"2014-06-04T13:03:50.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":60,"end":82,"url":"http://t.co/yN8v8BCQoM","expanded_url":"http://bit.ly/1l5gT7A","display_url":"bit.ly/1l5gT7A"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"474174692061106176","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: To report any potential or actual biological product shortage, e-mail #CBER at  CBERshortage@fda.hhs.gov  (http://t.co/UP0Oih0…","id":"474146972895817728","created_at":"2014-06-04T11:13:42.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":{},"hashtags":[{"start":83,"end":88,"tag":"CBER"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474146972895817728","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474146866389848065"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Yesterday we published an update on the investigation into supply of stolen #medicines: also #Avastin &amp; #MabThera: http://t.co/vIxnejxbcV","id":"474129735287857152","created_at":"2014-06-04T10:05:12.000Z","entities":{"mentions":{},"urls":[{"start":119,"end":141,"url":"http://t.co/vIxnejxbcV","expanded_url":"http://bit.ly/1l36Yzx","display_url":"bit.ly/1l36Yzx"}],"annotations":{},"hashtags":[{"start":76,"end":86,"tag":"medicines"},{"start":93,"end":101,"tag":"Avastin"},{"start":108,"end":117,"tag":"MabThera"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474129735287857152","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our revised #guideline on the acceptability of names for human #medicines is now available: http://t.co/nWo0bdqEfO","id":"474129119362695168","created_at":"2014-06-04T10:02:45.000Z","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/nWo0bdqEfO","expanded_url":"http://bit.ly/U9iFLw","display_url":"bit.ly/U9iFLw"}],"annotations":{},"hashtags":[{"start":12,"end":22,"tag":"guideline"},{"start":63,"end":73,"tag":"medicines"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"474129119362695168","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Just one click can help the #WorldHepatitisDay message reach millions. Sign up to the #hepatitis Thunderclap! http://t.co…","id":"474128280904544256","created_at":"2014-06-04T09:59:25.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":{},"hashtags":[{"start":46,"end":64,"tag":"WorldHepatitisDay"},{"start":104,"end":114,"tag":"hepatitis"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474128280904544256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"474125685406310400"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo: Where's the acceptance boundary for blood clots with birth-control pills? @steinarmadsen #LMK14 http://t.co/I1n4b1TClZ","id":"474105826354147328","created_at":"2014-06-04T08:30:12.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"},{"start":94,"end":108,"username":"steinarmadsen","id":"283916267"}],"urls":[{"start":116,"end":138,"url":"http://t.co/I1n4b1TClZ","expanded_url":"http://bit.ly/1mQZLRw","display_url":"bit.ly/1mQZLRw"}],"annotations":{},"hashtags":[{"start":109,"end":115,"tag":"LMK14"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474105826354147328","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo: CHMP assesses, approves and follows up on medicines in the centralised procedure: http://t.co/5DojNWfUzb #LMK14","id":"474104784195448832","created_at":"2014-06-04T08:26:03.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":102,"end":124,"url":"http://t.co/5DojNWfUzb","expanded_url":"http://bit.ly/1pEAuyF","display_url":"bit.ly/1pEAuyF"}],"annotations":[{"start":20,"end":23,"probability":0.523,"type":"Organization","normalized_text":"CHMP"}],"hashtags":[{"start":125,"end":131,"tag":"LMK14"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"474104784195448832","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published an update on the Italian investigation into the supply of stolen #medicines: http://t.co/vIxnejxbcV","id":"473865023102930944","created_at":"2014-06-03T16:33:20.000Z","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/vIxnejxbcV","expanded_url":"http://bit.ly/1l36Yzx","display_url":"bit.ly/1l36Yzx"}],"annotations":{},"hashtags":[{"start":81,"end":91,"tag":"medicines"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473865023102930944","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @nakosbalamotis: Regulatory info: Revised guideline on acceptability of names for human medicines is published #EMA #NRG http://t.co/5…","id":"473864552225189889","created_at":"2014-06-03T16:31:27.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":{},"annotations":{},"hashtags":[{"start":116,"end":120,"tag":"EMA"},{"start":121,"end":125,"tag":"NRG"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473864552225189889","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473862360403161088"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a revised #guideline on the acceptability of names for human #medicines: http://t.co/nWo0bdqEfO","id":"473864023164088320","created_at":"2014-06-03T16:29:21.000Z","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/nWo0bdqEfO","expanded_url":"http://bit.ly/U9iFLw","display_url":"bit.ly/U9iFLw"}],"annotations":{},"hashtags":[{"start":28,"end":38,"tag":"guideline"},{"start":79,"end":89,"tag":"medicines"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"473864023164088320","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: Risk assessment http://t.co/EEwv9RwqFM on wild-type poliovirus in Israel&amp;Syria  not changed ff @WHO PHEIC declaration http…","id":"473859609867087872","created_at":"2014-06-03T16:11:49.000Z","entities":{"mentions":[{"start":116,"end":120,"username":"WHO","id":"14499829"}],"urls":[{"start":33,"end":55,"url":"http://t.co/EEwv9RwqFM","expanded_url":"http://bit.ly/1p4EnKE","display_url":"bit.ly/1p4EnKE"}],"annotations":[{"start":83,"end":88,"probability":0.9953,"type":"Place","normalized_text":"Israel"},{"start":90,"end":94,"probability":0.8907,"type":"Place","normalized_text":"Syria"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473859609867087872","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473854395021787136"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: ECDC assesses risk of #polio importation, sustained transmission to #EU ff recent @WHO #PHEIC declaration http://t.co/sjkfEAfl…","id":"473859481626243072","created_at":"2014-06-03T16:11:18.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":95,"end":99,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":[{"start":35,"end":41,"tag":"polio"},{"start":81,"end":84,"tag":"EU"},{"start":100,"end":106,"tag":"PHEIC"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473859481626243072","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473850799177891840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Biologics Research Project: Candidate universal influenza A vaccine reduces virus transmission in mice  http://t.co/xWCw1kp4hK","id":"473859391721336832","created_at":"2014-06-03T16:10:57.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":117,"end":139,"url":"http://t.co/xWCw1kp4hK","expanded_url":"http://1.usa.gov/U99lal","display_url":"1.usa.gov/U99lal"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473859391721336832","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473850323120185344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Follow the news from the French medicines agency by signing up for ANSM Actu, their monthly newsletter  http://t.co/dh5APOJMzc","id":"473858413861285889","created_at":"2014-06-03T16:07:04.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":114,"end":136,"url":"http://t.co/dh5APOJMzc","expanded_url":"http://bit.ly/Sqt04k","display_url":"bit.ly/Sqt04k"}],"annotations":[{"start":77,"end":85,"probability":0.4595,"type":"Organization","normalized_text":"ANSM Actu"}],"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"473858413861285889","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: EGA calls @EU_Commission for  “Preventive application of safety features to increase #patientsafety” #GRIPAGM #AntiCounter…","id":"473857420830072832","created_at":"2014-06-03T16:03:07.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":27,"end":41,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{},"hashtags":[{"start":102,"end":116,"tag":"patientsafety"},{"start":118,"end":126,"tag":"GRIPAGM"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473857420830072832","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473831186494935041"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: Event at @Europarl_EN on how #EUresearch benefit #asthma #allergy and #COPD #patients. Register at: http://t.co/GUN8nviaB…","id":"473857330011201536","created_at":"2014-06-03T16:02:45.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":27,"end":39,"username":"Europarl_EN","id":"36329597"}],"urls":{},"annotations":{},"hashtags":[{"start":47,"end":58,"tag":"EUresearch"},{"start":67,"end":74,"tag":"asthma"},{"start":75,"end":83,"tag":"allergy"},{"start":88,"end":93,"tag":"COPD"},{"start":94,"end":103,"tag":"patients"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473857330011201536","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473829230254768129"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Discover the latest edition of the French medicines agency's newsletter http://t.co/vKsu6Zvjv2","id":"473822349209636864","created_at":"2014-06-03T13:43:45.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":82,"end":104,"url":"http://t.co/vKsu6Zvjv2","expanded_url":"http://bit.ly/1hVwQsL","display_url":"bit.ly/1hVwQsL"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"473822349209636864","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: CVM Update - FDA Approves First Oral Drug for #Fleas and #Ticks in #Dogs with Three Month http://t.co/Aj12oDQbJb #Pets","id":"473819463503314944","created_at":"2014-06-03T13:32:17.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":111,"end":133,"url":"http://t.co/Aj12oDQbJb","expanded_url":"http://1.usa.gov/1m7PwXi","display_url":"1.usa.gov/1m7PwXi"}],"annotations":[{"start":34,"end":36,"probability":0.8352,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":67,"end":73,"tag":"Fleas"},{"start":78,"end":84,"tag":"Ticks"},{"start":88,"end":93,"tag":"Dogs"},{"start":134,"end":139,"tag":"Pets"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473819463503314944","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473814259978502144"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Webcast recordings of the symposium will be posted on our website after the event. http://t.co/0QrvKyyt7r #FDARegSci Day 2 st…","id":"473811468102926336","created_at":"2014-06-03T13:00:31.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":97,"end":119,"url":"http://t.co/0QrvKyyt7r","expanded_url":"http://ht.ly/xziVr","display_url":"ht.ly/xziVr"}],"annotations":{},"hashtags":[{"start":120,"end":130,"tag":"FDARegSci"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473811468102926336","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473809538060406784"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: If you're tuning in for the first time today, the program and abstracts book is available at (PDF): http://t.co/Ikd1vfK6bb #F…","id":"473808197795741696","created_at":"2014-06-03T12:47:31.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Ikd1vfK6bb","expanded_url":"http://ht.ly/xoUvE","display_url":"ht.ly/xoUvE"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473808197795741696","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473807831507148800"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_TB: Annual meeting of the EU/EEA #TB Surveillance Network: chance to discuss latest  #tuberculosis data, #MDRTB &amp; more http://t.co…","id":"473804657228541952","created_at":"2014-06-03T12:33:27.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"annotations":[{"start":35,"end":36,"probability":0.6082,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":42,"end":45,"tag":"TB"},{"start":94,"end":107,"tag":"tuberculosis"},{"start":114,"end":120,"tag":"MDRTB"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473804657228541952","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473804558565920768"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Tune into Day 2 of the MCMi Regulatory Science Symposium. Webcast: http://t.co/u867eE6kMV  Agenda: http://t.co/JFP0Uc9Rq9  #F…","id":"473804126112198656","created_at":"2014-06-03T12:31:21.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":81,"end":103,"url":"http://t.co/u867eE6kMV","expanded_url":"http://ow.ly/xxM11","display_url":"ow.ly/xxM11"},{"start":113,"end":135,"url":"http://t.co/JFP0Uc9Rq9","expanded_url":"http://ow.ly/xxM12","display_url":"ow.ly/xxM12"}],"annotations":[{"start":37,"end":69,"probability":0.4274,"type":"Other","normalized_text":"MCMi Regulatory Science Symposium"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473804126112198656","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473803941038534657"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAcdrhIndustry: OpenFDA: Innovative Initiative Opens Door to Wealth of FDA’s Publicly Available Data http://t.co/xvEXNfaQKv #fda #medi…","id":"473801172558835712","created_at":"2014-06-03T12:19:37.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"urls":[{"start":106,"end":128,"url":"http://t.co/xvEXNfaQKv","expanded_url":"http://1.usa.gov/1nKrzfn","display_url":"1.usa.gov/1nKrzfn"}],"annotations":[{"start":76,"end":78,"probability":0.7987,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":129,"end":133,"tag":"fda"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473801172558835712","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473789577598353408"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @nakosbalamotis: Article &gt; #UK likes the look of #EMA quicker approvals pilot http://t.co/akgBi36OJ0","id":"473769832253763584","created_at":"2014-06-03T10:15:04.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"nakosbalamotis","id":"39364251"}],"urls":[{"start":84,"end":106,"url":"http://t.co/akgBi36OJ0","expanded_url":"http://pharmatimes.com/Article/14-06-03/UK_likes_the_look_of_EMA_quicker_approvals_pilot.aspx","display_url":"pharmatimes.com/Article/14-06-…"}],"annotations":{},"hashtags":[{"start":33,"end":36,"tag":"UK"},{"start":55,"end":59,"tag":"EMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473769832253763584","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473769779539361793"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Please RT: One click can help the #WorldHepatitisDay message reach millions. Sign up to the #hepatitis Thunderclap! http:…","id":"473748636732751872","created_at":"2014-06-03T08:50:51.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":{},"hashtags":[{"start":52,"end":70,"tag":"WorldHepatitisDay"},{"start":110,"end":120,"tag":"hepatitis"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473748636732751872","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473735466882441216"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@byzondereekster The list of medicines under evaluation is here: http://t.co/mj9hwo6F0b. You can also check http://t.co/ZawcY9h5eL.","id":"473747875638550528","created_at":"2014-06-03T08:47:50.000Z","entities":{"mentions":[{"start":0,"end":16,"username":"byzondereekster","id":"284748226"}],"urls":[{"start":65,"end":87,"url":"http://t.co/mj9hwo6F0b","expanded_url":"http://bit.ly/1tDN3I6","display_url":"bit.ly/1tDN3I6"},{"start":108,"end":130,"url":"http://t.co/ZawcY9h5eL","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"473747875638550528","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"284748226"},{"text":"RT @EATGx: 2013 EATG Annual Report: 2013 EATG Annual Report is now available. You can download the full report and execut... http://t.co/Fx…","id":"473494244716724227","created_at":"2014-06-02T15:59:59.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473494244716724227","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473440053704663041"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Register for the open #NDA plenary meeting. 26/06/14 http://t.co/00RXB9Vdhe #DieteticProducts #Nutrition","id":"473493649419165697","created_at":"2014-06-02T15:57:37.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":66,"end":88,"url":"http://t.co/00RXB9Vdhe","expanded_url":"http://bit.ly/1gAiWkr","display_url":"bit.ly/1gAiWkr"}],"annotations":{},"hashtags":[{"start":35,"end":39,"tag":"NDA"},{"start":89,"end":106,"tag":"DieteticProducts"},{"start":107,"end":117,"tag":"Nutrition"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473493649419165697","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473464055844597761"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: #Patients of #asthma #allergy and #COPD and the benefits of #EUresearch. Event at EP http://t.co/GUN8nviaBF @IPCRG @UEMSE…","id":"473492212173787137","created_at":"2014-06-02T15:51:55.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":126,"end":132,"username":"IPCRG","id":"320655052"}],"urls":[{"start":103,"end":125,"url":"http://t.co/GUN8nviaBF","expanded_url":"http://bit.ly/1piouQl","display_url":"bit.ly/1piouQl"}],"annotations":{},"hashtags":[{"start":18,"end":27,"tag":"Patients"},{"start":31,"end":38,"tag":"asthma"},{"start":39,"end":47,"tag":"allergy"},{"start":52,"end":57,"tag":"COPD"},{"start":78,"end":89,"tag":"EUresearch"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473492212173787137","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473477560022872064"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: #H2020 funding opportunities #Nanotechnology &amp; Advanced Materials for more effective #Healthcare http://t.co/aqqNZpNAJW WP …","id":"473437113959333888","created_at":"2014-06-02T12:12:58.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":117,"end":139,"url":"http://t.co/aqqNZpNAJW","expanded_url":"http://bit.ly/1mIKUbL","display_url":"bit.ly/1mIKUbL"}],"annotations":{},"hashtags":[{"start":16,"end":22,"tag":"H2020"},{"start":45,"end":60,"tag":"Nanotechnology"},{"start":105,"end":116,"tag":"Healthcare"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473437113959333888","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473431484578406400"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: What are food-borne zoonotic diseases? Find out in our Understanding #Science http://t.co/VUaeerLgNw","id":"473437006262198272","created_at":"2014-06-02T12:12:33.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":91,"end":113,"url":"http://t.co/VUaeerLgNw","expanded_url":"http://youtu.be/RV-IxADqsTY","display_url":"youtu.be/RV-IxADqsTY"}],"annotations":{},"hashtags":[{"start":82,"end":90,"tag":"Science"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473437006262198272","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473435117093130240"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We welcome the Clinical Trials Regulation published last week in the Official Journal of the EU: http://t.co/ofY2uImInB","id":"473424650958286848","created_at":"2014-06-02T11:23:27.000Z","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/ofY2uImInB","expanded_url":"http://bit.ly/Sf4hzU","display_url":"bit.ly/Sf4hzU"}],"annotations":[{"start":15,"end":40,"probability":0.4935,"type":"Other","normalized_text":"Clinical Trials Regulation"}],"hashtags":{}},"public_metrics":{"retweet_count":11,"reply_count":2,"like_count":2,"quote_count":0},"conversation_id":"473424650958286848","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Interested in organizing mutual joint visits and audits of laboratories within the #OMCL Network? Apply today! http://t.co/Q…","id":"473403264621641728","created_at":"2014-06-02T09:58:28.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":98,"end":103,"tag":"OMCL"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473403264621641728","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"473385564109307904"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our reflection paper on #microbiological aspects of #herbal medicines: http://t.co/u19G34rUOM #consultation","id":"473399672879730689","created_at":"2014-06-02T09:44:12.000Z","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/u19G34rUOM","expanded_url":"http://bit.ly/1oRgc37","display_url":"bit.ly/1oRgc37"}],"annotations":{},"hashtags":[{"start":53,"end":69,"tag":"microbiological"},{"start":81,"end":88,"tag":"herbal"},{"start":123,"end":136,"tag":"consultation"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473399672879730689","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to answer our call for data for use in #herbal assessment work on #Polygoni avicularis herba: http://t.co/2BNOLbBSz8","id":"473399504507793408","created_at":"2014-06-02T09:43:31.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/2BNOLbBSz8","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"annotations":{},"hashtags":[{"start":54,"end":61,"tag":"herbal"},{"start":81,"end":90,"tag":"Polygoni"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473399504507793408","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to answer our call for data for #herbal assessment work on #Glycine max (#soy bean lecithin): http://t.co/N4vKrmDDvr","id":"473399325947871232","created_at":"2014-06-02T09:42:49.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/N4vKrmDDvr","expanded_url":"http://bit.ly/1tOtqip","display_url":"bit.ly/1tOtqip"}],"annotations":{},"hashtags":[{"start":47,"end":54,"tag":"herbal"},{"start":74,"end":82,"tag":"Glycine"},{"start":88,"end":92,"tag":"soy"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473399325947871232","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to answer our call for data for the systematic review of the #herbal monograph on #Meliloti herba: http://t.co/7wm33B5Fzq","id":"473399101359677441","created_at":"2014-06-02T09:41:55.000Z","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/7wm33B5Fzq","expanded_url":"http://bit.ly/Oqgtfa","display_url":"bit.ly/Oqgtfa"}],"annotations":{},"hashtags":[{"start":76,"end":83,"tag":"herbal"},{"start":97,"end":106,"tag":"Meliloti"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473399101359677441","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #veterinary committee (#CVMP) meets this week. We'll publish highlights this Friday: http://t.co/Jp9NsmuMUT","id":"473396555102568448","created_at":"2014-06-02T09:31:48.000Z","entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/Jp9NsmuMUT","expanded_url":"http://bit.ly/1jt5VnD","display_url":"bit.ly/1jt5VnD"}],"annotations":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":27,"end":32,"tag":"CVMP"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473396555102568448","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our draft Community #herbal monograph on #Ginkgo biloba L., folium (ginkgo leaf): http://t.co/6gas9Zb39T","id":"473393818822524928","created_at":"2014-06-02T09:20:56.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/6gas9Zb39T","expanded_url":"http://bit.ly/1eWeyKC","display_url":"bit.ly/1eWeyKC"}],"annotations":{},"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":77,"tag":"Ginkgo"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"473393818822524928","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRApress: MHRA Enforcement Team's Operation Pangea VII raids feature on tonight’s episode of The One Show 7pm @BBCOne http://t.co/YwTt…","id":"471689351962050560","created_at":"2014-05-28T16:27:59.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"},{"start":115,"end":122,"username":"BBCOne","id":"871686942"}],"urls":{},"annotations":[{"start":98,"end":113,"probability":0.6032,"type":"Other","normalized_text":"The One Show 7pm"}],"hashtags":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471689351962050560","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471689088186449922"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA is working to prevent drug-induced liver injuries while developing new treatments: http://t.co/cPwXiriprf","id":"471685779304251393","created_at":"2014-05-28T16:13:47.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":107,"end":129,"url":"http://t.co/cPwXiriprf","expanded_url":"http://go.usa.gov/8U85","display_url":"go.usa.gov/8U85"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471685779304251393","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471685039831674880"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Did you know there are new #HepC treatments with higher cure rates? @liverUSA #Hepatitis C webinar starting now http://t.…","id":"471683881696256000","created_at":"2014-05-28T16:06:15.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":86,"end":95,"username":"liverUSA","id":"105244363"}],"urls":{},"annotations":{},"hashtags":[{"start":45,"end":50,"tag":"HepC"},{"start":96,"end":106,"tag":"Hepatitis"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471683881696256000","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471682343539712001"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #PublicConsultation on the Draft Guidance on #Statistical Reporting. Deadline: 23 July 2014\nhttp://t.co/GiZqEuwkYj","id":"471683722543366144","created_at":"2014-05-28T16:05:37.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":105,"end":127,"url":"http://t.co/GiZqEuwkYj","expanded_url":"http://bit.ly/1pj8Qaj","display_url":"bit.ly/1pj8Qaj"}],"annotations":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"},{"start":58,"end":70,"tag":"Statistical"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471683722543366144","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471682316952436736"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Publication of the European Regulation on clinical trials witrh medicinal products for human use http://t.co/54G9xvhDy0","id":"471681288605540352","created_at":"2014-05-28T15:55:57.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":111,"end":133,"url":"http://t.co/54G9xvhDy0","expanded_url":"http://bit.ly/1nUM5Wg","display_url":"bit.ly/1nUM5Wg"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"471681288605540352","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: The French medicines agency has published information on the May #CHMP meeting http://t.co/TBo3wFnTSx","id":"471677863356563456","created_at":"2014-05-28T15:42:20.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":89,"end":111,"url":"http://t.co/TBo3wFnTSx","expanded_url":"http://bit.ly/1pjBIiA","display_url":"bit.ly/1pjBIiA"}],"annotations":{},"hashtags":[{"start":75,"end":80,"tag":"CHMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471677863356563456","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We welcome publication of the Clinical Trials Regulation: http://t.co/ofY2uImInB","id":"471659842625863680","created_at":"2014-05-28T14:30:44.000Z","entities":{"mentions":{},"urls":[{"start":58,"end":80,"url":"http://t.co/ofY2uImInB","expanded_url":"http://bit.ly/Sf4hzU","display_url":"bit.ly/Sf4hzU"}],"annotations":[{"start":30,"end":55,"probability":0.6847,"type":"Other","normalized_text":"Clinical Trials Regulation"}],"hashtags":{}},"public_metrics":{"retweet_count":21,"reply_count":2,"like_count":6,"quote_count":0},"conversation_id":"471659842625863680","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: \"WHO To Develop Global Action Plan Against Antibiotic Resistance\" http://t.co/cUfwRbQeGl","id":"471658515992694784","created_at":"2014-05-28T14:25:27.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":77,"end":99,"url":"http://t.co/cUfwRbQeGl","expanded_url":"http://bit.ly/1nUpIAh","display_url":"bit.ly/1nUpIAh"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471658515992694784","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471658129739239424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @US_FDA: Drugs/supplements can wreak havoc on your liver. Info on drug-induced liver injury prevention http://t.co/IIt02i8X1u http://t.c…","id":"471658292822155264","created_at":"2014-05-28T14:24:34.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":106,"end":128,"url":"http://t.co/IIt02i8X1u","expanded_url":"http://go.usa.gov/8U5T","display_url":"go.usa.gov/8U5T"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471658292822155264","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471655734833594368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Advice on the use of medicines before conception, during #pregnancy and during #breastfeeding http://t.co/SgmUskZeA8","id":"471657872557092864","created_at":"2014-05-28T14:22:54.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":114,"end":136,"url":"http://t.co/SgmUskZeA8","expanded_url":"http://bit.ly/Sf3BdJ","display_url":"bit.ly/Sf3BdJ"}],"annotations":{},"hashtags":[{"start":77,"end":87,"tag":"pregnancy"},{"start":99,"end":113,"tag":"breastfeeding"}]},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"471657872557092864","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: .@FDACBER pilot to evaluate postmarketing vaccine safety reports (VAERS) - requests to participate due June 27, 2014. http://…","id":"471644786248937472","created_at":"2014-05-28T13:30:54.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"},{"start":15,"end":23,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471644786248937472","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471643696153509888"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Have a look at the proceedings for ECHA’s first Topical Scientific Workshop http://t.co/P9tb7WG8aM http://t.co/hhw3uP3aoS","id":"471644525652619264","created_at":"2014-05-28T13:29:52.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":89,"end":111,"url":"http://t.co/P9tb7WG8aM","expanded_url":"http://bit.ly/1gA885D","display_url":"bit.ly/1gA885D"},{"start":112,"end":134,"url":"http://t.co/hhw3uP3aoS","expanded_url":"https://twitter.com/EU_ECHA/status/471632084050935808/photo/1","display_url":"pic.twitter.com/hhw3uP3aoS"}],"annotations":[{"start":48,"end":87,"probability":0.2795,"type":"Other","normalized_text":"ECHA’s first Topical Scientific Workshop"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471644525652619264","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471632084050935808"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_471632082356039680"]}},{"text":"RT @EC_AVService: Help the EC to improve its online presence by taking this survey: http://t.co/Lhe42AYPS9\n@EU_Commission http://t.co/7S63C…","id":"471644168914497537","created_at":"2014-05-28T13:28:27.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EC_AVService","id":"56392389"},{"start":107,"end":121,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":84,"end":106,"url":"http://t.co/Lhe42AYPS9","expanded_url":"http://svy.mk/1tUasbl","display_url":"svy.mk/1tUasbl"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471644168914497537","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471631711269560320"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: #Sday9 Did you miss our Stakeholders Day or want to have one more look? All materials are available on our website http://t.co…","id":"471644074899152897","created_at":"2014-05-28T13:28:04.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{},"hashtags":[{"start":13,"end":19,"tag":"Sday9"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471644074899152897","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471627618371264513"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Why are #Bees under threat? Watch our Understanding #Science video http://t.co/IFoWDn1r2r","id":"471643891016695809","created_at":"2014-05-28T13:27:21.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":80,"end":102,"url":"http://t.co/IFoWDn1r2r","expanded_url":"http://youtu.be/ys4xcom6nnc","display_url":"youtu.be/ys4xcom6nnc"}],"annotations":{},"hashtags":[{"start":21,"end":26,"tag":"Bees"},{"start":65,"end":73,"tag":"Science"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471643891016695809","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471623179371548672"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #veterinary committee meets next week. Highlights will be published on Friday: http://t.co/Jp9NsmuMUT","id":"471613391963160576","created_at":"2014-05-28T11:26:09.000Z","entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/Jp9NsmuMUT","expanded_url":"http://bit.ly/1jt5VnD","display_url":"bit.ly/1jt5VnD"}],"annotations":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471613391963160576","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our reflection paper on #microbiological aspects of #herbal medicines: http://t.co/u19G34rUOM #consultation","id":"471612540469121025","created_at":"2014-05-28T11:22:46.000Z","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/u19G34rUOM","expanded_url":"http://bit.ly/1oRgc37","display_url":"bit.ly/1oRgc37"}],"annotations":{},"hashtags":[{"start":53,"end":69,"tag":"microbiological"},{"start":81,"end":88,"tag":"herbal"},{"start":123,"end":136,"tag":"consultation"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471612540469121025","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Send us your comments on our concept paper on plasma-derived #fibrin sealant / #haemostatic products: http://t.co/hDJogrfJBe #consultation","id":"471611896840613889","created_at":"2014-05-28T11:20:12.000Z","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/hDJogrfJBe","expanded_url":"http://bit.ly/1mDwPxM","display_url":"bit.ly/1mDwPxM"}],"annotations":{},"hashtags":[{"start":61,"end":68,"tag":"fibrin"},{"start":79,"end":91,"tag":"haemostatic"},{"start":125,"end":138,"tag":"consultation"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471611896840613889","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to comment on our question and answer on expression of potency in #vancomycin products: http://t.co/IbFp96WoCB #consultation","id":"471611616841453568","created_at":"2014-05-28T11:19:06.000Z","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/IbFp96WoCB","expanded_url":"http://bit.ly/OWnpS8","display_url":"bit.ly/OWnpS8"}],"annotations":{},"hashtags":[{"start":80,"end":91,"tag":"vancomycin"},{"start":125,"end":138,"tag":"consultation"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471611616841453568","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to comment on our #guideline on core product information for human #fibrinogen products: http://t.co/0gjP4JGxNi #consultation","id":"471611435173576704","created_at":"2014-05-28T11:18:22.000Z","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/0gjP4JGxNi","expanded_url":"http://bit.ly/1mS70wH","display_url":"bit.ly/1mS70wH"}],"annotations":{},"hashtags":[{"start":32,"end":42,"tag":"guideline"},{"start":81,"end":92,"tag":"fibrinogen"},{"start":126,"end":139,"tag":"consultation"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"471611435173576704","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to respond to our call for data for use in assessment work on #Polygoni avicularis herba: http://t.co/2BNOLbBSz8 #herbal","id":"471610999641214976","created_at":"2014-05-28T11:16:39.000Z","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/2BNOLbBSz8","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"annotations":{},"hashtags":[{"start":77,"end":86,"tag":"Polygoni"},{"start":128,"end":135,"tag":"herbal"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"471610999641214976","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to respond to our call for data for assessment work on #Glycine max (#soy bean lecithin): http://t.co/N4vKrmDDvr #herbal","id":"471609890608525312","created_at":"2014-05-28T11:12:14.000Z","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/N4vKrmDDvr","expanded_url":"http://bit.ly/1tOtqip","display_url":"bit.ly/1tOtqip"}],"annotations":{},"hashtags":[{"start":70,"end":78,"tag":"Glycine"},{"start":84,"end":88,"tag":"soy"},{"start":128,"end":135,"tag":"herbal"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471609890608525312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to respond to our call for data for the systematic review of the monograph on #Meliloti herba: http://t.co/7wm33B5Fzq #herbal","id":"471608065314537472","created_at":"2014-05-28T11:04:59.000Z","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/7wm33B5Fzq","expanded_url":"http://bit.ly/Oqgtfa","display_url":"bit.ly/Oqgtfa"}],"annotations":{},"hashtags":[{"start":93,"end":102,"tag":"Meliloti"},{"start":133,"end":140,"tag":"herbal"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471608065314537472","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our draft Community #herbal monograph on #Ginkgo biloba L., folium (ginkgo leaf): http://t.co/6gas9Zb39T","id":"471607604700282880","created_at":"2014-05-28T11:03:09.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/6gas9Zb39T","expanded_url":"http://bit.ly/1eWeyKC","display_url":"bit.ly/1eWeyKC"}],"annotations":{},"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":77,"tag":"Ginkgo"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"471607604700282880","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: Shared mechanisms of neurodegeneration in #Alzheimer’s disease &amp; #Parkinson’s disease: http://t.co/68SAhIM8qd","id":"471603713078210560","created_at":"2014-05-28T10:47:41.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":109,"end":131,"url":"http://t.co/68SAhIM8qd","expanded_url":"http://bit.ly/RAD2Pu","display_url":"bit.ly/RAD2Pu"}],"annotations":{},"hashtags":[{"start":60,"end":70,"tag":"Alzheimer"},{"start":87,"end":97,"tag":"Parkinson"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471603713078210560","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471603099732168704"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropeanLung: Study warns that 90% of medical entries on Wikipedia contain mistakes http://t.co/JJZEwu6cHW (1/2)","id":"471599414621241344","created_at":"2014-05-28T10:30:37.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"urls":[{"start":88,"end":110,"url":"http://t.co/JJZEwu6cHW","expanded_url":"http://bit.ly/1kK7qCt","display_url":"bit.ly/1kK7qCt"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471599414621241344","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471599274749616128"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Visit the Italian medicines agency's website with all information on #medicines and #pregnancy http://t.co/LVNEVHn0OI","id":"471593710585913344","created_at":"2014-05-28T10:07:57.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":115,"end":137,"url":"http://t.co/LVNEVHn0OI","expanded_url":"http://bit.ly/1hxvt33","display_url":"bit.ly/1hxvt33"}],"annotations":{},"hashtags":[{"start":89,"end":99,"tag":"medicines"},{"start":104,"end":114,"tag":"pregnancy"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471593710585913344","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Exactly 2 months until #WorldHepatitisDay! Like FB page to find out more about this years campaign &amp; what you can do http…","id":"471577886189953024","created_at":"2014-05-28T09:05:04.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":[{"start":66,"end":67,"probability":0.4875,"type":"Organization","normalized_text":"FB"}],"hashtags":[{"start":41,"end":59,"tag":"WorldHepatitisDay"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471577886189953024","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471577686549073921"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: Here's a full list of all our guidance and quality standards published this month: https://t.co/v3PDpciF4I","id":"471577739175411712","created_at":"2014-05-28T09:04:29.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":98,"end":121,"url":"https://t.co/v3PDpciF4I","expanded_url":"https://beta.nice.org.uk/Guidance","display_url":"beta.nice.org.uk/Guidance"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471577739175411712","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471577533620944896"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a concept paper on plasma-derived #fibrin sealant / #haemostatic products for #consultation: http://t.co/hDJogrfJBe","id":"471572788336410625","created_at":"2014-05-28T08:44:48.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/hDJogrfJBe","expanded_url":"http://bit.ly/1mDwPxM","display_url":"bit.ly/1mDwPxM"}],"annotations":{},"hashtags":[{"start":50,"end":57,"tag":"fibrin"},{"start":68,"end":80,"tag":"haemostatic"},{"start":94,"end":107,"tag":"consultation"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471572788336410625","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: InfoDay 3rd #EU #Health Programme &amp;e calls for proposals on 10 June 2014 in Luxembourg. Check also national info days http:/…","id":"471570141776736256","created_at":"2014-05-28T08:34:18.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":[{"start":91,"end":100,"probability":0.9332,"type":"Place","normalized_text":"Luxembourg"}],"hashtags":[{"start":27,"end":30,"tag":"EU"},{"start":31,"end":38,"tag":"Health"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471570141776736256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471568984891228160"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're closed tomorrow and Friday. An emergency phone number will be available: http://t.co/V7p0BVCetl","id":"471566854163804160","created_at":"2014-05-28T08:21:13.000Z","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/V7p0BVCetl","expanded_url":"http://bit.ly/1myz3P0","display_url":"bit.ly/1myz3P0"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471566854163804160","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on our question and answer on expression of potency in composition of #vancomycin products: http://t.co/IbFp96WoCB","id":"471561540068724736","created_at":"2014-05-28T08:00:07.000Z","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/IbFp96WoCB","expanded_url":"http://bit.ly/OWnpS8","display_url":"bit.ly/OWnpS8"}],"annotations":{},"hashtags":[{"start":95,"end":106,"tag":"vancomycin"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471561540068724736","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on our #guideline on core summary of product characteristics for human #fibrinogen products: http://t.co/0gjP4JGxNi","id":"471561423425142784","created_at":"2014-05-28T07:59:39.000Z","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/0gjP4JGxNi","expanded_url":"http://bit.ly/1mS70wH","display_url":"bit.ly/1mS70wH"}],"annotations":{},"hashtags":[{"start":32,"end":42,"tag":"guideline"},{"start":96,"end":107,"tag":"fibrinogen"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471561423425142784","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week to comment on our reflection paper on wording of the indication of #medicines for type-2 #diabetes: http://t.co/CumfG4sDDx","id":"471330683231936514","created_at":"2014-05-27T16:42:46.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/CumfG4sDDx","expanded_url":"http://bit.ly/1cnfjfN","display_url":"bit.ly/1cnfjfN"}],"annotations":{},"hashtags":[{"start":76,"end":86,"tag":"medicines"},{"start":98,"end":107,"tag":"diabetes"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"471330683231936514","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes of our Management Board meeting in March are now available: http://t.co/pF1fZosqJc","id":"471330383553130496","created_at":"2014-05-27T16:41:34.000Z","entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/pF1fZosqJc","expanded_url":"http://bit.ly/1mxa6TU","display_url":"bit.ly/1mxa6TU"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471330383553130496","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We are closed on 29-30 May. An emergency phone number will be available: http://t.co/V7p0BVCetl","id":"471285215118495744","created_at":"2014-05-27T13:42:06.000Z","entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/V7p0BVCetl","expanded_url":"http://bit.ly/1myz3P0","display_url":"bit.ly/1myz3P0"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"471285215118495744","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #EU #Health Programme - Annual work plan for 2014 adopted on 26.05 http://t.co/R5vBzJHQyt","id":"471267649260113920","created_at":"2014-05-27T12:32:17.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":82,"end":104,"url":"http://t.co/R5vBzJHQyt","expanded_url":"http://europa.eu/!wR99jH","display_url":"europa.eu/!wR99jH"}],"annotations":{},"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":19,"end":26,"tag":"Health"}]},"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471267649260113920","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471211950597480449"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: The new #eHealth in Focus newsletter is out, topics: #eHF14, #telemedicine, #patientempowerment &amp; more... http://t.co/a3AA0…","id":"471267587930980352","created_at":"2014-05-27T12:32:03.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":{},"annotations":{},"hashtags":[{"start":24,"end":32,"tag":"eHealth"},{"start":69,"end":75,"tag":"eHF14"},{"start":77,"end":90,"tag":"telemedicine"},{"start":92,"end":111,"tag":"patientempowerment"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471267587930980352","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471212326662963200"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Press Centre (#EUResearchAlerts) - Top scientists to decide who governs the European Research Council: European... htt…","id":"471267381311188992","created_at":"2014-05-27T12:31:14.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":97,"end":121,"probability":0.4224,"type":"Organization","normalized_text":"European Research Council"}],"hashtags":[{"start":35,"end":52,"tag":"EUResearchAlerts"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471267381311188992","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471228745244606464"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #EDQM signs confidentiality agreement with Taiwan FDA concerning the procedure for #certification of suitability http://t.co…","id":"471267332590145536","created_at":"2014-05-27T12:31:02.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":[{"start":58,"end":63,"probability":0.6844,"type":"Place","normalized_text":"Taiwan"}],"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":98,"end":112,"tag":"certification"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471267332590145536","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471228952674308096"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EMCDDA: Here we chart developments in Internet-based drug treatment and explore some of the benefits : http://t.co/cLyU89gAkz #edr2014","id":"471267098497667072","created_at":"2014-05-27T12:30:06.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":107,"end":129,"url":"http://t.co/cLyU89gAkz","expanded_url":"http://www.emcdda.europa.eu/topics/pods/internet-based-drug-treatment","display_url":"emcdda.europa.eu/topics/pods/in…"}],"annotations":{},"hashtags":[{"start":130,"end":138,"tag":"edr2014"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471267098497667072","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471239168308576256"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Have a look at the IMI 2 - Call 1 indicative topic texts - they are now available via the IMI website http://t.co/L87NJIZn7n","id":"471266728266055680","created_at":"2014-05-27T12:28:38.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":114,"end":136,"url":"http://t.co/L87NJIZn7n","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471266728266055680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471251834796269568"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSApanel renewal: #EFSA is looking for #entomologists for its #AnimalHealth and #AnimalWelfare panel. Apply online http://t.…","id":"471266546472734720","created_at":"2014-05-27T12:27:55.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":33,"end":38,"tag":"EFSA"},{"start":54,"end":68,"tag":"entomologists"},{"start":77,"end":90,"tag":"AnimalHealth"},{"start":95,"end":109,"tag":"AnimalWelfare"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471266546472734720","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471259531247620096"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: \"#ePrescription and personal #eHealth navigator for all Europeans\": http://t.co/LaP4ewP996 #eHF14","id":"471266483000311808","created_at":"2014-05-27T12:27:39.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":84,"end":106,"url":"http://t.co/LaP4ewP996","expanded_url":"http://ow.ly/xibSW","display_url":"ow.ly/xibSW"}],"annotations":{},"hashtags":[{"start":17,"end":31,"tag":"ePrescription"},{"start":45,"end":53,"tag":"eHealth"},{"start":107,"end":113,"tag":"eHF14"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471266483000311808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"471264591591538689"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes of our Management Board meeting in March: http://t.co/pF1fZosqJc","id":"471211058129293312","created_at":"2014-05-27T08:47:25.000Z","entities":{"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/pF1fZosqJc","expanded_url":"http://bit.ly/1mxa6TU","display_url":"bit.ly/1mxa6TU"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"471211058129293312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on a reflection paper on wording of the indication for #medicines for type-2 #diabetes: http://t.co/CumfG4sDDx","id":"471207878230298624","created_at":"2014-05-27T08:34:47.000Z","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/CumfG4sDDx","expanded_url":"http://bit.ly/1cnfjfN","display_url":"bit.ly/1cnfjfN"}],"annotations":{},"hashtags":[{"start":80,"end":90,"tag":"medicines"},{"start":102,"end":111,"tag":"diabetes"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"471207878230298624","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@DLNY911 @RemingtonNevin @DCoEPage There are several options for prevention, please refer to your doctor or national medicines regulator.","id":"471207120889970688","created_at":"2014-05-27T08:31:46.000Z","entities":{"mentions":[{"start":0,"end":8,"username":"DLNY911","id":"37296801"},{"start":9,"end":24,"username":"RemingtonNevin","id":"432161814"},{"start":25,"end":34,"username":"dcoepage","id":"1205760003375800320"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468429965839446017","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"471117537196146688"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"37296801"},{"text":"RT @EFSA_EU: #EFSApanel: Prof. More - Become a member to make a difference and work closely with key scientists. http://t.co/osrcX2XG6R","id":"470957672771387392","created_at":"2014-05-26T16:00:33.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":113,"end":135,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470957672771387392","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470957543343542272"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAWomen: Stay informed on our latest activities by signing up for our email updates: http://t.co/IbacsSFyMF","id":"470948952842727424","created_at":"2014-05-26T15:25:54.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":90,"end":112,"url":"http://t.co/IbacsSFyMF","expanded_url":"http://ow.ly/wluuX","display_url":"ow.ly/wluuX"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470948952842727424","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470948823863689217"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Annual report of the Director 2013 now online with details of ECDC's activities, results and finances http://t.co/vL98jW9Ibu","id":"470940294427725824","created_at":"2014-05-26T14:51:30.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":115,"end":137,"url":"http://t.co/vL98jW9Ibu","expanded_url":"http://bit.ly/DIR-report-2013","display_url":"bit.ly/DIR-report-2013"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470940294427725824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470937457903808512"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: Herbal remedies and dietary supplements: http://t.co/SWRcuOaDuj","id":"470939796098265088","created_at":"2014-05-26T14:49:31.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":54,"end":76,"url":"http://t.co/SWRcuOaDuj","expanded_url":"http://bit.ly/1jRpA50","display_url":"bit.ly/1jRpA50"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"470939796098265088","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Important information on Invirase (saquinavir) from the Italian medicines agency http://t.co/QNB74oTsgb","id":"470927177048129537","created_at":"2014-05-26T13:59:23.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":101,"end":123,"url":"http://t.co/QNB74oTsgb","expanded_url":"http://bit.ly/1ozUsYH","display_url":"bit.ly/1ozUsYH"}],"annotations":[{"start":45,"end":52,"probability":0.3922,"type":"Organization","normalized_text":"Invirase"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"470927177048129537","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: #Cancer registries are critical for evaluating the impact of national control programmes, incl vaccination, screening, treatment e…","id":"470926868527730691","created_at":"2014-05-26T13:58:09.000Z","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":[{"start":9,"end":16,"tag":"Cancer"}]},"public_metrics":{"retweet_count":76,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470926868527730691","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470911847986921472"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: New guidelines for establishing #cancer registries http://t.co/jQ1UMsg46p","id":"470926737103388672","created_at":"2014-05-26T13:57:38.000Z","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":60,"end":82,"url":"http://t.co/jQ1UMsg46p","expanded_url":"http://goo.gl/Ee9iqY","display_url":"goo.gl/Ee9iqY"}],"annotations":{},"hashtags":[{"start":41,"end":48,"tag":"cancer"}]},"public_metrics":{"retweet_count":64,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470926737103388672","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470904266828550144"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Download the Italian medicines agency's #medicine #database app for Android, iOS &amp; Windows http://t.co/cjxBDBkGmE","id":"470926621281886208","created_at":"2014-05-26T13:57:10.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":115,"end":137,"url":"http://t.co/cjxBDBkGmE","expanded_url":"http://bit.ly/1gvbh6W","display_url":"bit.ly/1gvbh6W"}],"annotations":[{"start":88,"end":94,"probability":0.9544,"type":"Product","normalized_text":"Android"},{"start":97,"end":99,"probability":0.9008,"type":"Product","normalized_text":"iOS"},{"start":103,"end":109,"probability":0.855,"type":"Product","normalized_text":"Windows"}],"hashtags":[{"start":60,"end":69,"tag":"medicine"},{"start":70,"end":79,"tag":"database"}]},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"470926621281886208","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Ladies scientists, don’t hesitate to apply for #EFSApanel renewal. More information http://t.co/osrcX2XG6R","id":"470925970514657280","created_at":"2014-05-26T13:54:35.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":97,"end":119,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":60,"end":70,"tag":"EFSApanel"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470925970514657280","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470897144208318464"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSAJournal: Statement on a conceptual framework for #bovine #tuberculosis http://t.co/sxxo4YkSPz","id":"470925895835086848","created_at":"2014-05-26T13:54:17.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"urls":[{"start":79,"end":101,"url":"http://t.co/sxxo4YkSPz","expanded_url":"http://bit.ly/1jmxpv4","display_url":"bit.ly/1jmxpv4"}],"annotations":{},"hashtags":[{"start":57,"end":64,"tag":"bovine"},{"start":65,"end":78,"tag":"tuberculosis"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470925895835086848","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470896470707941377"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: 76th meeting of the Heads of Medicines Agencies http://t.co/FNEpqJMFXg","id":"470924853399523328","created_at":"2014-05-26T13:50:09.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":63,"end":85,"url":"http://t.co/FNEpqJMFXg","expanded_url":"http://bit.ly/1ozSIyL","display_url":"bit.ly/1ozSIyL"}],"annotations":[{"start":35,"end":61,"probability":0.688,"type":"Organization","normalized_text":"Heads of Medicines Agencies"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470924853399523328","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: 76th meeting of the Heads of Medicines Agencies http://t.co/VzJ8iTow1S","id":"470924701829976064","created_at":"2014-05-26T13:49:32.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":61,"end":83,"url":"http://t.co/VzJ8iTow1S","expanded_url":"http://bit.ly/1gvazq2","display_url":"bit.ly/1gvazq2"}],"annotations":[{"start":33,"end":59,"probability":0.688,"type":"Organization","normalized_text":"Heads of Medicines Agencies"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"470924701829976064","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: The Italian medicines agency is presenting projects on pregnancy &amp; paediatrics with @bealorenzin http://t.co/Iq6clZDf1p","id":"470924423105888256","created_at":"2014-05-26T13:48:26.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":108,"end":120,"username":"BeaLorenzin","id":"515229378"}],"urls":[{"start":121,"end":143,"url":"http://t.co/Iq6clZDf1p","expanded_url":"http://bit.ly/1ozSjMv","display_url":"bit.ly/1ozSjMv"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"470924423105888256","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We recommended #Translarna for treatment of #Duchenne muscular dystrophy: http://t.co/lwcpeT2gsx","id":"470908458574032896","created_at":"2014-05-26T12:45:00.000Z","entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/lwcpeT2gsx","expanded_url":"http://bit.ly/1gWcRPJ","display_url":"bit.ly/1gWcRPJ"}],"annotations":{},"hashtags":[{"start":15,"end":26,"tag":"Translarna"},{"start":44,"end":53,"tag":"Duchenne"}]},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":6,"quote_count":0},"conversation_id":"470908458574032896","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Last week the CHMP endorsed PRAC recommendation on #RAS-acting agents: http://t.co/UvDvqT3q5F","id":"470908274406350849","created_at":"2014-05-26T12:44:16.000Z","entities":{"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/UvDvqT3q5F","expanded_url":"http://bit.ly/1jK6fEb","display_url":"bit.ly/1jK6fEb"}],"annotations":{},"hashtags":[{"start":51,"end":55,"tag":"RAS"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470908274406350849","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We recommended approval of #Gazyvaro for chronic lymphocytic leukaemia: http://t.co/9qy5lIYWtC","id":"470908159662755841","created_at":"2014-05-26T12:43:48.000Z","entities":{"mentions":{},"urls":[{"start":72,"end":94,"url":"http://t.co/9qy5lIYWtC","expanded_url":"http://bit.ly/1nj8JM1","display_url":"bit.ly/1nj8JM1"}],"annotations":{},"hashtags":[{"start":27,"end":36,"tag":"Gazyvaro"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"470908159662755841","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Last Friday we published the #CHMP meeting highlights: http://t.co/XkDla2UJO0","id":"470908061256003584","created_at":"2014-05-26T12:43:25.000Z","entities":{"mentions":{},"urls":[{"start":55,"end":77,"url":"http://t.co/XkDla2UJO0","expanded_url":"http://bit.ly/1nj8y3y","display_url":"bit.ly/1nj8y3y"}],"annotations":{},"hashtags":[{"start":29,"end":34,"tag":"CHMP"}]},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"470908061256003584","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: The May issue of Regulatory News from the Innovation Office is out now - Paediatric medicine and more. http://t.co/clO1Ef42G9","id":"470873878995017728","created_at":"2014-05-26T10:27:35.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":115,"end":137,"url":"http://t.co/clO1Ef42G9","expanded_url":"http://bit.ly/1hpTmJW","display_url":"bit.ly/1hpTmJW"}],"annotations":[{"start":54,"end":70,"probability":0.4689,"type":"Organization","normalized_text":"Innovation Office"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470873878995017728","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470869988673585152"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes of the April meeting of our human #medicine committee (#CHMP) are available on our website: http://t.co/ZVNd9jwEyN","id":"470865755840733185","created_at":"2014-05-26T09:55:19.000Z","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/ZVNd9jwEyN","expanded_url":"http://bit.ly/1r0HMOU","display_url":"bit.ly/1r0HMOU"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":47,"end":56,"tag":"medicine"},{"start":68,"end":73,"tag":"CHMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"470865755840733185","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Send us your comments on our draft #herbal monograph on #Agrimonia eupatoria L., herba (#agrimony): http://t.co/7CSjXHGF0i","id":"470865292760203264","created_at":"2014-05-26T09:53:28.000Z","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/7CSjXHGF0i","expanded_url":"http://bit.ly/1ooaVPF","display_url":"bit.ly/1ooaVPF"}],"annotations":{},"hashtags":[{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":66,"tag":"Agrimonia"},{"start":88,"end":97,"tag":"agrimony"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470865292760203264","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo: Do you buy medicines online? See results from international action against falsified medicines: http://t.co/qT5V0xICpX","id":"470862311675408384","created_at":"2014-05-26T09:41:37.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":116,"end":138,"url":"http://t.co/qT5V0xICpX","expanded_url":"http://bit.ly/1tcFqs5","display_url":"bit.ly/1tcFqs5"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470862311675408384","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Look at ND4BB project COMBACTE's new videos:@ general audience:http://t.co/PgGbCRGSqB; @ interested professionals:http://t.co/t…","id":"470858742108815360","created_at":"2014-05-26T09:27:26.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":75,"end":97,"url":"http://t.co/PgGbCRGSqB","expanded_url":"http://bit.ly/1w6xoFq","display_url":"bit.ly/1w6xoFq"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470858742108815360","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470858648907165696"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: #AIFA editorial - Randomised clinical trials and the limits of evidence-based medicine http://t.co/mw5RDpCioH","id":"470854779661737984","created_at":"2014-05-26T09:11:42.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":107,"end":129,"url":"http://t.co/mw5RDpCioH","expanded_url":"http://bit.ly/1pa0fXs","display_url":"bit.ly/1pa0fXs"}],"annotations":{},"hashtags":[{"start":20,"end":25,"tag":"AIFA"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470854779661737984","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: Great 2 see the World Health Assembly recognising the need 4 urgent international action on antimicrobial resistance  http:/…","id":"470846652967038976","created_at":"2014-05-26T08:39:24.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":[{"start":31,"end":51,"probability":0.5076,"type":"Organization","normalized_text":"World Health Assembly"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"470846652967038976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"470830963950235648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRApress: UK leads the way with £8.6m seizure in international operation targeting dangerous counterfeit &amp; unlicensed medicines http:/…","id":"469862075846909954","created_at":"2014-05-23T15:27:03.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":{},"annotations":[{"start":15,"end":16,"probability":0.9338,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469862075846909954","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469794417742979072"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: Patients and professionals agree future vision for hospital pharmacy in Europe http://t.co/sG6dyAsUqM","id":"469861825136586753","created_at":"2014-05-23T15:26:03.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":94,"end":116,"url":"http://t.co/sG6dyAsUqM","expanded_url":"http://www.eureporter.co/magazine/2014/05/16/patients-and-professionals-agree-future-vision-for-hospital-pharmacy-in-europe/","display_url":"eureporter.co/magazine/2014/…"}],"annotations":[{"start":87,"end":92,"probability":0.9971,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469861825136586753","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469808756922933250"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSAJournal: Technical specifications on randomised sampling for #AMR monitoring http://t.co/CbgIDjyqXD","id":"469861590876291072","created_at":"2014-05-23T15:25:07.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"urls":[{"start":85,"end":107,"url":"http://t.co/CbgIDjyqXD","expanded_url":"http://bit.ly/1vRnfMD","display_url":"bit.ly/1vRnfMD"}],"annotations":{},"hashtags":[{"start":69,"end":73,"tag":"AMR"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469861590876291072","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469820358590464000"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA targets illegal online pharmacies in globally coordinated action. http://t.co/4PW64limOO","id":"469861399796416512","created_at":"2014-05-23T15:24:21.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":90,"end":112,"url":"http://t.co/4PW64limOO","expanded_url":"http://go.usa.gov/85AP","display_url":"go.usa.gov/85AP"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"}]},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469861399796416512","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469832633372123136"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA is looking for #epidemiologists for its #AnimalHealth and #AnimalWelfare panel. Apply online http://t.co/osrcX2XG6R","id":"469861120661258240","created_at":"2014-05-23T15:23:15.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":112,"end":134,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":34,"end":50,"tag":"epidemiologists"},{"start":59,"end":72,"tag":"AnimalHealth"},{"start":77,"end":91,"tag":"AnimalWelfare"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469861120661258240","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469840722829778944"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Updated #RAGIDA guidelines: a chart to decide when to consider #TB contact tracing of passengers http://t.co/xRZ5sLitth","id":"469860884010237953","created_at":"2014-05-23T15:22:19.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":110,"end":132,"url":"http://t.co/xRZ5sLitth","expanded_url":"https://twitter.com/ECDC_EU/status/469847228585345024/photo/1","display_url":"pic.twitter.com/xRZ5sLitth"}],"annotations":{},"hashtags":[{"start":21,"end":28,"tag":"RAGIDA"},{"start":76,"end":79,"tag":"TB"}]},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469860884010237953","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469847228585345024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_469847227054039040"]}},{"text":"We've published the draft herbal monograph on #Agrimonia eupatoria L., herba (#Agrimony herb): http://t.co/7CSjXHGF0i","id":"469859520026804224","created_at":"2014-05-23T15:16:53.000Z","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/7CSjXHGF0i","expanded_url":"http://bit.ly/1ooaVPF","display_url":"bit.ly/1ooaVPF"}],"annotations":{},"hashtags":[{"start":46,"end":56,"tag":"Agrimonia"},{"start":78,"end":87,"tag":"Agrimony"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469859520026804224","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes of last month's meeting of our human medicines committee (#CHMP): http://t.co/ZVNd9jwEyN","id":"469842258314145793","created_at":"2014-05-23T14:08:18.000Z","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/ZVNd9jwEyN","expanded_url":"http://bit.ly/1r0HMOU","display_url":"bit.ly/1r0HMOU"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":87,"end":92,"tag":"CHMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"469842258314145793","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've recommended #Translarna for treatment of #Duchenne muscular dystrophy: http://t.co/lwcpeT2gsx","id":"469811476761694209","created_at":"2014-05-23T12:05:59.000Z","entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/lwcpeT2gsx","expanded_url":"http://bit.ly/1gWcRPJ","display_url":"bit.ly/1gWcRPJ"}],"annotations":{},"hashtags":[{"start":18,"end":29,"tag":"Translarna"},{"start":47,"end":56,"tag":"Duchenne"}]},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"469811476761694209","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"CHMP has endorsed PRAC recommendation on #RAS-acting agents: http://t.co/UvDvqT3q5F","id":"469810482283806721","created_at":"2014-05-23T12:02:02.000Z","entities":{"mentions":{},"urls":[{"start":61,"end":83,"url":"http://t.co/UvDvqT3q5F","expanded_url":"http://bit.ly/1jK6fEb","display_url":"bit.ly/1jK6fEb"}],"annotations":{},"hashtags":[{"start":41,"end":45,"tag":"RAS"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"469810482283806721","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've recommended approval of #Gazyvaro for chronic lymphocytic leukaemia: http://t.co/9qy5lIYWtC","id":"469808638400671744","created_at":"2014-05-23T11:54:42.000Z","entities":{"mentions":{},"urls":[{"start":75,"end":97,"url":"http://t.co/9qy5lIYWtC","expanded_url":"http://bit.ly/1nj8JM1","display_url":"bit.ly/1nj8JM1"}],"annotations":{},"hashtags":[{"start":30,"end":39,"tag":"Gazyvaro"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"469808638400671744","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've just published the #CHMP meeting highlights: http://t.co/XkDla2UJO0","id":"469808223957299200","created_at":"2014-05-23T11:53:03.000Z","entities":{"mentions":{},"urls":[{"start":51,"end":73,"url":"http://t.co/XkDla2UJO0","expanded_url":"http://bit.ly/1nj8y3y","display_url":"bit.ly/1nj8y3y"}],"annotations":{},"hashtags":[{"start":25,"end":30,"tag":"CHMP"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"469808223957299200","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EASDnews: Study of 850,000 people shows women with #diabetes 44% more likely to develop coronary heart disease than men - http://t.co/X…","id":"469773340392312832","created_at":"2014-05-23T09:34:27.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":{},"annotations":{},"hashtags":[{"start":55,"end":64,"tag":"diabetes"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469773340392312832","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469747590301773824"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: Study Calls for Revisiting Cardiac Screening Guidelines for Survivors of Childhood Cancer #CHF http://t.co/CJwPPw2nwM via @Anna…","id":"469772735716282368","created_at":"2014-05-23T09:32:02.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":107,"end":129,"url":"http://t.co/CJwPPw2nwM","expanded_url":"http://ow.ly/xaSXF","display_url":"ow.ly/xaSXF"}],"annotations":{},"hashtags":[{"start":102,"end":106,"tag":"CHF"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469772735716282368","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469765365766316032"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on draft #VICH guideline #GL52 on #bioequivalence: blood-level bioequivalence study: http://t.co/kAF9fWVm4o","id":"469772136304087041","created_at":"2014-05-23T09:29:39.000Z","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/kAF9fWVm4o","expanded_url":"http://bit.ly/1fiZXpk","display_url":"bit.ly/1fiZXpk"}],"annotations":{},"hashtags":[{"start":34,"end":39,"tag":"VICH"},{"start":50,"end":55,"tag":"GL52"},{"start":59,"end":74,"tag":"bioequivalence"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469772136304087041","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Less than two weeks left to comment on our Q&amp;A on expression of potency in composition of #vancomycin products: http://t.co/IbFp96WoCB","id":"469771146104422400","created_at":"2014-05-23T09:25:43.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/IbFp96WoCB","expanded_url":"http://bit.ly/OWnpS8","display_url":"bit.ly/OWnpS8"}],"annotations":{},"hashtags":[{"start":94,"end":105,"tag":"vancomycin"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469771146104422400","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Less than two weeks left to comment on our draft #guideline on core #SmPC for human #fibrinogen products: http://t.co/0gjP4JGxNi","id":"469770465066885120","created_at":"2014-05-23T09:23:01.000Z","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/0gjP4JGxNi","expanded_url":"http://bit.ly/1mS70wH","display_url":"bit.ly/1mS70wH"}],"annotations":{},"hashtags":[{"start":49,"end":59,"tag":"guideline"},{"start":68,"end":73,"tag":"SmPC"},{"start":84,"end":95,"tag":"fibrinogen"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469770465066885120","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week to comment on a concept paper on #pharmacokinetics and #pharmacodynamics in development of #antibacterials: http://t.co/2YDNq69VhV","id":"469769821148938240","created_at":"2014-05-23T09:20:27.000Z","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/2YDNq69VhV","expanded_url":"http://bit.ly/1pE8ObL","display_url":"bit.ly/1pE8ObL"}],"annotations":{},"hashtags":[{"start":42,"end":59,"tag":"pharmacokinetics"},{"start":64,"end":81,"tag":"pharmacodynamics"},{"start":100,"end":115,"tag":"antibacterials"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469769821148938240","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week to comment on our concept paper on updating best practice #guideline for #3Rs in testing of medicines: http://t.co/C6I09L9G99","id":"469769087066058752","created_at":"2014-05-23T09:17:32.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/C6I09L9G99","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"annotations":{},"hashtags":[{"start":67,"end":77,"tag":"guideline"},{"start":82,"end":86,"tag":"3Rs"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469769087066058752","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes are available from last month's meeting of our #Pharmacovigilance Risk Assessment Committee (#PRAC): http://t.co/pcR9y9bDRU","id":"469758967846305792","created_at":"2014-05-23T08:37:20.000Z","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/pcR9y9bDRU","expanded_url":"http://bit.ly/1vLITBR","display_url":"bit.ly/1vLITBR"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":60,"end":78,"tag":"Pharmacovigilance"},{"start":106,"end":111,"tag":"PRAC"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"469758967846305792","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda is available for this week's #Paediatric Committee (#PDCO) meeting: http://t.co/4TgqSpgTcI","id":"469758617361870848","created_at":"2014-05-23T08:35:56.000Z","entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/4TgqSpgTcI","expanded_url":"http://bit.ly/1jXH3UT","display_url":"bit.ly/1jXH3UT"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":41,"end":52,"tag":"Paediatric"},{"start":64,"end":69,"tag":"PDCO"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469758617361870848","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: New viral #hepatitis resolution adopted at #WHA67. Now time to take action. Get involved with #WorldHepatitisDay 2014 htt…","id":"469514002071302144","created_at":"2014-05-22T16:23:55.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":{},"hashtags":[{"start":28,"end":38,"tag":"hepatitis"},{"start":61,"end":67,"tag":"WHA67"},{"start":112,"end":130,"tag":"WorldHepatitisDay"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469514002071302144","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469513837951983616"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRApress: Operation Pangea VII - Decrease your risk of buying a fake medicine, always buy from registered pharmacies @TheGPhC http://t…","id":"469513924132749312","created_at":"2014-05-22T16:23:37.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"},{"start":122,"end":130,"username":"TheGPhC","id":"455779111"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469513924132749312","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469512279709745153"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRApress: Last week MHRA seized 5,000+ doses of fake asthma, fertility &amp; thyroid drugs. Be safe, buy from a registered pharmacy http:/…","id":"469510838223929344","created_at":"2014-05-22T16:11:21.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469510838223929344","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469510590851858432"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA approves #Entyvio to treat #UlcerativeColitis and #Crohns disease. http://t.co/7JSaeQXqsn","id":"469503223146246145","created_at":"2014-05-22T15:41:06.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":91,"end":113,"url":"http://t.co/7JSaeQXqsn","expanded_url":"http://go.usa.gov/89J9","display_url":"go.usa.gov/89J9"}],"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":33,"end":41,"tag":"Entyvio"},{"start":51,"end":69,"tag":"UlcerativeColitis"},{"start":74,"end":81,"tag":"Crohns"}]},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469503223146246145","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469500960197595137"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: FLURISK project: #EFSA looks at transmission of #Influenza viruses from animals to humans http://t.co/OLo6Xavgdd","id":"469503160672079872","created_at":"2014-05-22T15:40:51.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":103,"end":125,"url":"http://t.co/OLo6Xavgdd","expanded_url":"http://bit.ly/SmymxG","display_url":"bit.ly/SmymxG"}],"annotations":{},"hashtags":[{"start":30,"end":35,"tag":"EFSA"},{"start":61,"end":71,"tag":"Influenza"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469503160672079872","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469500440095522816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Publication of the monthly bulletin for the month of April 2014 http://t.co/N10tOswhUr","id":"469490313833492480","created_at":"2014-05-22T14:49:48.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":78,"end":100,"url":"http://t.co/N10tOswhUr","expanded_url":"http://bit.ly/1n4nSyp","display_url":"bit.ly/1n4nSyp"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469490313833492480","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Tomorrow (May 23) - last day to register for MCMi Regulatory Science Symposium. http://t.co/5kp0fed3Ds Silver Spring, MD or w…","id":"469479991487758337","created_at":"2014-05-22T14:08:47.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":94,"end":116,"url":"http://t.co/5kp0fed3Ds","expanded_url":"http://ht.ly/x8S37","display_url":"ht.ly/x8S37"}],"annotations":[{"start":59,"end":91,"probability":0.6515,"type":"Organization","normalized_text":"MCMi Regulatory Science Symposium"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469479991487758337","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469479865562181632"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Operation Pangea VII: the French medicines agency is fighting the illicit online #sale of #medicines http://t.co/ZklztCB7Ju","id":"469479146624917504","created_at":"2014-05-22T14:05:25.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":111,"end":133,"url":"http://t.co/ZklztCB7Ju","expanded_url":"http://bit.ly/RX7805","display_url":"bit.ly/RX7805"}],"annotations":[{"start":10,"end":29,"probability":0.3335,"type":"Other","normalized_text":"Operation Pangea VII"}],"hashtags":[{"start":91,"end":96,"tag":"sale"},{"start":100,"end":110,"tag":"medicines"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469479146624917504","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've just published the #agenda for this week's #Paediatric Committee (#PDCO) meeting: http://t.co/4TgqSpgTcI","id":"469463920798089216","created_at":"2014-05-22T13:04:55.000Z","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/4TgqSpgTcI","expanded_url":"http://bit.ly/1jXH3UT","display_url":"bit.ly/1jXH3UT"}],"annotations":{},"hashtags":[{"start":25,"end":32,"tag":"agenda"},{"start":49,"end":60,"tag":"Paediatric"},{"start":72,"end":77,"tag":"PDCO"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469463920798089216","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EATGx: Knowledge Gaps in HIV Treatment in Eastern Europe: On 06 June EATG, together with ITPCru, ECUO and Svitanok wi... http://t.co/1i…","id":"469458907950505984","created_at":"2014-05-22T12:45:00.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EATGx","id":"273916420"}],"urls":{},"annotations":[{"start":46,"end":59,"probability":0.8565,"type":"Place","normalized_text":"Eastern Europe"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469458907950505984","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469458037229383680"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've just published the #minutes from the April meeting of the #Pharmacovigilance Risk Assessment Committee, #PRAC: http://t.co/pcR9y9bDRU","id":"469457669095690240","created_at":"2014-05-22T12:40:05.000Z","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/pcR9y9bDRU","expanded_url":"http://bit.ly/1vLITBR","display_url":"bit.ly/1vLITBR"}],"annotations":{},"hashtags":[{"start":25,"end":33,"tag":"minutes"},{"start":64,"end":82,"tag":"Pharmacovigilance"},{"start":110,"end":115,"tag":"PRAC"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"469457669095690240","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: Extended deadline for comments and feedback on @ECDC_EU #varicella #vaccination guidance: you have until 23 June. http://t…","id":"469457298516348928","created_at":"2014-05-22T12:38:36.000Z","entities":{"mentions":[{"start":64,"end":72,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{},"hashtags":[{"start":73,"end":83,"tag":"varicella"},{"start":84,"end":96,"tag":"vaccination"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469457298516348928","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469457031020425216"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: “Every human infection is one too many” says virologist Ron Fouchier to #EFSA http://t.co/PmBE72OlJ0","id":"469453556257669121","created_at":"2014-05-22T12:23:44.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":91,"end":113,"url":"http://t.co/PmBE72OlJ0","expanded_url":"http://bit.ly/1tof0W3","display_url":"bit.ly/1tof0W3"}],"annotations":[{"start":69,"end":80,"probability":0.9684,"type":"Person","normalized_text":"Ron Fouchier"}],"hashtags":[{"start":85,"end":90,"tag":"EFSA"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469453556257669121","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469453114937192448"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @sanidadgob: @sanidadgob brings together the Heads of #Medicines Agencies in Toledo, organised by @AEMPSGOB - http://t.co/1ty9IeNPXj …","id":"469451796046700545","created_at":"2014-05-22T12:16:44.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"},{"start":16,"end":27,"username":"sanidadgob","id":"232124120"},{"start":101,"end":110,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":113,"end":135,"url":"http://t.co/1ty9IeNPXj","expanded_url":"http://bit.ly/1n3AsOo","display_url":"bit.ly/1n3AsOo"}],"annotations":[{"start":80,"end":85,"probability":0.985,"type":"Place","normalized_text":"Toledo"}],"hashtags":[{"start":57,"end":67,"tag":"Medicines"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469451796046700545","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: The Spanish medicines agency is organising the 76th meeting of the Heads of Medicines Agencies http://t.co/fdDHCINrIL","id":"469451077482725376","created_at":"2014-05-22T12:13:53.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":109,"end":131,"url":"http://t.co/fdDHCINrIL","expanded_url":"http://bit.ly/1n3zIZv","display_url":"bit.ly/1n3zIZv"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469451077482725376","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Transmission of #influenza viruses from animals to humans: check our #Infographic http://t.co/OLo6Xavgdd http://t.co/OOIfAogDG2","id":"469428295151652864","created_at":"2014-05-22T10:43:21.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":95,"end":117,"url":"http://t.co/OLo6Xavgdd","expanded_url":"http://bit.ly/SmymxG","display_url":"bit.ly/SmymxG"},{"start":118,"end":140,"url":"http://t.co/OOIfAogDG2","expanded_url":"https://twitter.com/EFSA_EU/status/469426659427631104/photo/1","display_url":"pic.twitter.com/OOIfAogDG2"}],"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"influenza"},{"start":82,"end":94,"tag":"Infographic"}]},"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469428295151652864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469426659427631104"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_469426655766020096"]}},{"text":"RT @ECDC_HIVAIDS: Latest edition of HIV prevention news Europe from @aidsmap http://t.co/cNWjAeKRcD  And  ECDC report on migrant health htt…","id":"469397566317404161","created_at":"2014-05-22T08:41:15.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"},{"start":68,"end":76,"username":"aidsmap","id":"153818168"}],"urls":[{"start":77,"end":99,"url":"http://t.co/cNWjAeKRcD","expanded_url":"http://bit.ly/1oicFKh","display_url":"bit.ly/1oicFKh"}],"annotations":[{"start":36,"end":38,"probability":0.7302,"type":"Other","normalized_text":"HIV"},{"start":56,"end":61,"probability":0.829,"type":"Place","normalized_text":"Europe"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469397566317404161","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469386264396181504"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Interesting article: Can technology improve #patientsafety? - http://t.co/nk7mcenMCm via @guardian #eprescription #ehealth","id":"469155540833415168","created_at":"2014-05-21T16:39:32.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":105,"end":114,"username":"guardian","id":"87818409"}],"urls":[{"start":78,"end":100,"url":"http://t.co/nk7mcenMCm","expanded_url":"http://gu.com/p/3pbnv/tw","display_url":"gu.com/p/3pbnv/tw"}],"annotations":{},"hashtags":[{"start":60,"end":74,"tag":"patientsafety"},{"start":115,"end":129,"tag":"eprescription"},{"start":130,"end":138,"tag":"ehealth"}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469155540833415168","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469108728705593344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: We are #hiring for Program Analyst. Apply Now! http://t.co/GmzDgEkDnT #jobs","id":"469154749385039873","created_at":"2014-05-21T16:36:23.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":68,"end":90,"url":"http://t.co/GmzDgEkDnT","expanded_url":"http://1.usa.gov/HT5gRs","display_url":"1.usa.gov/HT5gRs"}],"annotations":{},"hashtags":[{"start":28,"end":35,"tag":"hiring"},{"start":91,"end":96,"tag":"jobs"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469154749385039873","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469143134765858816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: First locally acquired infection of Schistosoma haematobium in Corsica, France. Know the disease &amp; risk to #EU http://t.co/hSh…","id":"469154166498418689","created_at":"2014-05-21T16:34:04.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":76,"end":82,"probability":0.9947,"type":"Place","normalized_text":"Corsica"},{"start":85,"end":90,"probability":0.781,"type":"Place","normalized_text":"France"}],"hashtags":[{"start":124,"end":127,"tag":"EU"}]},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469154166498418689","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469142944285749249"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Save the Date: #ICT Proposers' Day 2014, 9-10 Oct, Florence - http://t.co/uzso3Aa2Qs #ICTproposer14 #H2020; @EU_ehealth wil…","id":"469117776175824897","created_at":"2014-05-21T14:09:28.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":124,"end":135,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":78,"end":100,"url":"http://t.co/uzso3Aa2Qs","expanded_url":"http://bit.ly/1mXIcRR","display_url":"bit.ly/1mXIcRR"}],"annotations":{},"hashtags":[{"start":31,"end":35,"tag":"ICT"},{"start":101,"end":115,"tag":"ICTproposer14"},{"start":116,"end":122,"tag":"H2020"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469117776175824897","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469113368947982336"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Chris Goldring: how MIP-DILI is using stem cells to study prevention of liver damage caused by drugs #IMISF2014 http://t.co/7nE…","id":"469041582772338688","created_at":"2014-05-21T09:06:42.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":[{"start":12,"end":25,"probability":0.9827,"type":"Person","normalized_text":"Chris Goldring"}],"hashtags":[{"start":113,"end":123,"tag":"IMISF2014"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"469041582772338688","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"469041368640520192"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Parvoduk, a #veterinary vaccine for Muscovy ducks: http://t.co/psGdg2zYGP","id":"469032493967245312","created_at":"2014-05-21T08:30:35.000Z","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/psGdg2zYGP","expanded_url":"http://bit.ly/1gKa0sV","display_url":"bit.ly/1gKa0sV"}],"annotations":{},"hashtags":[{"start":29,"end":38,"tag":"Parvoduk"},{"start":42,"end":53,"tag":"veterinary"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"469032493967245312","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #DuoResp #Spiromax, a #medicine for #asthma and #COPD: http://t.co/WrGtJRhhz3","id":"469032221643657216","created_at":"2014-05-21T08:29:30.000Z","entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/WrGtJRhhz3","expanded_url":"http://bit.ly/1nieF3w","display_url":"bit.ly/1nieF3w"}],"annotations":{},"hashtags":[{"start":42,"end":50,"tag":"DuoResp"},{"start":51,"end":60,"tag":"Spiromax"},{"start":64,"end":73,"tag":"medicine"},{"start":78,"end":85,"tag":"asthma"},{"start":90,"end":95,"tag":"COPD"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"469032221643657216","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Commission: Help improve @EU_Commission online presence by taking this survey: http://t.co/zzVA3wN8MY","id":"468793769350156290","created_at":"2014-05-20T16:41:59.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":32,"end":46,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":86,"end":108,"url":"http://t.co/zzVA3wN8MY","expanded_url":"http://svy.mk/1tUasbl","display_url":"svy.mk/1tUasbl"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468793769350156290","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468793718389374976"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Final Rule; Technical Amendments; Oral Dosage Form New Animal Drugs; Change of Sponsor http://t.co/5QHEqgVXHk","id":"468789903850213376","created_at":"2014-05-20T16:26:37.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":108,"end":130,"url":"http://t.co/5QHEqgVXHk","expanded_url":"http://1.usa.gov/1jzSuYz","display_url":"1.usa.gov/1jzSuYz"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468789903850213376","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468789081418498048"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Federal Register, Defining Small Numbers of Animals for Minor Use Designation http://t.co/NAmHBI1Y3D","id":"468787219910885376","created_at":"2014-05-20T16:15:57.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":99,"end":121,"url":"http://t.co/NAmHBI1Y3D","expanded_url":"http://1.usa.gov/1sPZdNF","display_url":"1.usa.gov/1sPZdNF"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468787219910885376","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468785962450161665"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe_VPI: Follow &amp; contribute to discussions about key issues affecting world health #SocialGood http://t.co/eMHGWPs7Ne\n#polio #v…","id":"468787135307608064","created_at":"2014-05-20T16:15:37.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":[{"start":111,"end":133,"url":"http://t.co/eMHGWPs7Ne","expanded_url":"http://bit.ly/1vzXiku","display_url":"bit.ly/1vzXiku"}],"annotations":{},"hashtags":[{"start":99,"end":110,"tag":"SocialGood"},{"start":134,"end":140,"tag":"polio"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468787135307608064","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468785223069859840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #FDA Small Business Regulatory Education for Industry (REdI) Conference on June 16-17. Registration now open. http://t.c…","id":"468784752242466816","created_at":"2014-05-20T16:06:09.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468784752242466816","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468783641234255872"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: FDA to Retain Current Small Numbers of Animals for Minor Use in Major Species http://t.co/vBmNA2ZT7D","id":"468784675063091201","created_at":"2014-05-20T16:05:50.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":99,"end":121,"url":"http://t.co/vBmNA2ZT7D","expanded_url":"http://1.usa.gov/RRG2HK","display_url":"1.usa.gov/RRG2HK"}],"annotations":[{"start":21,"end":23,"probability":0.5622,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468784675063091201","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468783516231405569"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Update of the question-and-answer section on the pharmacovigilance legislation http://t.co/rDWj2gAqGn","id":"468780016957145088","created_at":"2014-05-20T15:47:20.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":93,"end":115,"url":"http://t.co/rDWj2gAqGn","expanded_url":"http://bit.ly/1j5rDxD","display_url":"bit.ly/1j5rDxD"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"468780016957145088","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: French medicines agency's commission for benefit/risk evaluation of health products 10 April 2014: summary http://t.co/anAuYMVb9W","id":"468759117025525760","created_at":"2014-05-20T14:24:17.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":117,"end":139,"url":"http://t.co/anAuYMVb9W","expanded_url":"http://bit.ly/1gKN2lp","display_url":"bit.ly/1gKN2lp"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468759117025525760","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: EURORDIS keeps track of orphan designations &amp; #raredisease medicines authorised by the European Medicines Agency http://t.co/…","id":"468745133048221696","created_at":"2014-05-20T13:28:43.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":[{"start":101,"end":125,"probability":0.6292,"type":"Organization","normalized_text":"European Medicines Agency"}],"hashtags":[{"start":64,"end":76,"tag":"raredisease"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468745133048221696","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468744190571319296"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Interested in recommendations  4 tackling #Hepatitis- the silent epidemic? Check out the new #IFPMA report http://t.co/34XlqurJMW","id":"468726423415717888","created_at":"2014-05-20T12:14:22.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":118,"end":140,"url":"http://t.co/34XlqurJMW","expanded_url":"http://bit.ly/1lXUf0u","display_url":"bit.ly/1lXUf0u"}],"annotations":{},"hashtags":[{"start":53,"end":63,"tag":"Hepatitis"},{"start":104,"end":110,"tag":"IFPMA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468726423415717888","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468726180720705536"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Know someone who's made a consistent contribution to regulatory affairs? Nominate them now http://t.co/MiKeTDPno5 #RegAwards…","id":"468720011578970112","created_at":"2014-05-20T11:48:53.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":106,"end":128,"url":"http://t.co/MiKeTDPno5","expanded_url":"http://bit.ly/1fRGiRW","display_url":"bit.ly/1fRGiRW"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468720011578970112","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468719968247627776"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@leoniefen That was the last issue on SSRIs referred to us. Please forward your question to http://t.co/1ZfEj0gY24 so we can investigate.","id":"468719818364170240","created_at":"2014-05-20T11:48:07.000Z","entities":{"mentions":[{"start":0,"end":10,"username":"leoniefen","id":"313427304"}],"urls":[{"start":92,"end":114,"url":"http://t.co/1ZfEj0gY24","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":[{"start":38,"end":42,"probability":0.3528,"type":"Other","normalized_text":"SSRIs"}],"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"468709423352147968","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"468718313670205441"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"313427304"},{"text":"RT @Hep_Alliance: #WHA67 continues today. Viral #hepatitis is one of the key issues to be discussed. Tune in here for daily updates http://…","id":"468717714379669504","created_at":"2014-05-20T11:39:46.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":{},"hashtags":[{"start":18,"end":24,"tag":"WHA67"},{"start":48,"end":58,"tag":"hepatitis"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468717714379669504","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468715507127177216"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@leoniefen This recommendation was only for children and adolescents (up to 18 years). See pages 571-573 here: http://t.co/eibk0S1OKN","id":"468717260354617344","created_at":"2014-05-20T11:37:57.000Z","entities":{"mentions":[{"start":0,"end":10,"username":"leoniefen","id":"313427304"}],"urls":[{"start":111,"end":133,"url":"http://t.co/eibk0S1OKN","expanded_url":"http://bit.ly/1vy9faz","display_url":"bit.ly/1vy9faz"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"468709423352147968","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"468715378181668864"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"313427304"},{"text":"We've published the EPAR for #DuoResp #Spiromax (#budesonide / #formoterol), a #medicine for #asthma and #COPD: http://t.co/WrGtJRhhz3","id":"468715887839956992","created_at":"2014-05-20T11:32:30.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/WrGtJRhhz3","expanded_url":"http://bit.ly/1nieF3w","display_url":"bit.ly/1nieF3w"}],"annotations":{},"hashtags":[{"start":29,"end":37,"tag":"DuoResp"},{"start":38,"end":47,"tag":"Spiromax"},{"start":49,"end":60,"tag":"budesonide"},{"start":63,"end":74,"tag":"formoterol"},{"start":79,"end":88,"tag":"medicine"},{"start":93,"end":100,"tag":"asthma"},{"start":105,"end":110,"tag":"COPD"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468715887839956992","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Regulatory Rapporteur looks at regulatory compliance, from pharmacovigilance and xEVMPD to medical devices. http://t.co/whdD…","id":"468715429935198208","created_at":"2014-05-20T11:30:41.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"annotations":[{"start":15,"end":35,"probability":0.3903,"type":"Organization","normalized_text":"Regulatory Rapporteur"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468715429935198208","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468715032080318464"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_HIVAIDS: #HIV &amp; #STI network meeting: 3day event to exchange best practices in surveillance,monitoring, prevention and control htt…","id":"468715413829070848","created_at":"2014-05-20T11:30:37.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"urls":{},"annotations":{},"hashtags":[{"start":18,"end":22,"tag":"HIV"},{"start":29,"end":33,"tag":"STI"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468715413829070848","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468714532496744449"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_TB: ECDC fully supports new #TB post-2015 global strategy approved at #WHA67 and will work w @WHO to implement it in #EU http://t.…","id":"468715017412837376","created_at":"2014-05-20T11:29:03.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":102,"end":106,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":[{"start":37,"end":40,"tag":"TB"},{"start":79,"end":85,"tag":"WHA67"},{"start":126,"end":129,"tag":"EU"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468715017412837376","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468713938583289856"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@leoniefen The outcomes of our 2005 review are here: http://t.co/NCJpEPWq5N. For more information send a question at http://t.co/1ZfEj0gY24.","id":"468714475861078016","created_at":"2014-05-20T11:26:54.000Z","entities":{"mentions":[{"start":0,"end":10,"username":"leoniefen","id":"313427304"}],"urls":[{"start":53,"end":75,"url":"http://t.co/NCJpEPWq5N","expanded_url":"http://bit.ly/SdJFbm","display_url":"bit.ly/SdJFbm"},{"start":117,"end":139,"url":"http://t.co/1ZfEj0gY24","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"468709423352147968","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"468712536385531904"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"313427304"},{"text":"We've published the assessment report for #Parvoduk, a #veterinary vaccine for Muscovy ducks: http://t.co/psGdg2zYGP","id":"468709423352147968","created_at":"2014-05-20T11:06:49.000Z","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/psGdg2zYGP","expanded_url":"http://bit.ly/1gKa0sV","display_url":"bit.ly/1gKa0sV"}],"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Parvoduk"},{"start":55,"end":66,"tag":"veterinary"}]},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"468709423352147968","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our reflection paper on wording the indication for medicines for type-2 #diabetes: http://t.co/CumfG4sDDx","id":"468708695510360064","created_at":"2014-05-20T11:03:55.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/CumfG4sDDx","expanded_url":"http://bit.ly/1cnfjfN","display_url":"bit.ly/1cnfjfN"}],"annotations":{},"hashtags":[{"start":101,"end":110,"tag":"diabetes"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468708695510360064","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @europarlAV: European Parliament Highlights 2009 - 2014 - main events and legislative work VIDEO from #AVarchives to download: http://t.…","id":"468708441843073024","created_at":"2014-05-20T11:02:55.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"europarlAV","id":"570018183"}],"urls":{},"annotations":{},"hashtags":[{"start":105,"end":116,"tag":"AVarchives"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468708441843073024","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468707909996929024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: Australian HP colleague describes her impact in improving #antimicrobial #prescribing practice in hospitals http://t.co/c45D…","id":"468706391692419072","created_at":"2014-05-20T10:54:46.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":{},"hashtags":[{"start":73,"end":87,"tag":"antimicrobial"},{"start":88,"end":100,"tag":"prescribing"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468706391692419072","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468706068718039041"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: New science of Toxgnostics: study of genetic predictors of toxicity from anti-cancer therapy http://t.co/Lueic2xz9e via @Nature…","id":"468704353554284544","created_at":"2014-05-20T10:46:40.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":105,"end":127,"url":"http://t.co/Lueic2xz9e","expanded_url":"http://ow.ly/x2PAB","display_url":"ow.ly/x2PAB"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468704353554284544","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468697156569006080"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: #Sday9 programme in detail: http://t.co/cK56ADa1nd http://t.co/Pw87fMceJS","id":"468704205105278976","created_at":"2014-05-20T10:46:05.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":41,"end":63,"url":"http://t.co/cK56ADa1nd","expanded_url":"http://bit.ly/1om1EtC","display_url":"bit.ly/1om1EtC"},{"start":64,"end":86,"url":"http://t.co/Pw87fMceJS","expanded_url":"https://twitter.com/EU_ECHA/status/468696070663704576/photo/1","display_url":"pic.twitter.com/Pw87fMceJS"}],"annotations":{},"hashtags":[{"start":13,"end":19,"tag":"Sday9"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468704205105278976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468696070663704576"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_468696067136319488"]}},{"text":"RT @BushbyKate: PhenoSearch on the @TREAT_NMD site registry lets us learn about novel phenotypes and genes @rdneuromics @ConnectRD http://t…","id":"468704089464127488","created_at":"2014-05-20T10:45:37.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":35,"end":45,"username":"TREAT_NMD","id":"301911808"},{"start":107,"end":119,"username":"rdneuromics","id":"1223994960"},{"start":120,"end":130,"username":"ConnectRD","id":"1227295489"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468704089464127488","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468694975459643392"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: PRESS RELEASE: \"EFPIA launches clinical trial data portal gateway\" http://t.co/gMZVeuAYUG","id":"468702165620768769","created_at":"2014-05-20T10:37:59.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":78,"end":100,"url":"http://t.co/gMZVeuAYUG","expanded_url":"http://bit.ly/1gJOW5O","display_url":"bit.ly/1gJOW5O"}],"annotations":[{"start":27,"end":31,"probability":0.6195,"type":"Organization","normalized_text":"EFPIA"}],"hashtags":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468702165620768769","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468679454253133824"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our draft Community #herbal monograph on #Cetraria islandica (Iceland moss) is now open for #consultation: http://t.co/NI6UBR2lON","id":"468674785707573248","created_at":"2014-05-20T08:49:11.000Z","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/NI6UBR2lON","expanded_url":"http://bit.ly/1hXMcg3","display_url":"bit.ly/1hXMcg3"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"herbal"},{"start":41,"end":50,"tag":"Cetraria"},{"start":92,"end":105,"tag":"consultation"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468674785707573248","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #BiResp #Spiromax (#budesonide / #formoterol), a #medicine for #asthma and #COPD, is available: http://t.co/UrjEyfO4Lq","id":"468674300380471296","created_at":"2014-05-20T08:47:15.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/UrjEyfO4Lq","expanded_url":"http://bit.ly/1qPobkG","display_url":"bit.ly/1qPobkG"}],"annotations":{},"hashtags":[{"start":13,"end":20,"tag":"BiResp"},{"start":21,"end":30,"tag":"Spiromax"},{"start":32,"end":43,"tag":"budesonide"},{"start":46,"end":57,"tag":"formoterol"},{"start":62,"end":71,"tag":"medicine"},{"start":76,"end":83,"tag":"asthma"},{"start":88,"end":93,"tag":"COPD"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468674300380471296","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Hemangiol (#propranolol), a #medicine for proliferating infantile #haemangioma is available: http://t.co/D6FB95yyEX","id":"468674165923663872","created_at":"2014-05-20T08:46:43.000Z","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/D6FB95yyEX","expanded_url":"http://bit.ly/1jvpyRp","display_url":"bit.ly/1jvpyRp"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"Hemangiol"},{"start":25,"end":37,"tag":"propranolol"},{"start":42,"end":51,"tag":"medicine"},{"start":80,"end":92,"tag":"haemangioma"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"468674165923663872","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda for this week's #CHMP meeting on human #medicines is available on our website: http://t.co/knqC5ZrRtQ","id":"468673737416777728","created_at":"2014-05-20T08:45:01.000Z","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/knqC5ZrRtQ","expanded_url":"http://bit.ly/1j28Tz7","display_url":"bit.ly/1j28Tz7"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":33,"tag":"CHMP"},{"start":51,"end":61,"tag":"medicines"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468673737416777728","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our reflection paper on wording the indication for medicines for type-2 #diabetes: http://t.co/CumfG4sDDx","id":"468673390157783040","created_at":"2014-05-20T08:43:38.000Z","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/CumfG4sDDx","expanded_url":"http://bit.ly/1cnfjfN","display_url":"bit.ly/1cnfjfN"}],"annotations":{},"hashtags":[{"start":101,"end":110,"tag":"diabetes"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468673390157783040","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Fit for... children: the importance of the availability of specific medicines for children http://t.co/Co5YAzg5im","id":"468672280126832640","created_at":"2014-05-20T08:39:13.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":111,"end":133,"url":"http://t.co/Co5YAzg5im","expanded_url":"http://bit.ly/1p8wtzt","display_url":"bit.ly/1p8wtzt"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468672280126832640","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: EU must spend more on #research and development - http://t.co/bdDtcM5844 http://t.co/CBfpXgY5EI via @FT","id":"468670757498019840","created_at":"2014-05-20T08:33:10.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":114,"end":117,"username":"FT","id":"18949452"}],"urls":[{"start":64,"end":86,"url":"http://t.co/bdDtcM5844","expanded_url":"http://FT.com","display_url":"FT.com"},{"start":87,"end":109,"url":"http://t.co/CBfpXgY5EI","expanded_url":"http://on.ft.com/1lXoOTZ","display_url":"on.ft.com/1lXoOTZ"}],"annotations":[{"start":14,"end":15,"probability":0.4984,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":36,"end":45,"tag":"research"}]},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468670757498019840","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468662290808844288"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: EU must spend more on #research and development - http://t.co/IOZtYRTduk http://t.co/vZ2laZE1Ac via @FT","id":"468670746815127553","created_at":"2014-05-20T08:33:08.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":121,"end":124,"username":"FT","id":"18949452"}],"urls":[{"start":71,"end":93,"url":"http://t.co/IOZtYRTduk","expanded_url":"http://FT.com","display_url":"FT.com"},{"start":94,"end":116,"url":"http://t.co/vZ2laZE1Ac","expanded_url":"http://on.ft.com/1lXoOTZ","display_url":"on.ft.com/1lXoOTZ"}],"annotations":[{"start":21,"end":22,"probability":0.4984,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":43,"end":52,"tag":"research"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468670746815127553","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468662290787885056"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Temporary use authorisations: favorable opinions from the French medicines agency, 15 May 2014: http://t.co/CiJHJJMhLa","id":"468423967653761024","created_at":"2014-05-19T16:12:31.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":106,"end":128,"url":"http://t.co/CiJHJJMhLa","expanded_url":"http://bit.ly/1p6pAia","display_url":"bit.ly/1p6pAia"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"468423967653761024","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a draft Community #herbal monograph on #Cetraria islandica (Iceland moss) for #consultation: http://t.co/NI6UBR2lON","id":"468421663332515840","created_at":"2014-05-19T16:03:22.000Z","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/NI6UBR2lON","expanded_url":"http://bit.ly/1hXMcg3","display_url":"bit.ly/1hXMcg3"}],"annotations":{},"hashtags":[{"start":34,"end":41,"tag":"herbal"},{"start":55,"end":64,"tag":"Cetraria"},{"start":94,"end":107,"tag":"consultation"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468421663332515840","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #BiResp #Spiromax (#budesonide / #formoterol), a #medicine for #asthma and #COPD: http://t.co/UrjEyfO4Lq","id":"468413776182910976","created_at":"2014-05-19T15:32:01.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/UrjEyfO4Lq","expanded_url":"http://bit.ly/1qPobkG","display_url":"bit.ly/1qPobkG"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"BiResp"},{"start":37,"end":46,"tag":"Spiromax"},{"start":48,"end":59,"tag":"budesonide"},{"start":62,"end":73,"tag":"formoterol"},{"start":78,"end":87,"tag":"medicine"},{"start":92,"end":99,"tag":"asthma"},{"start":104,"end":109,"tag":"COPD"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468413776182910976","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Commission: Don't miss any new public consultation or a roadmap from @EU_Commission - subscribe for automatic alerts here: http://t.…","id":"468402308834148352","created_at":"2014-05-19T14:46:27.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":76,"end":90,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468402308834148352","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468402028071636992"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: #WHA67 update happening live online right now - tune in here http://t.co/Y6dbTu0znb to find out what's been happening tod…","id":"468394469696765952","created_at":"2014-05-19T14:15:18.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":[{"start":79,"end":101,"url":"http://t.co/Y6dbTu0znb","expanded_url":"http://goo.gl/lzBsym","display_url":"goo.gl/lzBsym"}],"annotations":{},"hashtags":[{"start":18,"end":24,"tag":"WHA67"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468394469696765952","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468394285671657473"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The assessment report for #Hemangiol (#propranolol), a #medicine for proliferating infantile #haemangioma is live:\n http://t.co/D6FB95yyEX","id":"468393549667762176","created_at":"2014-05-19T14:11:39.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/D6FB95yyEX","expanded_url":"http://bit.ly/1jvpyRp","display_url":"bit.ly/1jvpyRp"}],"annotations":{},"hashtags":[{"start":26,"end":36,"tag":"Hemangiol"},{"start":38,"end":50,"tag":"propranolol"},{"start":55,"end":64,"tag":"medicine"},{"start":93,"end":105,"tag":"haemangioma"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"468393549667762176","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Study-Assessment of Febrile Seizures in children after Trivalent Influenza Vaccines during 2010-11 flu season http://t.co/asj6…","id":"468388760917655552","created_at":"2014-05-19T13:52:37.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":[{"start":68,"end":95,"probability":0.4169,"type":"Organization","normalized_text":"Trivalent Influenza Vaccines"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468388760917655552","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468386410765234176"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: #Podcast: #FDA warns of next-day impairment with sleep aid #Lunesta and lowers recommended dose. http://t.co/ekR5lMpAdv","id":"468388212709539840","created_at":"2014-05-19T13:50:26.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ekR5lMpAdv","expanded_url":"http://go.usa.gov/8W3w","display_url":"go.usa.gov/8W3w"}],"annotations":{},"hashtags":[{"start":19,"end":27,"tag":"Podcast"},{"start":29,"end":33,"tag":"FDA"},{"start":78,"end":86,"tag":"Lunesta"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468388212709539840","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468378488509304832"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda for this week's meeting of our human #medicine committee, #CHMP, is now available: http://t.co/knqC5ZrRtQ","id":"468376781352095744","created_at":"2014-05-19T13:05:01.000Z","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/knqC5ZrRtQ","expanded_url":"http://bit.ly/1j28Tz7","display_url":"bit.ly/1j28Tz7"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":49,"end":58,"tag":"medicine"},{"start":70,"end":75,"tag":"CHMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468376781352095744","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're holding a workshop with the German Society for Transfusion Medicine &amp; Immunohaematology on #advancedtherapies: http://t.co/f8USldrDUE","id":"468376466057863168","created_at":"2014-05-19T13:03:46.000Z","entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/f8USldrDUE","expanded_url":"http://bit.ly/1vrTIsH","display_url":"bit.ly/1vrTIsH"}],"annotations":[{"start":34,"end":92,"probability":0.0882,"type":"Other","normalized_text":"German Society for Transfusion Medicine & Immunohaematology"}],"hashtags":[{"start":101,"end":119,"tag":"advancedtherapies"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468376466057863168","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: \"Proof that cancer stem cells exist?\" - http://t.co/9IhcTi8ydP","id":"468375936694775808","created_at":"2014-05-19T13:01:39.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":51,"end":73,"url":"http://t.co/9IhcTi8ydP","expanded_url":"http://bit.ly/1gZEAJC","display_url":"bit.ly/1gZEAJC"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468375936694775808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468372168603344896"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: #CMDh: the French medicines agency publishes information on the April meeting http://t.co/WEaT3qmBTs","id":"468375335487406080","created_at":"2014-05-19T12:59:16.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":88,"end":110,"url":"http://t.co/WEaT3qmBTs","expanded_url":"http://bit.ly/1jvajIm","display_url":"bit.ly/1jvajIm"}],"annotations":{},"hashtags":[{"start":10,"end":15,"tag":"CMDh"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468375335487406080","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: The French medicines agency publishes information on the April meeting of the European #CMDh...","id":"468374679246630912","created_at":"2014-05-19T12:56:40.000Z","entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":{},"annotations":{},"hashtags":[{"start":97,"end":102,"tag":"CMDh"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468374679246630912","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Last week to submit abstracts for #ESCAIDE 2014! Closing date: Sunday, 25 May 2014 http://t.co/HF4wiIV2MH","id":"468373929036615680","created_at":"2014-05-19T12:53:41.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":96,"end":118,"url":"http://t.co/HF4wiIV2MH","expanded_url":"http://bit.ly/1jMlp5O","display_url":"bit.ly/1jMlp5O"}],"annotations":{},"hashtags":[{"start":47,"end":55,"tag":"ESCAIDE"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468373929036615680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468363194093031424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe: Some diseases may soon become untreatable due to antibiotic resistance. Join the discussion.  #WHA67 http://t.co/JSiShW3Npo…","id":"468373433538314241","created_at":"2014-05-19T12:51:43.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":117,"end":139,"url":"http://t.co/JSiShW3Npo","expanded_url":"http://bit.ly/1lGYHRc","display_url":"bit.ly/1lGYHRc"}],"annotations":{},"hashtags":[{"start":110,"end":116,"tag":"WHA67"}]},"public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468373433538314241","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468348177540993024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're organising a workshop on #advancedtherapies with German Society for Transfusion Medicine and Immunohaematology: http://t.co/f8USldrDUE","id":"468333026364383233","created_at":"2014-05-19T10:11:09.000Z","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/f8USldrDUE","expanded_url":"http://bit.ly/1vrTIsH","display_url":"bit.ly/1vrTIsH"}],"annotations":{},"hashtags":[{"start":31,"end":49,"tag":"advancedtherapies"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"468333026364383233","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: An update from the Italian Medicines Agency into the investigation of the Herceptin theft and falsification case http://t.co…","id":"468321981390422016","created_at":"2014-05-19T09:27:16.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":[{"start":34,"end":57,"probability":0.8352,"type":"Organization","normalized_text":"Italian Medicines Agency"}],"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468321981390422016","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468321762846179328"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Ulunar #Breezhaler (#indacaterol / #glycopyrronium bromide), a #medicine for #COPD, is now available: http://t.co/qwOOOTnNRg","id":"468316485396746240","created_at":"2014-05-19T09:05:25.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/qwOOOTnNRg","expanded_url":"http://bit.ly/1j25GE7","display_url":"bit.ly/1j25GE7"}],"annotations":{},"hashtags":[{"start":13,"end":20,"tag":"Ulunar"},{"start":21,"end":32,"tag":"Breezhaler"},{"start":34,"end":46,"tag":"indacaterol"},{"start":49,"end":64,"tag":"glycopyrronium"},{"start":77,"end":86,"tag":"medicine"},{"start":91,"end":96,"tag":"COPD"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468316485396746240","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Today's World Health Assembly schedule can be found here http://t.co/zy2PSGrXeb #WHA67","id":"468314256417751041","created_at":"2014-05-19T08:56:34.000Z","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":66,"end":88,"url":"http://t.co/zy2PSGrXeb","expanded_url":"http://goo.gl/RIUpCj","display_url":"goo.gl/RIUpCj"}],"annotations":{},"hashtags":[{"start":89,"end":95,"tag":"WHA67"}]},"public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468314256417751041","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468312064155746304"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: PhEur publishes finished product monograph, Sitagliptin phosphate tablets for comment http://t.co/osvpVSFHHh #european #phar…","id":"468314094261792768","created_at":"2014-05-19T08:55:55.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":101,"end":123,"url":"http://t.co/osvpVSFHHh","expanded_url":"http://bit.ly/1gYXUqv","display_url":"bit.ly/1gYXUqv"}],"annotations":{},"hashtags":[{"start":124,"end":133,"tag":"european"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468314094261792768","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468311564446363648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUlondonrep: Recieve notifications on European Commission's public consultations https://t.co/DXhmlGpoeg","id":"468313964859101184","created_at":"2014-05-19T08:55:24.000Z","entities":{"mentions":{},"urls":[{"start":85,"end":108,"url":"https://t.co/DXhmlGpoeg","expanded_url":"https://webgate.ec.europa.eu/notifications/homePage.do","display_url":"webgate.ec.europa.eu/notifications/…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468313964859101184","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468308839268622336"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: #Sday9 On Wednesday you can follow the Stakeholders' Day on-line http://t.co/KSxFKdLvAE http://t.co/08JFNR3yBR","id":"468313939479392256","created_at":"2014-05-19T08:55:18.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":78,"end":100,"url":"http://t.co/KSxFKdLvAE","expanded_url":"http://bit.ly/1k1PmmQ","display_url":"bit.ly/1k1PmmQ"},{"start":101,"end":123,"url":"http://t.co/08JFNR3yBR","expanded_url":"https://twitter.com/EU_ECHA/status/468307401318612993/photo/1","display_url":"pic.twitter.com/08JFNR3yBR"}],"annotations":{},"hashtags":[{"start":13,"end":19,"tag":"Sday9"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468313939479392256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468307401318612993"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_468307398525210624"]}},{"text":"RT @Aifa_ufficiale: Herceptin case: more counterfeit medicines identified. Investigations find wholesalers and... http://t.co/dgwMuIo2rE","id":"468313772952924160","created_at":"2014-05-19T08:54:38.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":114,"end":136,"url":"http://t.co/dgwMuIo2rE","expanded_url":"http://bit.ly/1n8K2BT","display_url":"bit.ly/1n8K2BT"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468313772952924160","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: #Herceptin case: #AIFA identifies other medicines. Investigation into wholesalers and operators http://t.co/DKnDtJzgHa","id":"468312373980573696","created_at":"2014-05-19T08:49:05.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":116,"end":138,"url":"http://t.co/DKnDtJzgHa","expanded_url":"http://bit.ly/1n8JE6t","display_url":"bit.ly/1n8JE6t"}],"annotations":{},"hashtags":[{"start":20,"end":30,"tag":"Herceptin"},{"start":37,"end":42,"tag":"AIFA"}]},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"468312373980573696","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Visit #WorldHepatitisDay site &amp;take part in #thinkhepatitis pic campaign, post events on map &amp; learn about #hepatitis htt…","id":"468311640044486656","created_at":"2014-05-19T08:46:10.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":{},"hashtags":[{"start":24,"end":42,"tag":"WorldHepatitisDay"},{"start":66,"end":81,"tag":"thinkhepatitis"},{"start":133,"end":143,"tag":"hepatitis"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"468311640044486656","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"468292549619109888"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: #Cardiovascular effects of #levodopa in #Parkinson's disease: http://t.co/DVgZrV63Vd","id":"467345147316162560","created_at":"2014-05-16T16:45:40.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":80,"end":102,"url":"http://t.co/DVgZrV63Vd","expanded_url":"http://www.epda.eu.com/en/research-papers/2014/prd/05-12-prelatdisord-1/","display_url":"epda.eu.com/en/research-pa…"}],"annotations":{},"hashtags":[{"start":18,"end":33,"tag":"Cardiovascular"},{"start":45,"end":54,"tag":"levodopa"},{"start":58,"end":68,"tag":"Parkinson"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467345147316162560","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467345033872424960"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUCouncil: In Brussels tomorrow? We would love it if you drop by for #EUOpenDoors! Our doors open at 10AM http://t.co/jAFyomVNfA http:/…","id":"467344271390285824","created_at":"2014-05-16T16:42:11.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EUCouncil","id":"206717989"}],"urls":[{"start":110,"end":132,"url":"http://t.co/jAFyomVNfA","expanded_url":"http://ow.ly/wzwom","display_url":"ow.ly/wzwom"}],"annotations":[{"start":18,"end":25,"probability":0.9637,"type":"Place","normalized_text":"Brussels"}],"hashtags":[{"start":73,"end":85,"tag":"EUOpenDoors"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467344271390285824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467343969199079424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRApress: MHRA publishes its position on the benefits and risks of statins http://t.co/m851bAqhFC","id":"467344252524331008","created_at":"2014-05-16T16:42:07.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":80,"end":102,"url":"http://t.co/m851bAqhFC","expanded_url":"http://www.mhra.gov.uk/NewsCentre/CON416702","display_url":"mhra.gov.uk/NewsCentre/CON…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467344252524331008","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467343107017932800"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_HIVAIDS: Is Europe ready for #PrEP? An ECDC comment on new clinical guidelines for #HIV prevention published by @CDCgov http://t.c…","id":"467344080914362369","created_at":"2014-05-16T16:41:26.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"},{"start":121,"end":128,"username":"CDCgov","id":"146569971"}],"urls":{},"annotations":[{"start":21,"end":26,"probability":0.9581,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":38,"end":43,"tag":"PrEP"},{"start":92,"end":96,"tag":"HIV"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467344080914362369","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467343049555976192"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Another #flu season draws to its close. Characteristics detailed in @ECDC_EU weekly report http://t.co/FrWOBtaNXq http://t.co…","id":"467330606322708480","created_at":"2014-05-16T15:47:53.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":82,"end":90,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":105,"end":127,"url":"http://t.co/FrWOBtaNXq","expanded_url":"http://bit.ly/1j2w7JG","display_url":"bit.ly/1j2w7JG"}],"annotations":{},"hashtags":[{"start":22,"end":26,"tag":"flu"}]},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467330606322708480","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467327815734820864"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAMedWatch: MedWatch April 2014 Drug Safety Labeling Changes includes 53 products with revisions to Prescribing Information http://t.c…","id":"467322090467889154","created_at":"2014-05-16T15:14:03.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"urls":{},"annotations":[{"start":17,"end":24,"probability":0.589,"type":"Organization","normalized_text":"MedWatch"}],"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467322090467889154","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467316833272332288"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: #H2020 #SME #health #call for proposal. Good luck! http://t.co/oZ7BXO1rGl http://t.co/N7Ol4RYwqq","id":"467321913350832128","created_at":"2014-05-16T15:13:21.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":67,"end":89,"url":"http://t.co/oZ7BXO1rGl","expanded_url":"http://bit.ly/McOkXv","display_url":"bit.ly/McOkXv"},{"start":90,"end":112,"url":"http://t.co/N7Ol4RYwqq","expanded_url":"https://twitter.com/EU_eHealth/status/467313659828772865/photo/1","display_url":"pic.twitter.com/N7Ol4RYwqq"}],"annotations":{},"hashtags":[{"start":16,"end":22,"tag":"H2020"},{"start":23,"end":27,"tag":"SME"},{"start":28,"end":35,"tag":"health"},{"start":36,"end":41,"tag":"call"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467321913350832128","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467313659828772865"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_467313658914426881"]}},{"text":"RT @Europarl_EN: Coming to #EUOpenDoors? Save our @Foursquare list @ https://t.co/yn6VX4Obul and try to do it all in 1 day! #WeDareYou http…","id":"467321645578080257","created_at":"2014-05-16T15:12:17.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":50,"end":61,"username":"Foursquare","id":"804341497441255424"}],"urls":[{"start":69,"end":92,"url":"https://t.co/yn6VX4Obul","expanded_url":"https://foursquare.com/europarl_en/list/eu-open-doors-brussels-2014","display_url":"foursquare.com/europarl_en/li…"}],"annotations":{},"hashtags":[{"start":27,"end":39,"tag":"EUOpenDoors"},{"start":124,"end":134,"tag":"WeDareYou"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467321645578080257","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467303472686444544"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Ulunar #Breezhaler (#indacaterol / #glycopyrronium bromide), a #medicine for #COPD: http://t.co/qwOOOTnNRg","id":"467300040906907648","created_at":"2014-05-16T13:46:26.000Z","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/qwOOOTnNRg","expanded_url":"http://bit.ly/1j25GE7","display_url":"bit.ly/1j25GE7"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"Ulunar"},{"start":37,"end":48,"tag":"Breezhaler"},{"start":50,"end":62,"tag":"indacaterol"},{"start":65,"end":80,"tag":"glycopyrronium"},{"start":93,"end":102,"tag":"medicine"},{"start":107,"end":112,"tag":"COPD"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467300040906907648","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda for this week's meeting of our Committee for #AdvancedTherapies: http://t.co/gCM8QqnXZx","id":"467297857058635776","created_at":"2014-05-16T13:37:45.000Z","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/gCM8QqnXZx","expanded_url":"http://bit.ly/1guOhoG","display_url":"bit.ly/1guOhoG"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":73,"end":91,"tag":"AdvancedTherapies"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467297857058635776","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on the draft #VICH guideline 52 on #bioequivalence: http://t.co/kAF9fWVm4o  #veterinary","id":"467297469169434624","created_at":"2014-05-16T13:36:13.000Z","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/kAF9fWVm4o","expanded_url":"http://bit.ly/1fiZXpk","display_url":"bit.ly/1fiZXpk"}],"annotations":{},"hashtags":[{"start":39,"end":44,"tag":"VICH"},{"start":61,"end":76,"tag":"bioequivalence"},{"start":102,"end":113,"tag":"veterinary"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467297469169434624","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The May meeting of our human #medicines committee, #CHMP, is next week. We're publishing highlights on Friday: http://t.co/6Zaee9yuXb","id":"467297066407182336","created_at":"2014-05-16T13:34:37.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/6Zaee9yuXb","expanded_url":"http://bit.ly/1gurZ6L","display_url":"bit.ly/1gurZ6L"}],"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"medicines"},{"start":51,"end":56,"tag":"CHMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467297066407182336","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Commission: Tomorrow EU institutions will open their doors in #Brussels! Come and visit, here's all the info: http://t.co/VWqLlDlD7V…","id":"467296484262940672","created_at":"2014-05-16T13:32:18.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":117,"end":139,"url":"http://t.co/VWqLlDlD7V","expanded_url":"http://bit.ly/1lptBM4","display_url":"bit.ly/1lptBM4"}],"annotations":{},"hashtags":[{"start":69,"end":78,"tag":"Brussels"}]},"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467296484262940672","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467296354487005184"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our paper on implementing best practice with regard to #3Rs in testing of #medicines: http://t.co/C6I09L9G99","id":"467296420446613505","created_at":"2014-05-16T13:32:03.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/C6I09L9G99","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"annotations":{},"hashtags":[{"start":84,"end":88,"tag":"3Rs"},{"start":103,"end":113,"tag":"medicines"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467296420446613505","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our paper on #pharmacokinetics and #pharmacodynamics in #antibacterial medicines: http://t.co/2YDNq69VhV","id":"467296229261869056","created_at":"2014-05-16T13:31:17.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/2YDNq69VhV","expanded_url":"http://bit.ly/1pE8ObL","display_url":"bit.ly/1pE8ObL"}],"annotations":{},"hashtags":[{"start":42,"end":59,"tag":"pharmacokinetics"},{"start":64,"end":81,"tag":"pharmacodynamics"},{"start":85,"end":99,"tag":"antibacterial"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467296229261869056","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: EGA and @EFPIA join forces for an integrated European industrial policy for #pharmaceuticals http://t.co/D0DaGDFaqh #EBS20…","id":"467295632856981504","created_at":"2014-05-16T13:28:55.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":25,"end":31,"username":"EFPIA","id":"52084584"}],"urls":[{"start":110,"end":132,"url":"http://t.co/D0DaGDFaqh","expanded_url":"http://www.egagenerics.com/index.php/press-room/press-releases/2014/318-pharmaceutical-industry-associations-join-forces-for-an-integrated-european-industrial-policy-for-pharmaceuticals-at-the-european-business-summit","display_url":"egagenerics.com/index.php/pres…"}],"annotations":{},"hashtags":[{"start":93,"end":109,"tag":"pharmaceuticals"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467295632856981504","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467286072213651456"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: EGA Vision 2015 http://t.co/myHbg13zoP #patients #quality #value #sustainability #partnership","id":"467295213749551104","created_at":"2014-05-16T13:27:15.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":33,"end":55,"url":"http://t.co/myHbg13zoP","expanded_url":"http://www.egagenerics.com/images/publication/PDF/EGA_Vision_2015.pdf","display_url":"egagenerics.com/images/publica…"}],"annotations":{},"hashtags":[{"start":56,"end":65,"tag":"patients"},{"start":66,"end":74,"tag":"quality"},{"start":75,"end":81,"tag":"value"},{"start":82,"end":97,"tag":"sustainability"},{"start":98,"end":110,"tag":"partnership"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467295213749551104","source":"TweetDeck","lang":"et","referenced_tweets":[{"type":"retweeted","id":"467281519997091840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Attending our MCMi Regulatory Science Symposium June 2-3? http://t.co/NNIrcquEKo There's a hashtag for that. #FDARegSci","id":"467294960585564160","created_at":"2014-05-16T13:26:15.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":72,"end":94,"url":"http://t.co/NNIrcquEKo","expanded_url":"http://ht.ly/wSrzx","display_url":"ht.ly/wSrzx"}],"annotations":[{"start":28,"end":60,"probability":0.3088,"type":"Organization","normalized_text":"MCMi Regulatory Science Symposium"}],"hashtags":[{"start":123,"end":133,"tag":"FDARegSci"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467294960585564160","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467277131085803520"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Commission: Help us make it easier for you to interact with the @EU_Commission online. Take this survey: http://t.co/zzVA3wN8MY","id":"467294887818592258","created_at":"2014-05-16T13:25:57.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":71,"end":85,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":112,"end":134,"url":"http://t.co/zzVA3wN8MY","expanded_url":"http://svy.mk/1tUasbl","display_url":"svy.mk/1tUasbl"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467294887818592258","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467274623202373632"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: #Sday9 If you are not coming to our Stakeholders' Day, watch the event on-line on 21 May http://t.co/KSxFKdLvAE http://t.co/xH…","id":"467294620486234112","created_at":"2014-05-16T13:24:54.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":102,"end":124,"url":"http://t.co/KSxFKdLvAE","expanded_url":"http://bit.ly/1k1PmmQ","display_url":"bit.ly/1k1PmmQ"}],"annotations":{},"hashtags":[{"start":13,"end":19,"tag":"Sday9"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467294620486234112","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467269791687118851"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Refusal of a national licence for Sodium chloride APL 500 mg capsule http://t.co/8StnGSO47l","id":"467294376566464512","created_at":"2014-05-16T13:23:55.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":81,"end":103,"url":"http://t.co/8StnGSO47l","expanded_url":"http://bit.ly/1hQPWzK","display_url":"bit.ly/1hQPWzK"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467294376566464512","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda for this week's meeting of the Committee for #AdvancedTherapies is now available: http://t.co/gCM8QqnXZx","id":"467249644087820288","created_at":"2014-05-16T10:26:10.000Z","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/gCM8QqnXZx","expanded_url":"http://bit.ly/1guOhoG","display_url":"bit.ly/1guOhoG"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":57,"end":75,"tag":"AdvancedTherapies"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467249644087820288","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSAJournal: #Schmallenberg virus: State of Art http://t.co/40Io7ypc1R","id":"467247963400843265","created_at":"2014-05-16T10:19:30.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"urls":[{"start":52,"end":74,"url":"http://t.co/40Io7ypc1R","expanded_url":"http://bit.ly/1jliPJM","display_url":"bit.ly/1jliPJM"}],"annotations":{},"hashtags":[{"start":17,"end":31,"tag":"Schmallenberg"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467247963400843265","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467247715819462656"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Consumer: In #Brussels tomorrow? Join us at #EUOpenDoors for our debate w. #Consumer Affairs Director @DespinaSpanou, 14:00 CET http…","id":"467247671238221824","created_at":"2014-05-16T10:18:20.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":109,"end":123,"username":"DespinaSpanou","id":"234453946"}],"urls":{},"annotations":{},"hashtags":[{"start":20,"end":29,"tag":"Brussels"},{"start":51,"end":63,"tag":"EUOpenDoors"},{"start":82,"end":91,"tag":"Consumer"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467247671238221824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467247451850956801"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: About 3000 new substances were registered before the 2013 deadline. ECHA’s general report for 2013 gives more details http://t…","id":"467243308977504257","created_at":"2014-05-16T10:01:00.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467243308977504257","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467243248155893761"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_OSHA: No plans for wknd? This Sat, #EU institutions will have #euopendoors day in #Brussels. More info - http://t.co/FCyE5jMLJO","id":"467234016517959680","created_at":"2014-05-16T09:24:04.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_OSHA","id":"23600999"}],"urls":[{"start":112,"end":134,"url":"http://t.co/FCyE5jMLJO","expanded_url":"http://ow.ly/wUpqq","display_url":"ow.ly/wUpqq"}],"annotations":{},"hashtags":[{"start":42,"end":45,"tag":"EU"},{"start":69,"end":81,"tag":"euopendoors"},{"start":89,"end":98,"tag":"Brussels"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467234016517959680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467232977463037952"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: In 2013, the EMA released 81 positive opinions for new medicines of which 16 were for cancer. http://t.co/qP8F4xlKkh","id":"467227138283016192","created_at":"2014-05-16T08:56:45.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":107,"end":129,"url":"http://t.co/qP8F4xlKkh","expanded_url":"http://bit.ly/1nR02Ij","display_url":"bit.ly/1nR02Ij"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"467227138283016192","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: \"One of our biggest successes is revitalised international cooperation with the EMA and other agencies\" G. Cessak","id":"467225271083761664","created_at":"2014-05-16T08:49:19.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"annotations":[{"start":95,"end":97,"probability":0.3976,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"467225271083761664","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Antibiotic-resistant bacteria as a global emergency: the first global report from the WHO http://t.co/8xyVcI6OlY","id":"467223588291235840","created_at":"2014-05-16T08:42:38.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":110,"end":132,"url":"http://t.co/8xyVcI6OlY","expanded_url":"http://bit.ly/1nQXSIE","display_url":"bit.ly/1nQXSIE"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467223588291235840","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on the draft #VICH guideline 52 on #bioequivalence: http://t.co/kAF9fWVm4o #veterinary","id":"467223328114372608","created_at":"2014-05-16T08:41:36.000Z","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/kAF9fWVm4o","expanded_url":"http://bit.ly/1fiZXpk","display_url":"bit.ly/1fiZXpk"}],"annotations":{},"hashtags":[{"start":39,"end":44,"tag":"VICH"},{"start":61,"end":76,"tag":"bioequivalence"},{"start":101,"end":112,"tag":"veterinary"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467223328114372608","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Registration now open for the June workshop of the European Network of #Paediatric #Research at the EMA (#EnprEMA): http://t.co/35ctY5eV9C","id":"467221881100435457","created_at":"2014-05-16T08:35:51.000Z","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/35ctY5eV9C","expanded_url":"http://bit.ly/1lsTucC","display_url":"bit.ly/1lsTucC"}],"annotations":{},"hashtags":[{"start":71,"end":82,"tag":"Paediatric"},{"start":83,"end":92,"tag":"Research"},{"start":105,"end":113,"tag":"EnprEMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467221881100435457","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Vokanamet (#canagliflozin / #metformin), a new #medicine for #diabetes, is available on our website: http://t.co/8EiBlRfONP","id":"467221367314997248","created_at":"2014-05-16T08:33:49.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/8EiBlRfONP","expanded_url":"http://bit.ly/RG3Wpx","display_url":"bit.ly/RG3Wpx"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"Vokanamet"},{"start":25,"end":39,"tag":"canagliflozin"},{"start":42,"end":52,"tag":"metformin"},{"start":61,"end":70,"tag":"medicine"},{"start":75,"end":84,"tag":"diabetes"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467221367314997248","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes of the March meeting of our committee for #herbal medicines are available on our website: http://t.co/nROoJnZ1U4","id":"467221098267168768","created_at":"2014-05-16T08:32:45.000Z","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/nROoJnZ1U4","expanded_url":"http://bit.ly/1jiwRvE","display_url":"bit.ly/1jiwRvE"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":55,"end":62,"tag":"herbal"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467221098267168768","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Apply now for our #EudraVigilance #training course in June on electronic reporting of individual case safety reports: http://t.co/G3WbTHlJs0","id":"467220675154165760","created_at":"2014-05-16T08:31:04.000Z","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/G3WbTHlJs0","expanded_url":"http://bit.ly/1jixcyA","display_url":"bit.ly/1jixcyA"}],"annotations":{},"hashtags":[{"start":18,"end":33,"tag":"EudraVigilance"},{"start":34,"end":43,"tag":"training"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467220675154165760","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: New issue of 'Information' from the Swedish medicines agency http://t.co/afH2tR3E7X","id":"467220312460120064","created_at":"2014-05-16T08:29:37.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":73,"end":95,"url":"http://t.co/afH2tR3E7X","expanded_url":"http://bit.ly/1nQVIss","display_url":"bit.ly/1nQVIss"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467220312460120064","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our human #medicines committee, #CHMP, meets next week. Highlights published on Friday: http://t.co/6Zaee9yuXb","id":"467219541698019328","created_at":"2014-05-16T08:26:33.000Z","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/6Zaee9yuXb","expanded_url":"http://bit.ly/1gurZ6L","display_url":"bit.ly/1gurZ6L"}],"annotations":{},"hashtags":[{"start":10,"end":20,"tag":"medicines"},{"start":32,"end":37,"tag":"CHMP"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"467219541698019328","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our paper on implementing best practice with regard to #3Rs in testing of #medicines: http://t.co/C6I09L9G99","id":"467218761461026816","created_at":"2014-05-16T08:23:27.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/C6I09L9G99","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"annotations":{},"hashtags":[{"start":84,"end":88,"tag":"3Rs"},{"start":103,"end":113,"tag":"medicines"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467218761461026816","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our paper on #pharmacokinetics and #pharmacodynamics in #antibacterial medicines: http://t.co/2YDNq69VhV","id":"467218134949437440","created_at":"2014-05-16T08:20:58.000Z","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/2YDNq69VhV","expanded_url":"http://bit.ly/1pE8ObL","display_url":"bit.ly/1pE8ObL"}],"annotations":{},"hashtags":[{"start":42,"end":59,"tag":"pharmacokinetics"},{"start":64,"end":81,"tag":"pharmacodynamics"},{"start":85,"end":99,"tag":"antibacterial"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"467218134949437440","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Latest #MERS-CoV data: 621 confirmed cases, 188 deaths by 16 May. Includes 2nd Dutch case. http://t.co/CTUaF6tPCt http://t.co…","id":"467217138445729792","created_at":"2014-05-16T08:17:00.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":105,"end":127,"url":"http://t.co/CTUaF6tPCt","expanded_url":"http://bit.ly/1jOPWVO","display_url":"bit.ly/1jOPWVO"}],"annotations":{},"hashtags":[{"start":21,"end":26,"tag":"MERS"}]},"public_metrics":{"retweet_count":85,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467217138445729792","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467216894890881025"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: EFPIA's latest newsletter is HERE!!! ---&gt; http://t.co/MchuAtlVtc","id":"467217041142075392","created_at":"2014-05-16T08:16:37.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":56,"end":78,"url":"http://t.co/MchuAtlVtc","expanded_url":"http://bit.ly/1oweA03","display_url":"bit.ly/1oweA03"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467217041142075392","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467216222338416640"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA Management Board appoints Bernhard Url as EFSA’s next Executive Director: http://t.co/mrBmmZ8mzx","id":"467215501924769792","created_at":"2014-05-16T08:10:30.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":93,"end":115,"url":"http://t.co/mrBmmZ8mzx","expanded_url":"http://bit.ly/1lGLUxU","display_url":"bit.ly/1lGLUxU"}],"annotations":[{"start":45,"end":56,"probability":0.661,"type":"Person","normalized_text":"Bernhard Url"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467215501924769792","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467209154944593920"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Update on human infection with avian influenza #H7N9 http://t.co/4N3izu3ujT","id":"467215384538779649","created_at":"2014-05-16T08:10:02.000Z","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":62,"end":84,"url":"http://t.co/4N3izu3ujT","expanded_url":"http://goo.gl/iNRVhJ","display_url":"goo.gl/iNRVhJ"}],"annotations":{},"hashtags":[{"start":56,"end":61,"tag":"H7N9"}]},"public_metrics":{"retweet_count":60,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467215384538779649","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467207269420392448"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @toxicovigilance: ECDD critical review: Tapentadol http://t.co/aKc7pLcTUI","id":"467215114127822848","created_at":"2014-05-16T08:08:58.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"urls":[{"start":54,"end":76,"url":"http://t.co/aKc7pLcTUI","expanded_url":"http://www.who.int/entity/medicines/areas/quality_safety/4_1_Review.pdf?ua=1","display_url":"who.int/entity/medicin…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467215114127822848","source":"TweetDeck","lang":"fr","referenced_tweets":[{"type":"retweeted","id":"467205824990158849"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @toxicovigilance: 36th ECDD critical reviews have been published by WHO http://t.co/Bu4SskIapM They are…","id":"467214948515733504","created_at":"2014-05-16T08:08:18.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"toxicovigilance","id":"2291691778"}],"urls":[{"start":75,"end":97,"url":"http://t.co/Bu4SskIapM","expanded_url":"http://www.who.int/medicines/areas/quality_safety/36thecddmeet/en/","display_url":"who.int/medicines/area…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"467214948515733504","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"467205750016987136"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've issued a draft #guideline on clinical investigation of medicines for juvenile idiopathic #arthritis: http://t.co/e8ob3WkCkE","id":"466979839556468736","created_at":"2014-05-15T16:34:04.000Z","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/e8ob3WkCkE","expanded_url":"http://bit.ly/1lClYUk","display_url":"bit.ly/1lClYUk"}],"annotations":{},"hashtags":[{"start":21,"end":31,"tag":"guideline"},{"start":95,"end":105,"tag":"arthritis"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466979839556468736","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSApanel renewal: #EFSA is looking for #toxicologists. Apply online http://t.co/osrcX2XG6R","id":"466979499687817216","created_at":"2014-05-15T16:32:43.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":83,"end":105,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":33,"end":38,"tag":"EFSA"},{"start":54,"end":68,"tag":"toxicologists"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466979499687817216","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466910898809229312"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EASDnews: Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity - full article: http://t…","id":"466979429638742016","created_at":"2014-05-15T16:32:26.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466979429638742016","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466912943788269568"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EPHA_EU: Tackling #age-related diseases through better prevention:http://t.co/eqyaKDFsaR (by MEPs @RTaylor_MEP, @GrosseteteF &amp; HeinzK.B…","id":"466978492534784000","created_at":"2014-05-15T16:28:43.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":102,"end":114,"username":"RTaylor_MEP","id":"2649558469"},{"start":116,"end":128,"username":"GrosseteteF","id":"472043689"}],"urls":[{"start":70,"end":92,"url":"http://t.co/eqyaKDFsaR","expanded_url":"http://bit.ly/1jiqQ2e","display_url":"bit.ly/1jiqQ2e"}],"annotations":{},"hashtags":[{"start":22,"end":26,"tag":"age"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466978492534784000","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466916447151988737"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Interested in IMI-JDRF diabetes patient focus meeting but can't attend? Live webstreaming available to all on 20/5 http://t.co/…","id":"466977548799606784","created_at":"2014-05-15T16:24:58.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466977548799606784","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466959965610319872"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: €9 million EU research programme in Autism described as ‘groundbreaking’ http://t.co/qjGRwPpVFQ","id":"466977109676933120","created_at":"2014-05-15T16:23:13.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":94,"end":116,"url":"http://t.co/qjGRwPpVFQ","expanded_url":"http://www.thejournal.ie/funding-autism-1466079-May2014/","display_url":"thejournal.ie/funding-autism…"}],"annotations":[{"start":32,"end":33,"probability":0.5075,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466977109676933120","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466973479548379136"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@alljoinjack Thanks for your message. If you have a query please send it to us at http://t.co/WmzsxywJC8 so we can reply to you directly.","id":"466977010896887808","created_at":"2014-05-15T16:22:50.000Z","entities":{"mentions":[{"start":0,"end":12,"username":"alljoinjack","id":"554667907"}],"urls":[{"start":82,"end":104,"url":"http://t.co/WmzsxywJC8","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"466909578588725248","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"466909578588725248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"554667907"},{"text":"We're holding a #EudraVigilance #training course in June on electronic reporting of individual case safety reports:  http://t.co/G3WbTHlJs0","id":"466926729286914048","created_at":"2014-05-15T13:03:02.000Z","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/G3WbTHlJs0","expanded_url":"http://bit.ly/1jixcyA","display_url":"bit.ly/1jixcyA"}],"annotations":{},"hashtags":[{"start":16,"end":31,"tag":"EudraVigilance"},{"start":32,"end":41,"tag":"training"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"466926729286914048","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've just published the #minutes of our  committee for #herbal medicines: http://t.co/nROoJnZ1U4","id":"466925846515945472","created_at":"2014-05-15T12:59:31.000Z","entities":{"mentions":{},"urls":[{"start":75,"end":97,"url":"http://t.co/nROoJnZ1U4","expanded_url":"http://bit.ly/1jiwRvE","display_url":"bit.ly/1jiwRvE"}],"annotations":{},"hashtags":[{"start":25,"end":33,"tag":"minutes"},{"start":56,"end":63,"tag":"herbal"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466925846515945472","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Vokanamet, a #medicine for #diabetes: http://t.co/8EiBlRfONP","id":"466913115788300288","created_at":"2014-05-15T12:08:56.000Z","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/8EiBlRfONP","expanded_url":"http://bit.ly/RG3Wpx","display_url":"bit.ly/RG3Wpx"}],"annotations":{},"hashtags":[{"start":42,"end":52,"tag":"Vokanamet"},{"start":56,"end":65,"tag":"medicine"},{"start":70,"end":79,"tag":"diabetes"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466913115788300288","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Register for the June workshop of the European Network of #Paediatric #Research at the EMA: http://t.co/35ctY5eV9C","id":"466893511267450880","created_at":"2014-05-15T10:51:02.000Z","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/35ctY5eV9C","expanded_url":"http://bit.ly/1lsTucC","display_url":"bit.ly/1lsTucC"}],"annotations":{},"hashtags":[{"start":58,"end":69,"tag":"Paediatric"},{"start":70,"end":79,"tag":"Research"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466893511267450880","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Registration for the Helsinki Chemicals Forum closes tomorrow. There are still a few seats left, so register now at http://t.c…","id":"466878031592955904","created_at":"2014-05-15T09:49:31.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":[{"start":34,"end":57,"probability":0.3694,"type":"Organization","normalized_text":"Helsinki Chemicals Forum"}],"hashtags":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466878031592955904","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466877737807151105"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a draft #guideline on clinical investigation of medicines for juvenile idiopathic #arthritis: http://t.co/e8ob3WkCkE","id":"466865569925718016","created_at":"2014-05-15T09:00:00.000Z","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/e8ob3WkCkE","expanded_url":"http://bit.ly/1lClYUk","display_url":"bit.ly/1lClYUk"}],"annotations":{},"hashtags":[{"start":24,"end":34,"tag":"guideline"},{"start":98,"end":108,"tag":"arthritis"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466865569925718016","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #FoodEnzymes, EFSA expert call, #Pesticide guidance, #EuropeDay. This and more on the EFSA Highlights newsletter http://t.co/N…","id":"466864576169254912","created_at":"2014-05-15T08:56:03.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{},"hashtags":[{"start":13,"end":25,"tag":"FoodEnzymes"},{"start":45,"end":55,"tag":"Pesticide"},{"start":66,"end":76,"tag":"EuropeDay"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466864576169254912","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466678091797262338"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Were you unable to attend the annual EURORDIS Membership Meeting? Read the eNews  report - available in 7 languages!  http://…","id":"466864340327743488","created_at":"2014-05-15T08:55:07.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466864340327743488","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466831915144978432"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: ECHA's general report 2013: successful entry into operation of the Biocidal Products Regulation. Read more http://t.co/aYtJ0kA…","id":"466864297294192640","created_at":"2014-05-15T08:54:57.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":[{"start":80,"end":107,"probability":0.3839,"type":"Organization","normalized_text":"Biocidal Products Regulation"}],"hashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466864297294192640","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466833823754616832"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've made a proposal with @US_FDA to support the investigation of new #medicines for #Gaucher disease in children: http://t.co/aULlYIEQlT","id":"466863192162185216","created_at":"2014-05-15T08:50:33.000Z","entities":{"mentions":[{"start":27,"end":34,"username":"US_FDA","id":"208120290"}],"urls":[{"start":116,"end":138,"url":"http://t.co/aULlYIEQlT","expanded_url":"http://bit.ly/1hLCVaF","display_url":"bit.ly/1hLCVaF"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"medicines"},{"start":86,"end":94,"tag":"Gaucher"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466863192162185216","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've reinforced our cooperation with @EU_ECHA in a memorandum of understanding: http://t.co/NS592rGIYf","id":"466862550186229760","created_at":"2014-05-15T08:48:00.000Z","entities":{"mentions":[{"start":38,"end":46,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":81,"end":103,"url":"http://t.co/NS592rGIYf","expanded_url":"http://bit.ly/1lyotaf","display_url":"bit.ly/1lyotaf"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466862550186229760","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @cancereu: all you need to know abt treatment of Metastatic #HER2 Positive #BreastCancer in one place http://t.co/603KWYQcbv","id":"466623574653292544","created_at":"2014-05-14T16:58:24.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":[{"start":105,"end":127,"url":"http://t.co/603KWYQcbv","expanded_url":"http://bit.ly/1jg94wt","display_url":"bit.ly/1jg94wt"}],"annotations":{},"hashtags":[{"start":63,"end":68,"tag":"HER2"},{"start":78,"end":91,"tag":"BreastCancer"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466623574653292544","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466622391414571008"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Excitement is building for #WorldHepatitisDay! Dont miss out- like the World Hepatitis Day FB page to stay up-2-date! htt…","id":"466619539317587969","created_at":"2014-05-14T16:42:22.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":[{"start":89,"end":107,"probability":0.6496,"type":"Other","normalized_text":"World Hepatitis Day"}],"hashtags":[{"start":45,"end":63,"tag":"WorldHepatitisDay"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466619539317587969","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466619234206744576"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HealthCanada: Risk of serotonin syndrome associated with serotonin blocking drugs used to treat nausea and vomiting http://t.co/el2HRCh…","id":"466612394190708736","created_at":"2014-05-14T16:13:58.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466612394190708736","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466606686325993472"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: #DidYouKnow The key factor in creating a generic medicine is establishing bioequivalence #quality #value #sustainability","id":"466603963971010561","created_at":"2014-05-14T15:40:28.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":{},"annotations":{},"hashtags":[{"start":17,"end":28,"tag":"DidYouKnow"},{"start":106,"end":114,"tag":"quality"},{"start":115,"end":121,"tag":"value"},{"start":122,"end":137,"tag":"sustainability"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466603963971010561","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466603219519827968"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @BushbyKate: Priorities at our @TREAT_NMD  #duchenne discussion included improving regulatory dialogue for therapy devt @alljoinjack @Ha…","id":"466603929179271168","created_at":"2014-05-14T15:40:20.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"},{"start":34,"end":44,"username":"TREAT_NMD","id":"301911808"},{"start":123,"end":135,"username":"alljoinjack","id":"554667907"}],"urls":{},"annotations":{},"hashtags":[{"start":46,"end":55,"tag":"duchenne"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466603929179271168","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466602773346521088"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Clinical pharmacology biosimilar draft guidance now avail. for comment - PDF: http://t.co/lFQ5lIhdUl FR notice: http://t.co/m…","id":"466603793086685184","created_at":"2014-05-14T15:39:48.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":92,"end":114,"url":"http://t.co/lFQ5lIhdUl","expanded_url":"http://ht.ly/wQ9pL","display_url":"ht.ly/wQ9pL"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466603793086685184","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466599700767182848"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: #Pharma policy. Venice. Doesn't get much better. Policymakers, apply now for the @OBShealth summer school. http://t.co/mazmW…","id":"466588436422733824","created_at":"2014-05-14T14:38:46.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":96,"end":106,"username":"OBShealth","id":"254489771"}],"urls":{},"annotations":[{"start":31,"end":36,"probability":0.7535,"type":"Place","normalized_text":"Venice"}],"hashtags":[{"start":15,"end":22,"tag":"Pharma"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466588436422733824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466587859382972416"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Consumer: Help us improve your experience on our websites! What are your reasons for interacting with @EU_Commission? Survey: https:…","id":"466588278096158722","created_at":"2014-05-14T14:38:08.000Z","entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":109,"end":123,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466588278096158722","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466584473744973824"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAWomen: Today is the last day to register for our upcoming public meeting on #pregnancy registries: http://t.co/AtX77uqLZD","id":"466588257367896064","created_at":"2014-05-14T14:38:04.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":106,"end":128,"url":"http://t.co/AtX77uqLZD","expanded_url":"http://ow.ly/wl2nu","display_url":"ow.ly/wl2nu"}],"annotations":{},"hashtags":[{"start":83,"end":93,"tag":"pregnancy"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466588257367896064","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466583855605231616"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've enhanced our cooperation with @EU_ECHA by signing a memorandum of understanding: http://t.co/NS592rGIYf","id":"466580233601441792","created_at":"2014-05-14T14:06:10.000Z","entities":{"mentions":[{"start":36,"end":44,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":87,"end":109,"url":"http://t.co/NS592rGIYf","expanded_url":"http://bit.ly/1lyotaf","display_url":"bit.ly/1lyotaf"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"466580233601441792","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: Project to reduce antibiotic prescribing in primary care wins 2014 NICE Shared Learning Award http://t.co/m6ndixlL9X #NICEco…","id":"466577616670298113","created_at":"2014-05-14T13:55:47.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":109,"end":131,"url":"http://t.co/m6ndixlL9X","expanded_url":"http://beta.nice.org.uk/News/Article/project-to-reduce-antibiotic-prescribing-wins-2014-nice-shared-learning-award","display_url":"beta.nice.org.uk/News/Article/p…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466577616670298113","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466577486407798784"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Commission: What are your reasons for interacting with the @EU_Commission website? Tell us in this survey http://t.co/zzVA3wN8MY","id":"466577500047704067","created_at":"2014-05-14T13:55:19.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":66,"end":80,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":113,"end":135,"url":"http://t.co/zzVA3wN8MY","expanded_url":"http://svy.mk/1tUasbl","display_url":"svy.mk/1tUasbl"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466577500047704067","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466577323115167744"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo: New supervisor for addictive drugs: http://t.co/DLYm7K1mDJ","id":"466577456028483584","created_at":"2014-05-14T13:55:08.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":56,"end":78,"url":"http://t.co/DLYm7K1mDJ","expanded_url":"http://bit.ly/RQmgwr","display_url":"bit.ly/RQmgwr"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466577456028483584","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: Monitoring safety of medicines: EMA presents 1st report on implementation of pharmacovigilance legislation 2 the EC - htt…","id":"466576986941706241","created_at":"2014-05-14T13:53:16.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466576986941706241","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466574942171967488"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: #EC is looking for #experts for #Horizon2020 for #Research &amp; #Innovation @Horizon2020jobs http://t.co/dRmRHN2Ze4 http://t.c…","id":"466574446862815232","created_at":"2014-05-14T13:43:11.000Z","entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":93,"end":109,"username":"Horizon2020jobs","id":"1646388968"}],"urls":[{"start":110,"end":132,"url":"http://t.co/dRmRHN2Ze4","expanded_url":"http://bit.ly/1d7Qmjs","display_url":"bit.ly/1d7Qmjs"}],"annotations":{},"hashtags":[{"start":16,"end":19,"tag":"EC"},{"start":35,"end":43,"tag":"experts"},{"start":48,"end":60,"tag":"Horizon2020"},{"start":65,"end":74,"tag":"Research"},{"start":81,"end":92,"tag":"Innovation"}]},"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466574446862815232","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466573888366071808"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've released a proposal with @US_FDA to help investigation of new #medicines for #Gaucher disease in children: http://t.co/aULlYIEQlT","id":"466574158307270656","created_at":"2014-05-14T13:42:02.000Z","entities":{"mentions":[{"start":31,"end":38,"username":"US_FDA","id":"208120290"}],"urls":[{"start":113,"end":135,"url":"http://t.co/aULlYIEQlT","expanded_url":"http://bit.ly/1hLCVaF","display_url":"bit.ly/1hLCVaF"}],"annotations":{},"hashtags":[{"start":68,"end":78,"tag":"medicines"},{"start":83,"end":91,"tag":"Gaucher"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"466574158307270656","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFA_Patients: .@EMA_News report on #pharmacovigilance: increase of ~9,000 patients reports of suspected adverse drug reactions http://t…","id":"466572308207771648","created_at":"2014-05-14T13:34:41.000Z","entities":{"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":19,"end":28,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":[{"start":39,"end":57,"tag":"pharmacovigilance"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466572308207771648","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466568941150560256"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: \"Researchers discover genetic marker linked to OCD\" http://t.co/MVuwYrNFrK","id":"466572051336007680","created_at":"2014-05-14T13:33:40.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":63,"end":85,"url":"http://t.co/MVuwYrNFrK","expanded_url":"http://bit.ly/1qCDzR7","display_url":"bit.ly/1qCDzR7"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466572051336007680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466564955920424960"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @JeanGeorgesAE: Interested in the @IMI_JU funded EMIF project? Find their latest newsletter here: http://t.co/5IeawNtmsY","id":"466571211670298626","created_at":"2014-05-14T13:30:20.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":37,"end":44,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":101,"end":123,"url":"http://t.co/5IeawNtmsY","expanded_url":"http://emif.eu/emif/news/european-medical-researchers-generate-new-insights-existing-patient-data?utm_source=NewsletterMay2014&utm_medium=email&utm_campaign=EMIFExternalNewsletterMay2014","display_url":"emif.eu/emif/news/euro…"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466571211670298626","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466549456977276928"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Worked w. Regulation EC No 470/2009? Your feedback sought on Maximum Residue Limits #MLR in #veterinary #medicines http://t.…","id":"466570159118102528","created_at":"2014-05-14T13:26:09.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{},"hashtags":[{"start":99,"end":103,"tag":"MLR"},{"start":107,"end":118,"tag":"veterinary"},{"start":119,"end":129,"tag":"medicines"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466570159118102528","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466535670488760320"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRAmedicines: Company-led drug recall: Paclitaxel 6mg/ml concentrate for solution for infusion, 16.7ml - Teva UK Limited - C... http:/…","id":"466570024472567808","created_at":"2014-05-14T13:25:36.000Z","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466570024472567808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466533979034628096"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA: Transatlantic Taskforce on Antimicrobial Resistance reports progress and outcomes of 17 recommendations http://t.co/uU7pj…","id":"466523517530693632","created_at":"2014-05-14T10:20:48.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":18,"end":40,"probability":0.3636,"type":"Organization","normalized_text":"Transatlantic Taskforce"}],"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466523517530693632","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466520245017276416"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @agesnews: EU medicine supervision more and more comprehensive @APA_Science interview with Christa Wirthumer-Hoche http://t.co/jZ50kwSRQM","id":"466516727929790465","created_at":"2014-05-14T09:53:50.000Z","entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":66,"end":78,"username":"APA_Science","id":"550287256"}],"urls":[{"start":118,"end":140,"url":"http://t.co/jZ50kwSRQM","expanded_url":"http://bit.ly/1gCZMF9","display_url":"bit.ly/1gCZMF9"}],"annotations":[{"start":94,"end":110,"probability":0.9632,"type":"Person","normalized_text":"Christa Wirthumer"}],"hashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"466516727929790465","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Scientific advice: guide published on parallel scientific advice pilot for consultation http://t.co/XJzPdaU0Ym","id":"466504706882162688","created_at":"2014-05-14T09:06:04.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":108,"end":130,"url":"http://t.co/XJzPdaU0Ym","expanded_url":"http://bit.ly/1gCMx7x","display_url":"bit.ly/1gCMx7x"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"466504706882162688","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The latest progress report from the Transatlantic Taskforce on #AntimicrobialResistance is now available: http://t.co/sAx42g3Y51","id":"466500906453049344","created_at":"2014-05-14T08:50:57.000Z","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/sAx42g3Y51","expanded_url":"http://bit.ly/1l9FQwa","display_url":"bit.ly/1l9FQwa"}],"annotations":[{"start":36,"end":58,"probability":0.5136,"type":"Organization","normalized_text":"Transatlantic Taskforce"}],"hashtags":[{"start":63,"end":87,"tag":"AntimicrobialResistance"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"466500906453049344","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: What do you know about #AMR? Learn more from report of Transatlantic Taskforce on Antimicrobial Resistance @EMA_News http://t.co…","id":"466494051357716481","created_at":"2014-05-14T08:23:43.000Z","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":118,"end":127,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":93,"end":116,"probability":0.436,"type":"Other","normalized_text":"Antimicrobial Resistance"}],"hashtags":[{"start":34,"end":38,"tag":"AMR"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466494051357716481","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466483959149625344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Check the new progress report from the Transatlantic Taskforce on #AntimicrobialResistance: http://t.co/sAx42g3Y51","id":"466247586375282688","created_at":"2014-05-13T16:04:21.000Z","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/sAx42g3Y51","expanded_url":"http://bit.ly/1l9FQwa","display_url":"bit.ly/1l9FQwa"}],"annotations":[{"start":39,"end":61,"probability":0.4257,"type":"Organization","normalized_text":"Transatlantic Taskforce"}],"hashtags":[{"start":66,"end":90,"tag":"AntimicrobialResistance"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"466247586375282688","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Exciting breakthroughs for diabetes and autism research made by the #EU Innovative Medicines Initiative http://t.co/qw…","id":"466199929552375809","created_at":"2014-05-13T12:54:59.000Z","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{},"hashtags":[{"start":89,"end":92,"tag":"EU"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466199929552375809","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466168477934710784"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: Mechanisms of #VEGF inhibitor-induced #hypertension need better understanding &amp; development of guidelines http://t.co/Qas5WnBRO8","id":"466199345940168704","created_at":"2014-05-13T12:52:40.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":122,"end":144,"url":"http://t.co/Qas5WnBRO8","expanded_url":"http://ow.ly/wMKiU","display_url":"ow.ly/wMKiU"}],"annotations":{},"hashtags":[{"start":26,"end":31,"tag":"VEGF"},{"start":50,"end":63,"tag":"hypertension"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466199345940168704","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466185852373450752"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Medical Devices Introductory Course - understand the regulatory requirements for medical devices http://t.co/tocHVdeph1 #med…","id":"466198904200237056","created_at":"2014-05-13T12:50:55.000Z","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":112,"end":134,"url":"http://t.co/tocHVdeph1","expanded_url":"http://bit.ly/meddevintro","display_url":"bit.ly/meddevintro"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466198904200237056","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466198473285832704"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for Para-aminosalicylic acid Lucane, a new #medicine to treat #tuberculosis: http://t.co/724qFemMKS","id":"466182633958158336","created_at":"2014-05-13T11:46:15.000Z","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/724qFemMKS","expanded_url":"http://bit.ly/1uUk9He","display_url":"bit.ly/1uUk9He"}],"annotations":{},"hashtags":[{"start":68,"end":77,"tag":"medicine"},{"start":87,"end":100,"tag":"tuberculosis"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"466182633958158336","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes from the April meeting of our #veterinary committee are now available: http://t.co/SSbFsTzRGx #CVMP","id":"466182512063283203","created_at":"2014-05-13T11:45:46.000Z","entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/SSbFsTzRGx","expanded_url":"http://bit.ly/1g1y61C","display_url":"bit.ly/1g1y61C"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":43,"end":54,"tag":"veterinary"},{"start":107,"end":112,"tag":"CVMP"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"466182512063283203","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Yesterday we published the highlights from last week's #veterinary committee meeting: http://t.co/hjdbAxxmqO #CVMP","id":"466182361320026113","created_at":"2014-05-13T11:45:10.000Z","entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/hjdbAxxmqO","expanded_url":"http://bit.ly/1sEvGsd","display_url":"bit.ly/1sEvGsd"}],"annotations":{},"hashtags":[{"start":55,"end":66,"tag":"veterinary"},{"start":109,"end":114,"tag":"CVMP"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"466182361320026113","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: How are IMI projects using iPS cells to advance medical research? Find out at #IMIsf2014 on 21/5. Sign up at http://t.co/8alEul…","id":"466165700911198208","created_at":"2014-05-13T10:38:58.000Z","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{},"hashtags":[{"start":90,"end":100,"tag":"IMIsf2014"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"466165700911198208","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"466143036825948160"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm_sante: The French medicines agency has published news on topics discussed the last monthly #PRAC meeting http://t.co/bVums15shH","id":"465887596217110529","created_at":"2014-05-12T16:13:53.000Z","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/bVums15shH","expanded_url":"http://bit.ly/1oIPF6C","display_url":"bit.ly/1oIPF6C"}],"annotations":{},"hashtags":[{"start":100,"end":105,"tag":"PRAC"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465887596217110529","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights from last week's #veterinary committee meeting. 2 new vaccines for dogs &amp; 2 for pigs: http://t.co/hjdbAxxmqO","id":"465883202973073408","created_at":"2014-05-12T15:56:25.000Z","entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/hjdbAxxmqO","expanded_url":"http://bit.ly/1sEvGsd","display_url":"bit.ly/1sEvGsd"}],"annotations":{},"hashtags":[{"start":48,"end":59,"tag":"veterinary"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465883202973073408","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: European Patients' Rights Day: 10 benefits the EU brings to patients http://t.co/G8yBskLNzu","id":"465882574808940544","created_at":"2014-05-12T15:53:56.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":82,"end":104,"url":"http://t.co/G8yBskLNzu","expanded_url":"http://europa.eu/rapid/press-release_MEMO-14-341_en.htm","display_url":"europa.eu/rapid/press-re…"}],"annotations":[{"start":60,"end":61,"probability":0.438,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465882574808940544","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"465882331891642368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes from the April meeting of our #veterinary committee: http://t.co/SSbFsTzRGx","id":"465871052376387584","created_at":"2014-05-12T15:08:09.000Z","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/SSbFsTzRGx","expanded_url":"http://bit.ly/1g1y61C","display_url":"bit.ly/1g1y61C"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":59,"end":70,"tag":"veterinary"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"465871052376387584","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: More effective medicines for longer. Patent-only pharmacokinetics or increased bioavailability? http://t.co/JfYtgdBD5H","id":"465870010838425600","created_at":"2014-05-12T15:04:00.000Z","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":116,"end":138,"url":"http://t.co/JfYtgdBD5H","expanded_url":"http://bit.ly/1g1xxVz","display_url":"bit.ly/1g1xxVz"}],"annotations":{},"hashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"465870010838425600","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for Para-aminosalicylic acid Lucane, a new #medicine to treat #tuberculosis: http://t.co/bympBTWuJT","id":"465861406844153857","created_at":"2014-05-12T14:29:49.000Z","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/bympBTWuJT","expanded_url":"http://bit.ly/1uUk9He","display_url":"bit.ly/1uUk9He"}],"annotations":{},"hashtags":[{"start":81,"end":90,"tag":"medicine"},{"start":100,"end":113,"tag":"tuberculosis"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"465861406844153857","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSApanel renewal: #EFSA is looking for #biochemists for its #GMO panel. Apply online http://t.co/osrcX2XG6R","id":"465855713592737792","created_at":"2014-05-12T14:07:11.000Z","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":100,"end":122,"url":"http://t.co/osrcX2XG6R","expanded_url":"http://bit.ly/1kq13Gw","display_url":"bit.ly/1kq13Gw"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"EFSApanel"},{"start":33,"end":38,"tag":"EFSA"},{"start":54,"end":66,"tag":"biochemists"},{"start":75,"end":79,"tag":"GMO"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"465855713592737792","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"465853914295070720"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}}]
